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SUMMARY 
The effects of inhaled aIr pollution particles on lung clearance mechanisms is an 
important factor in understanding how the mammalian lung deals with such pollutants 
and, as such, how exposure to these pollutants can be regulated. The nanoparticle 
(diameter S lOOnm) and transition metal components of PMIO (particulate matter with a 
diameter less than lO~m) have been implicated as playing major roles in the impairment 
of alveolar macrophage function and the subsequent retention of particles in the 
respiratory system. The aim ofthis study was to investigate the effects of components of 
PMIO on macrophage functions both directly, by examining macrophage phagocytosis 
and migration, and indirectly, by studying peripheral factors affecting macrophage 
function such as recruitment by type II cells and complement based mechanisms. 
We hypothesised that the alveolar epithelial type II cell line would release leukocyte 
chemoattractants in response to particle exposure and that this could be measured by use 
of a macrophage migration assay. A sub-toxic dose (125 ~g/ml)of surrogate air pollution 
particles (fine and nanoparticle carbon black and titanium dioxide) was established by 
measuring LOH release from a murine alveolar macrophage cell line (1774.2) and an 
alveolar epithelial type II cell line (L-2) in response to particle exposure. Optimisation of 
a chemotaxis assay and measurement of macrophage migration towards conditioned 
medium obtained from the particle-exposed type II cells was conducted and it was 
determined that carbon black nanoparticles induced type II cells to secrete a 
chemoattractant that resulted in significant increases in macrophage migration compared 
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to the negative control. This was in contrast to other particle types tested in this study 
which did not induce any increases in macrophage migration. 
It was also hypothesised that complement proteins could be involved in macrophage 
recruitment to sites of particle deposition and, as such, the migration of macrophages 
towards particle exposed blood serum was examined in vitro. Foetal bovine serum (FBS) 
was exposed to fine and nanoparticle caroon black and titanium dioxide (l-Smg/ml) for 2 
hours. It was found, in accord with the previous study involving type II cells, that carbon 
black nanoparticles could activate the generation of chemotactic factors in serum that 
could subsequently induce significant increases (p<0.001) in macrophage migration when 
serum was diluted to 10% using serum-free RPMI 1640 culture medium. This effect 
could be ameliorated by co-incubating the particle-treated serum in the presence of the 
antioxidant Trolox suggesting that oxidative stress played a role in the generation of the 
chemoattractant molecules. However, incubation of the serum with a pure oxidant'l;lt a 
range of doses did not result in the generation of chemotactic molecules suggesting that 
another factor could be involved in the chemoattractant generation. Further investigation 
to determine the exact molecular mechanism behind the chemoattractant generation is 
warranted. 
In contrast to the previous studies, we have also found evidence that components ofPMJO 
can cause decreased efficacy of macrophage clearance mechanisms in vivo and in vitro. 
It was hypothesised that PMIO instillation would result in a decrease in macrophage 
phagocytic potential and an increase in chemotactic potential ex vivo. Rats were instilled 
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with 125 and 250J.lg of PMIO collected from North Kensington, London or sterile saline 
(negative control). Post-instillation (18 hours), significantly elevated concentrations of 
TNFa were detected in the BAL fluid together with a significant increase in the number 
of BAL neutrophils. Phagocytosis and chemotaxis assays conducted with BAL 
macrophages ex vivo showed that macrophage migration towards a positive 
chemoattractant, Zymosan Activated Serum (ZAS), was significantly lower than the 
macrophages obtained from the negative control rats. Macrophage phagocytosis of latex 
beads ex vivo was also found to be significantly decreased when PMIO was visible inside 
the cell. An in vitro study where a macrophage cell line (J774.Al) was exposed to a low 
dose of Qanoparticle carbon black (31.25J.lg) together with varying concentrations 
, 
(100J.lM - lOOnM) of zinc chloride (ZnCh) was also conducted Exposure "of 
macrophages to nanoparticle carbon black and zinc chloride alone induced a decrease in 
macrophage phagocytosis. It was found that when macrophages were co-exposed ,to 
nanoparticle carbon black and ZnCh, there was an additive decrease in macroph4ge 
.... ~ 
phagocytic potential. 
The resul~ contained within this manuscript demonstrate that the components of PMIO 
can induce adverse effects on specific aspects of macrophage clearance mechanisms, but 
that nanoparticles can also stimulate the production of chemoattractants to aid in the 
recruitment of phagocytes and subsequent particle clearance. Although a contrary 
relationship appears to exist between these findings, the recruitment of leukocytes in 
response to particulate exposure is a mechanism that supports particle clearance. 
However, the retardation of phagocytic and chemotactic mechanisms in particle exposed 
VII 
macrophages may help to explain the increased toxicity, inflammation and retention time 
observed with nanoparticle inhalation. 
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and bioparticles are represented by the red outline area. 1774.Al cells co-
treated with lOJ.1M ZnCh / 3125J.Lg nanoparticle carbon black and then 
bioparticles are represented by the purple area. 
Table 5.5.8 Mean fluorescence data for gated population of treated and untreated 
1774.Al cells. 
Figure 5.5.9 Graph displaying the fluorescence for each cell treatment as a % of the 
fluorescence from the positive control cells. Results shown are from two 
repeated experiments. The purple bars represent the data from the first 
experiment and the red bars represent the data from the second 
experiment. 
Figure 6.1 The hypothesised consequences of nanoparticle entry into the alveolar 
region of the lung. 
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CHAPTERl 
GENERAL INTRODUCTION 
1 
1.1 GROSS ANATOMY OF THE MAMMALIAN LUNG 
The lung has evolved to act as the respiratory centre for mammals and, as such, is the 
area where gaseous exchange between the organism and the environment takes place. 
The body's blood supply is supplied to the lungs via the pulmonary artery and in the 
lungs the blood is oxygenated and carbon dioxide is removed. The oxygenated blood 
then flows out of the lungs via the pulmonary vein which returns the blood to the left 
atrium of the heart, ready for transport around the rest of the body. Since the body's 
blood supply passes through the lungs, they are therefore exposed to any systemic toxins 
or inflammatory substances contained within the blood that perfuses the lung tissue. In 
addition, the respiratory tissues will also be exposed to any potentially toxic substances 
present in inhaled air. 
Structurally the lung can be separated into two distinct areas; the conducting zone and the 
respiratory zone. The conducting zone leads from the pharynx down the trachea to the 
bronchi and terminal bronchioles and is concerned with the transport of air into the 
respiratory section of the lung. The respiratory zone is where gas exchange takes place 
and is a honeycombed area of respiratory bronchioles, alveolar sacs and alveoli (Tortora 
& Grabowski, 1992). Humans possess up to 23 branching airway generations from the 
proximal bronchi to the distal alveoli (Malpel & Cardroso, 2001). 
There are many types of cells which make up the various areas of the lung and these 
differ from region to region depending on the structural and functional requirements of a 
particular area. The varying cell types are exposed to differing concentrations and 
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compositions of inhaled material and as such, can respond in a different manner to a 
given material as is shown in subsequent chapters. 
1.2 CELLS OF THE LUNG 
Type U alveolar -----~ 
(septal) ceU 
Alveo\ar-
capillary 
(respiratory) 
membrane 
Type I alve 
(squamous 
pulmonary 
epithelial) cell 
Alveo\ar-----~ 
macrophage 
Red blood cell-------
Figure 1.1 - .Qlustration of cells in the alveolar region of a mammalian lung (picture 
taken from Principals of Anatomy and Physiology, 5th Ed., Tortora & Grabowski) 
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1.2.1 Type n Epithelial Cells 
The type II epithelial cells make up around 15% of the total number oflung cells but only 
covers around 5-7% of the alveolar surface (Dobbs, 1990). Type II cells have several 
important functions including maintaining the alveolar structure, as well as participating 
in the physiological and biochemical processes that occur in the lung (Simon & Paine III, 
1995). The type II cells are cuboidal in shape but the size depends upon the state oflung 
growth and repair (Dobbs, 1990). A study of human lung cells by Crapo et ai., (1982) 
found that the mean diameter of the cell nuclei was around 7.5 J.Ull but this can vary in 
other mammals (Dobbs, 1990). The cells have a microvillous apical surface and can be 
identified by the presence of lamella bodies within the cytoplasm (Fehrenbach, 2001). 
The type II cell has several roles in maintaining the structural and biochemical 
homeostasis of the lung. Arguably, the most important function of type II cells is the 
production and secretion of lung surfactant, a complex mixture of lipids, including 
several types of phospholipids, and several proteins such as Apoprotein A (utilised in 
surfactant homeostasis). The surfactant generates a low surface tension and, as a result, 
prevents alveolar collapse and ensures equal gaseous exchange over the surface of the 
alveoli (Dormans & van Bree, 1995). Although surfactant components can be generated 
by other types of cells such as Clara cells, the type II cell is the only cell that is capable of 
producing all of the substances required for the surfactant. The type II cells also take-up, 
metabolise and re-secrete up to 85% of the surfactant in order to maintain a novel and 
steady supply of surfactant (Fehrenbach, 2001). 
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Another important function of the type II cells is their almost unlimited capacity to 
proliferate and differentiate into type I cells in response to injury. This is important in 
maintaining the structural integrity of the lung following cell death (Fehrenbach, 2001 
and Adamson & Bowden, 1974). The cell death/proliferation cycle is carefully 
maintained in order to create a balance in the number of cells. Although type II cells are 
relatively resistant to injury due to high intracellular levels of antioxidants and xenobiotic 
metabolising enzymes, damage can occur to the cells (Cross, 1974). However, it is still 
not understood if all type II cells can act as stem cells, as opposed to just a small sub-
population possessing this capacity (Uhal, 1997). Fehrenbach (2001) also reviewed the 
capacity of the alveolar type II cells to phagocytose apoptotic type II cells, further aiding 
the balance in cell death and renewal. However, the proliferative ability of the type II 
cells must be controlled as abnormal proliferation may result in the development of lung 
tumours such as adenocarcinomas (Tsutahara et aI., 1993). 
The final and equally important major function of the type II cells is the ability to 
communicate with other cells, including adjacent epithelial pneumocytes, but, more 
importantly, the mobile cells such as neutrophils and alveolar macrophages (Fehrenbach, 
2001). This interaction with leukocytes enables the type II cells to signal to the 
macrophages that are already present in the alveolar space, as well as recruiting 
circulating macrophages to local sites of pulmonary inflammation such as that induced by 
respirable particulate deposition. It has been shown that type II cells can secrete many 
chemoattractants including interkeukin-8 (IL-8), macrophage inflammatory proteins 1 
and 2 (MIP-l & MIP-2), RANTES, granulocyte monocyte - colony stimulating factor 
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(GM-CSF) and tumour necrosis factor alpha (TNFa) (O'Brien et ai., 1998, Driscoll et ai., 
1996b, Donaldson et al., 2000a, Rosseau et at., 2000). Type II cells have also been 
shown to be capable of secreting proteins of both the alternative and classical 
complement pathways (Strunk et al., 1988). Pre-existing inflammation such as that 
caused by oxidative stress has also been shown to prime type II cells to release excessive 
amounts of inflammatory mediators. This may result in a higher level of cellular injury 
than would otherwise normally be induced by an inflammogenic material (Stringer & 
Kobzik, 1998). 
1.2.2 Type I Epithelial Cells 
Alveolar type I cells cover up to 93% ofthe alveolar surface (Crapo et al., 1982). The 
primary function of the type I cell is to act as a surface for gaseous exchange to take 
place. The type I and type II epithelial cell membranes can overlap and can join together 
by tight junctions which create a relatively solid barrier against the unwanted diffusion of 
electrolytes and hydrophilic solutes. Type I cells contain numerous vesicles and 
membrane buds which are expected to assist in the internalisation of proteins but it is 
unknown which type of transport processes are employed by type I cells compared to 
type II cells (Kim & Malik, 2003). The fluid transport that takes place between the 
alveolar region and the vasculature of the lung is carefully controlled to ensure adequate 
hydration of the alveolar space and swift resolution to any pulmonary oedema, resulting 
from diseases such as congestive heart failure or acute lung injury (Verkman et al., 
2000). Any damage to the epithelial cells can result in increased vascular permeability 
and the sloughing of cells into the air spaces which could result in decreased gas 
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exchange and an increase in pulmonary oedema (Newman et aI., 2000). However, any 
loss of type I cells can be remedied by the differentiation oftype II cells to ensure the 
structural stability of the airspaces (Adamson & Bowden, 1974). 
1.2.3 Neutrophils 
PolymoIphonuclear neutrophils (PMN) are white blood cells that typically comprise up to 
70% of circulating leukocytes in the peripheral blood of individuals in a nonnal 
immunological state. In the lung, the primary function of neutrophils is the phagocytosis 
of inhaled pathogens or particulates. Neutrophils possess a large array of proteolytic 
enzymes and the potential to produce reactive oxygen species to aid in the destruction of 
ingested items. As with macrophages, neutrophils migrate towards a site of localised 
inflammation or opsonised pathogens via the process of chemotaxis and, as such, possess 
a wide range of chemotaxin receptors on their surface. The granules that are contained 
within the neutrophil cytoplasm can contain proteases, acid hydro lases and 
metalloproteinases as well as lysozyme (Faurschou & Borregaard, 2003). The 
degranulation of neutrophils in response to an inflammatory response is carefully 
controlled as excessive production of these toxic substances can result in conditions such 
as septic shock, disseminated intravascular coagulation and, in the lung, acute respiratory 
distress syndrome (ARDS) (Neumann et al., 1999). 
Neutrophil sequestration into the pulmonary vasculature and alveolar space as well as the 
factors involved in recruitment has been investigated in a wide range of disease states. 
Several studies have demonstrated increased neutrophil influx into the lung as a result of 
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an inflammatory response to inhaled particles and, indeed, neutrophils are now 
commonly used as a marker of particle induced pulmonary inflammation (Brown et al., 
1995, Li et al., 1996). Studies have demonstrated increased levels of neutrophil 
chemoattractants in the lungs of individuals with diseases such as idiopathic pulmonary 
fibrosis (IPF) and asthma (Hunninghake et al., 1981 and Teran et al., 1997). In an 
investigation by Drost & MacNee (2002) which examined neutrophil deformability and 
chemotaxis induced by cytokines such as TNFa and IL-8, it was illustrated that both 
cytokines could enhance the neutrophil migratory response as well as increasing the 
response to stimulated cell deformability, a process which is pertinent in neutrophil 
sequestration through the pulmonary vasculature. Increased neutrophil presence in the 
lungs of pollution exposed animals could be correlated with the increased levels of both 
TNFa and MIP-2 that have been shown to occur in the bronchoalveolar lavage (BAL) 
fluid of particle exposed rats (Schins et al., 2004, Becher et al., 2001, Driscoll et al., 
2000). 
1.2.4 Alveolar Macropbages 
Alveolar macrophages are a distinct population of cells that act as the primary defence 
against inhaled particulates and bacteria in the alveolar space. The cells reside in the 
alveolar space in the film of pulmonary surfactant as free cells and are one of four 
pulmonary macrophage populations. Other forms include the pulmonary interstitial 
macrophage, the pulmonary intravascular macrophage and a dendritic "macrophage-like" 
cell which displays some phagocytic ability (Sibelle & Reynolds 1990 and Dorger & 
Krombach, 2000). Macrophages have also been identified in the upper airways which 
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may be alveolar macrophages transported up by the mucociliary escalator (MCE). 
However Brain et ai., (1984) describes the adherence of these macrophages to epithelial 
cells which suggests that they playa role in the removal of deposited elements from the 
airways. 
The alveolar macrophage is the only macrophage population in the body that is exposed 
to environmental air and, as such, this exposure may have some influence upon its 
behaviour (Lohmann-Matthes et ai., 1994 and Sibille & Reynolds, 1990). It is thought 
that the majority of lung macrophages are sourced from the bone marrow and are derived 
from peripheral blood monocytes (Blusse van Oud Ablas et ai., 1979 and Fels & Cohn 
1986). Some studies have also shown that alveolar macrophages may be capable of local 
replication under certain conditions (Shellito et ai., 1987; Tarling & Coggle, 1982 and 
Tarling et aI., 1987). Bitterman et ai., (1984) reported that, under chronic inflammation 
conditions in the lung, alveolar macrophages undergoing mitotic division were present, 
supporting the localised macrophage replication hypothesis. 
The studied functions of the alveolar macrophage have expanded over the past five 
decades to encompass many antimicrobial activities involving phagocytosis of foreign 
bodies, recruitment of other inflammatory cells such as PMNs, and antigen presentation 
(Sibille & Reynolds, 1990 and Fels & Cohn, 1986). Macrophages are capable of 
secreting more than 100 different products which include cytokines, complement 
proteins, fibroblastic growth factors, enzymes and reactive oxygen species. A more 
comprehensive list is detailed in table 1.2. The production ofthese substances is essential 
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to the macrophages primary function i.e. the phagocytosis and removal of foreign 
particulates from the alveolar space in an attempt to maintain a sterile environment. The 
potential for the macrophage to produce an armoury of proteolytic enzymes and reactive 
oxygen species only serves to achieve this goal. The activation and recruitment of 
macrophages to sites of inflammation is described in detail in sections 1.3.3. and 1.3.4. 
1.2.5 Clara Cells 
Clara cells are non-ciliated epithelial cells that are cuboidal in shape and are functionally 
similar to type II epithelial cells in that they are capable of secreting surfactant 
components, especially in the distal airways (McCormack, 2001 and Mills et ai., 1999). 
They also contain high levels of cytochrome P450 for xenobiotic metabolism 
(Widdicombe & Pack, 1982). The Clara cells are located in the terminal and respiratory 
bronchioles and are thought to under go differentiation when acting as stem cells to repair 
ciliated cells of the bronchial epithelium following damage (Bishop, 2004 and Otto, 
2002). They possess a dome-shaped apical projection which protrudes into the lumen 
and contains high numbers of mitochondria and electron dense secretory granules 
(Merceretai., 1994). A limited number of studies have investigated interactions between 
air pollution particles and Clara cells. An important investigation by Murphy et ai., 
(1998) observed that Clara cells exposed to both diesel exhaust and carbon black particles 
showed particle internalisation and decreased biotransformation capability. Finkelstein et 
ai., (1997) also showed increased mRNA expression for the cytokines IL-l, IL-6 and 
TNFa in Clara cells in response to particulate exposure. 
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1.3 LUNG DEFENCE 
1.3.1 Non-Specific Lung Defence Mechanisms 
Complementing the cellular defence mechanisms in the lung such as macrophages and 
neutrophils are physiological adaptations which help to prevent particles and organisms 
from being retained within the lung. The first method of defence includes the hairs lining 
the nose and upper airways. The hairs trap particles and prevent them from entering the 
delicate airways and bronchioles. This prevents some particulates from ever entering an 
area of the airways where an inflammatory response could be initiated. The second stage 
of defence, the mucociliary escalator (MCE), is situated primarily in the proximal 
airways and involves a mucus coating of the airways that generally traps particles that are 
greater than 5 J.l~ in diameter, as well as other respirable matter. The mucus is secreted 
by goblet cells that are part of the lining of the primary airways. Once particles have 
been trapped in the mucus, ciliated cells propel the mucus up towards the oesophagus 
where it can either be expelled or swallowed. Thompson et at., (1995) has also 
demonstrated that mucus has an antioxidant capacity which would help protect the 
pneumocytes from damaging free radicals. 
1.3.2 Lung Surfactant 
Lung surfactant is primarily produced by type II epithelial cells and is released into the 
epithelial lining fluid (ELF) in the gaseous exchange regions of the lung. Surfactant is a 
complex mixture of lipids, including several types of phospholipids such as 
phosphatidylcholine and phosphatidylglycerol, and several proteins, such as Apoprotein 
A (utilised in surfactant homeostasis). The surfactant generates a low surface tension and 
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as a result, prevents alveolar collapse and ensures equalised gaseous exchange over the 
surface of the alveoli (Dormans & Van Bree, 1995). Surfactant has also been reported to 
play an important role in lung defence against oxidants as it is also known to have a high 
antioxidant activity (Matalon et at., 1990 and Lang et at., 2002). Roveri et al., (1989) 
demonstrated that epithelial lining fluid contains antioxidant enzymes such as 
glutathione, glutathione peroxidase, superoxide dismutase and catalase which are all 
involved in the reduction of oxygen. A clever defence mechanism is also in place to 
ensure that the production of surfactant by epithelial cells is not compromised by oxidant 
damage. Brown (1994) illustrated how glutathione protects the signal transduction 
pathways of the type II cells against oxidants to make sure that more surfactant is 
released. 
Surfactant also has an important role concerning phagocytosis and removal of foreign 
particles from the lung. It has been shown that surfactant improves the chemotactic 
responses of pulmonary macrophages, as well as enhancing the phagocytic function of 
the macrophages (LaForce et al., 1973 and Hoffman et al., 1987). Clark et al., (2002) 
also suggested that surfactant proteins promote the rapid removal of apoptotic and 
necrotic macrophages from the lung. 
1.3.3 Macrophages in Pulmonary Homeostasis and Inflammation 
The movement of macrophages towards foreign particles or bacteria that are to be 
phagocytosed is controlled by the process of chemotaxis. Chemotaxis is defined by 
Wilkinson, (1998) as the directed movement of leukocytes towards a chemotactic 
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substance. For macrophages, this can be stimulated by several different signalling 
molecules such as complement proteins, immunoglobulins and members of the cytokine 
family known as chemokines (Fe Is & Cohn, 1986 and Lohmann-Matthes et al., 1994). 
However, there can be differences between species as to which signalling pathway proves 
to be the most effective. For example, it has been shown that rat alveolar macrophage 
movement is greatest towards complement-based stimuli, but on the other hand, hamster 
macrophage migration is based on a non-complement mechanism (Dorger & Krombach, 
2000). The movement of the macrophage also depends upon the state of activation of the 
macrophage, since activated macrophages show an increased chemotactic response 
compared to resting macrophages (Schneider and Dy, 1985). 
1.3.4 Macrophage Activation 
The concept of 'activated' macrophages has been used to describe the enhanced 
macrophage state during an immune response to pathogenic organisms and has been 
studied since Metchnikoff introduced the idea of leukocyte phagocytosis (Schenider & 
Dy, 1985 and Metchnikoff, 1905). An activated macrophage can be characterised by 
increased response to chemotactic stimuli, morphological changes, including an increase 
in size and spreading as well as a change in surface receptor and secretory product 
patterns (Schneider & Dy, 1985 and Driscoll et al., 1990). The change in surface 
receptors aids the macrophage in recognising many of the complement proteins and 
immunoglobulins which are involved in the opsonisation of inhaled organisms (Aderem 
and Underhill, 1999). 
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A macrophage can be activated by the binding of substances to the cell membrane. These 
substances can either be modulated by the organisms own immune system during the 
antigen presentation process or they could be sourced from a pathogenic origin such as 
bacterial products and surface proteins (Adams & Hamilton, 1984). The macrophage has 
a small number of ligands present on the surface but can bind to immunoglobulins via Fc 
receptors which exponentially increases the macrophages antigen recognition capability 
(pels & Cohn, 1986). Other immunological mediators include complement proteins and 
cytokines such as interferon gamma (IFNy) which is considered to be a potent effector of 
macrophage activation. lFNy induces increased production of cytokines by macrophages 
and can result in the expression of increased numbers of immunological receptors on the 
macrophage surface (Heasman et al., 2004 and Schneider & Dy (1985). It is thought that 
traditional or 'type I' activation of macrophages occurs in response to pathogen infection 
but recently the concept of alternative or type II activation by IL-4 and IL-13 has also 
been discussed, particularly during parasitic infection (Gordon, 2003, Namangala et al., 
2001 and Goerdt et al., 1999) 
1.3.5 Phagocytosis 
The phagocytosis of an opsonised particle or bacterium begins with location and 
recognition by the macrophage of the subject, aided by the binding of an opsonin such as 
C3b or immunoglobulin to the phagocytic subject (Donaldson & Tran, 2002). The item 
to be phagocytosed is normally larger than 0.5J.Ull, although Kruth et al., (1-999) have 
described a process of macrophage endocytosis, that they have termed 'patocytosis' 
which describes macrophage uptake of polystyrene micro spheres with a diameter of less 
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than 0.5Jl1ll. Once a macrophage has located the item to be phagocytosed, the subject is 
engulfed by the macrophage by extending its plasma membrane around the item and 
enclosing it inside a phagosome. Following uptake the phagosome fuses with lysosomes 
to become a phagolysosome. This may take anywhere in the region of 30 minutes to 
several hours (Aderem & Underhill, 1999). The lysosome contains powerful enzymes 
such as lysozyme, proteases, lipases, deoxyribonucleases, phosphatases and 
lipoproteinases which can break down the biologic components of the phagocytosed 
substances. The macrophage also has the potential to produce reactive oxygen species 
(ROS) such as hydrogen peroxide, superoxide and hydroxyl radicals (Fels & Cohn, 
1986). Free radicals and ROS have been shown to be damaging to living cells, capable of 
inducing lipid peroxidation, membrane damage, DNA scission and protein denaturation 
(Freeman & Crapo, 1982). If destruction of the phagocytosed material in the 
phagolysosome is unsuccessful, such is commonly the case with inorganic particles and 
fibres; the macrophage will normally migrate towards the mucociliary escalator and be 
carried out of the lung along with its particle burden. Alternatively, if the normal 
pathways of clearance fail, the particles will either transfer into the lymph nodes or 
remain in the interstitium 
1.3.6 The Macrophage Phagocytic Burst 
Macrophage phagocytosis is associated with an increase in the production of reactive 
oxygen and reactive nitrogen species, which are involved in the destruction of 
phagocytosed material (Bogdan, 2001). The primary pathway of oxidative metabolism is 
via the activation of the transmembrane enzyme NADPH oxidase which results in the 
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generation of extracellular superoxide which can subsequently be converted to hydrogen 
peroxide by superoxide dismutase or to hydroxyl radicals via the Haber-Weiss reaction 
(Bogdan et al., 2000, Adams & Hamilton, 1984 and Fels & Cohn, 1986). Extracellular 
nitric oxide species can be generated by the conversion of I-arginine and molecular 
oxygen by nitric oxide synthases, a pathway which also requires NADPH (Bogdan et al., 
2000). 
1.3.7 Macrophage Products 
Macrophages have also been shown to release powerful inflammatory mediators which 
can influence the pathogenesis of a particle induced disease and may cause harm in some 
situations (Sibille & Reynolds, 1990). The capacity of the macrophage to induce 
recruitment of inflammatory cells, such as neutrophils, eosinophils and more 
macrophages, to a location of particle deposition may initially seem like an appropriate 
response. However, several studies have shown that low doses of toxic particles such as 
quartz, or large particulate doses of low toxicity particles, for example, titanium dioxide 
(Ti02) can cause macrophages to release excessive amounts of pro-inflammatory 
substances such as cytokines, enzymes and ROS which, in addition to the damage caused 
by particulates, can also cause further injury to the lung tissue (Becher et al., 2001, 
Driscoll et al., 1990, 1997a, 1997b and Rehn et al., 2003). 
As mentioned previously in section 1.2.4 and as shown in table 1.2, macrophages can 
secrete a wide range of immunomodulatory mediators. Many of the secretory products 
are only produced during the inflammatory response but other secreted substances such 
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as apolipoprotein are utilised in normal lung homeostasis. It should be noted however, 
that although the macrophage secretes a wide range of substances, many, such as IL-l, 
TNFa and IL-6 share a common target or function. Other products that do not appear to 
have a particularly potent effect when studied singularly, may interact with other 
macrophage secretions in a synergistic or antagonistic manner, although this depends on 
the physiological state of the microenvironment into which the secretions are released 
(Keshav et at., 1990). For example, pre-existing inflammation, such as that displayed in 
COPD patients, could cause increased cytokine release. Gilmour et aI., (2001) 
demonstrated that lung epithelial cells that had been transfected with the adenoviral gene 
E 1 A showed increased IL-8 release in response to LPS stimulation. 
1.3.8 Macrophage Products in Pulmonary Inflammatory Modulation 
Several of the products of macrophages are invo lved in the modulation of inflammatory 
response. The family of cytokines secreted by the macrophage has received much 
attention in attempting to elucidate the targets and functions of each cytokine. IL-l is 
released by many other cells types as well as macrophages and is similar in function to 
TNFa. It is involved in the acute phase response and in the development of fibrosis, 
fever, shock and inflammation (Laskin & Laskin, 1996). It has been reported that 
elevated levels ofIL-l are found in the lung as a result of acute inflammatory lung injury 
(Brieland et at., 1995). Driscoll et at., (1990) reported increases in IL-l secretion by 
macrophages from rats treated with silica. Other studies found increased IL-l as a result 
of ozone exposure (pendino et at., 1994) and asbestos exposure (perkins et at., 1993). 
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TNFa is secreted by many different pneumocytes but activated macrophages are thought 
to be a major source. TNFa is known to modulate several pro-inflammatory reactions 
and has been implicated in inducing the release of other pro-inflammatory mediators 
including IL-l, IL-6, TGF~, colony stimulating factors and reactive oxygen species from 
phagocytic cells. It has also been reported to be involved with cell apoptosis, neutrophil 
and lymphocyte recruitment, cytotoxicity and tissue necrosis. It has also been shown to 
induce epithelial cells to release chemotactic factors for leukocyte recruitment. 
Numerous studies have shown increases in TNFa production in animal and cell models 
following exposure to particulates and fibres. For example, Driscoll et al., (1990) 
reported elevated TNFa levels in rats following pulmonary exposure to silica or Ti02• 
Becher et aI., (2001) reported increased concentrations of TNFa released from 
macrophages exposed to quartz particles in vitro. Many studies have also reported 
increased TNFa concentrations from cells as a result of air pollution particle exposure 
(Becker et al., 1996; Li et al., 1999; Jimenez et al., 2002 and Schins et al., 2004). Thus 
TNFa has been implicated as a major factor in the pathogenesis of particle induced lung 
disease. 
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MAJOR SECRETORY PRODUCTS OF MACROPHAGES 
COMPLEMENT PROTEINS 
Cl 
C2 
C3 
C3 b Inactivator 
C4 
C5 
ENZYMES 
Lysozyme 
Plasminogen activator 
Co llagenase 
Elastase 
Angiotensin converting enzyme 
Cysteine proteinase (Cathepsin L) 
Proteases 
Lipases 
Deoxyribonucleases 
Phosphatases 
Glycosidases 
Sulphatases 
Arginase 
PROTEINS 
Alpha I-proteinase inhibitor 
Alpha2-macroglobulin 
Plasminogen activator inhibitor 
Collagenase inhibitor 
IL-l inhibitor 
Neutrophil migration inhibitor 
Inhibitor of fibroblast growth 
Lipomodulin 
Glycoproteins 
Fibronectin 
Transferrin 
Transcobalamin II 
Apolipoprotein A and E 
CYTOKINES 
Interleukin-l alpha and beta (IL-lu & IL-l~) 
Interleukin-6 (IL-6) 
Macrophage inflammatory protein-2 (MIP-2) 
Interferon alpha and gamma (IFNu & IFN~) 
Transforming growth factor beta (TGF~) 
Tumour necrosis factor alpha (TNFu) 
Neutrophil chemotactic factor 
Colony stimulating factors (G-CSF, M-CSF & 
GM-CSF) 
BIOACTIVE LIPIDS 
Arachidonate metabolites 
Prostaglandin E2 
Prostaglandin F2a 
Cycloxygenase metabolites 
Thromboxane A2 
Lipoxygenase metabolites 
Leukotriene B4, C4, D4, E 
Platelet activating factors 
Monohydroxyeicosatraenoic acids (5-, 12-, 15-) 
Dihydroxyeicosatraenoic acids 
REACTIVE OXYGEN METABOLITES 
Superoxide anion 
Hydrogen peroxide 
Hydroxyl radical 
ANTIOXIDANTS 
Glutathione 
COAGULATION FACTORS 
Factor V 
FactorVn 
Factor IX 
Factor X 
1 ,25-dihydroxyvitamin D3 
Thromboplastin 
Prothrombin 
Prothromb inase 
Table 1.2 - Adapted from Fels & Cohn (1986) and Sibille & Reynolds (1990) 
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There are several other inflammatory mediators that also modulate the immune response 
during acute and chronic inflammation. IL-6, for example, is another cytokine with 
multiple activities such as B cell activation and induction of haematopoiesis. Studies 
have reported increased IL-6 release from macrophages as a result of air pollution 
particle exposure (Becker et aI., 1996 and Monn & Becker, 1999) and quartz exposure 
(Becher et ai., 2001). TGFJ3 is secreted by macrophages and has been described as a 
modulator of various cellular responses including cellular proliferation and 
differentiation, monocyte activation, cytokine release and leukocyte chemotaxis 
(Ashcroft, 1999). TGFJ3 has been shown to both activate and 'deactivate' monocytes and 
macrophages respectively (Wahl, 1992, Letterio & Roberts, 1998 and Ashcroft, 1999). 
TGFJ3 has also been shown to induce monocytes to release IL-6, IL-l and TNFa, all 
regulators of acute inflammatory responses (Chantry et ai., 1989 and Turner et ai., 1990). 
With reference to TGFJ3 involvement in response to particle exposure, studies have 
demonstrated that TGFJ3 plays an important role in fibrogenesis and fibrosis in rat 
airways following ambient particulate exposure (Dai et ai., 2003). This group also 
demonstrated that inhibiting TGFJ3 receptors on airway cells prevented increases in the 
expression of genes involved in collagen production. Colony stimulating factors, 
including GM-CSF are involved in stimulating the growth and differentiation of cells 
such as granulocytes, eosinophils and macrophages. This cytokine therefore clearly plays 
an important role in allergic diseases such as asthma (Gormand et ai., 1995) where 
increased secretion of GM-CSF is observed. Studies such as that by Bayram et ai., 
(1998) and Boland et ai., (2000) have examined mechanisms by which diesel exhaust 
particles can stimulate GM-CSF release from epithelial cells. 
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The recruitment and subsequent migration of inflammatory cells to a site of particle 
deposition or inflammation is an important aspect of the immune response as it allows 
rapid removal of any foreign particles and a quick resolution of the inflammatory state. 
Chemokines, a family of chemoattractants, were first detected via the use of cytokine 
assays and, as such, were initially classified as members of the cytokine family. The 
primary function of macrophage derived chemokines is to act as chemoattractants to 
induce the recruitment of leukocytes to sites of infection or inflammation. There are 
generally two categories into which chemokines can be categorised based upon their 
molecular structure; CC chemokines and CXC chemokines. CC chemokines bind to CC 
chemokine receptors on cells and have two adjacent cysteine residues and CXC 
chemokines bind to the CXC receptors on cells and possess two cysteine residues 
separated by another amino acid. The less common C group of chemokines do not 
possess two of the possible four cysteine residues. (Janeway et al., 1999). An example 
of a CXC chemokine would be IL-8 which is a chemoattractant for neutrophils whereas 
examples ofCC chemokines include MIP-la, MIP-lf3, MCP-l and RANTES which are 
all chemoattractants for monocytes. 
Chemotaxins such as MIP-2 have been shown to be released from alveolar macrophages 
following exposure to air pollution particles (Dong et aI., 1996 and Ning et aI., 2000) and 
was reported to be present in increased concentrations in BAL fluid taken from rats 
exposed to quartz (Duffin et aI., 2001). Elevated MIP-2 levels were also found in BAL 
fluid of rats treated with various transition metals such as copper, zinc, manganese, iron, 
vanadium and nickel (Rice et al., 2001). MIP-2 is a homologue of the human chemotaxin 
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IL-8 and is a potent chemoattractant for macrophages and neutrophils in rodents. It has 
also been reported that macrophages can release the complement protein C5, a pre-cursor 
to the macrophage and neutrophil chemoattractant C5a (Johnson & Hetland, 1988). 
Elevated levels of complement proteins have been described in individuals suffering from 
COPD and idiopathic pulmonary fibrosis (Lukacs & Ward, 1996). Warheit et at., (1988, 
1990) utilised hamster, rat, guinea pig and mouse models in vitro and in vivo, and 
suggested that alveolar macrophages were recruited to sites of particle deposition via a 
complement-mediated mechanism. This study referred to particles and fibres such as 
carbonyl iron, Zymosan, asbestos and fibre glass. The effects of particles on proteins of 
the complement system are discussed in greater detail in Chapter 3. 
As can be seen from the studies conducted on macrophage secretory products and their 
role in both infection and particle induced inflammatory responses, the alveolar 
macrophage is an important mediator of the immune response. The macrophage not only 
removes particles from the lung but can also influence the migration of more 
inflammatory cells to a site of inflammation. Thus, further studies are warranted to 
determine the effects of inhaled particles on macrophage clearance mechanisms. 
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1.4 PARTICULATE AIR POLLUTION (PMIO) 
1.4.1 PMIO Characteristics and Components 
The tenn PMIO is used to describe the mass of airborne particles collected by a method 
that has 50% efficiency for particles with an aerodynamic diameter of 10 J..Ull. The actual 
PMIO mixture comprises of a wide range of disparate materials sourced from various 
man-made and natural origins. The composition and toxicity of a given PMIO sample can 
vary enonnously depending on a wide range of factors such as location, weather, wind 
direction and season (Schins et al., 2004) or if the pollution is from indoor (gas cookers) 
or outdoor sources (Dick et al., 2001). The PMIO components can be classified according 
to several different categories (table 1.3) (Stone et al., 2003). 
Method of Description 
Classification 
Particle Size Coarse 2.5 -10~m diameter 
Fine Less than 2.5~m diameter 
Nanoparticle Less than 100nm diameter 
Primary and Primary Remains in the form in which they were generated 
Secondary Secondary Arise as a result of atmospheric chemical reactions 
Organic and Organic Derived from living sources e.g. spores and pollen 
inorganic 
Indoor and Indoor Generated by indoor sources such as cookers 
outdoor 
. Table 1.3 - PMIO component claSSIficatIon (adapted from Stone et al., 2003) 
Large particulate matter in the PMIO mixture, often called the coarse fraction, is 
predominantly composed of biological materials such as spores, pollen and small wind 
blown and soil particles. This component of the PMIO often has a basic pH. The fine and 
nanoparticulate (previously named the ultrafine fraction) components of PMIO are the 
fractions with the largest and most reactive surface area, most often having an acidic pH 
(Dockery and Pope, 1994). The coarse component of PMIO generally exists as single 
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particles while the fine and nanoparticle component can exist as single particles but can 
also exhibit a high degree of aggregation (Donaldson et al., 2001 and Donaldson & 
MacNee, 2001). Approximately 50% of the particles in the fine and nanoparticle 
fractions are made of carbon and the rest of the particles are composed of metal salts as 
well as ammonium sulphates and nitrates (Harrison and Yin, 2000). The major 
contributing source to the small particulate mixture is traffic exhaust particles. A survey 
in London in 1990 ascribed approximately 87% of the mass of airborne particulate to 
diesel exhaust emissions (Berube et al., 1999). 
As well as the particulate component of air pollution there are also several other 
substances that contribute to the PMIO mixture. The interactions between each of these 
components and how they can contribute to the toxicological effects of air pollution as a 
whole have been widely studied and several hypotheses have been formulated to explain 
the toxicity of the PMIO. The transition metal content of PM 10 has been implicated as a 
major factor in particle related toxicity. Exposures to metals have been assessed for their 
ability to cause pulmonary inflammation and exacerbation of disease. For example, it has 
been shown that exposure to metals can lead to pathological conditions such as COPD 
and pneumonia (Nemery, 1990 and Rice et al., 2001). Obviously, the transition metal 
content of a given PMIO sample can differ from another depending on the source of the 
PMIO. Common metal components ofPMIO include iron, zinc, copper, vanadium, cobalt, 
aluminium, manganese, titanium, silicon and sulphur (fao et aI., 2003). The transition 
metals in PMIO can undergo Fenton chemistry to produce reactive oxygen species (See 
diagram 1.3). The redox-cycling of the metals can be accomplished due to the fact that 
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reducing agents such as glutathione, ascorbate and NADH are readily found in the lung 
(Smith and Aust, 1997). Adamson et al., (2000) reported that zinc was the toxic factor in 
pulmonary responses to atmospheric air pollution. However, this study tested the toxic 
effects of individual metals and did not take into account mixtures of various metals or 
the interaction with other components of air pollution. Li et al., (1996) showed that 
samples of PMIO demonstrated free radical activity both in vivo and in vitro. This was 
shown by the ability of the PMIO sample to deplete glutathione (GSH) levels in vivo and 
by the breakage of supercoiled DNA plasmid exposed to the PMIO sample in vitro. The 
depletion of the DNA plasmid could be prevented by the addition of mannitol, a hydroxyl 
radical scavenger. A study by Gilmour et al., (1996) indicated that metals played an 
important role in the generation of the hydroxyl radical by PMIO. This was illustrated by 
the addition of a metal chelator, desferoxamine-B, which halted the depletion of 
supercoiled plasmid by PMIO. Donaldson et aI., (1997) examined the DNA cleaving 
potential of a PMIO solution that had been centrifuged to clarity and found that the 
supernatant exhibited the same potential as the uncentrifuged solution. This could 
indicate that that the free radical generating system had leached into the solution. It may 
also have been the case that the centrifugation of the solution did not completely remove 
all of the PMIO particles. 
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From Particle From Lung 
1 1 
Fe (III) + reductant (e.g. GSH, O2.-) ------.. Fe (II) 
... 
Fe (II) + O2 --..... Fe(lII) + O2.-
Fe(lI) + H20 2 -------+. Fe(lIl) + OH- + HO-
---------------------------------------------~ 
Note: Any transition metal could 
take the place of Fe 
1 
Hydroxyl 
Radical 
Figure 1.4 - The interaction of transition metal components with pulmonary reductants 
leading to free radical production (Diagram from Donaldson & Tran 2002). 
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Endotoxin is another component of PMIO that, in itself, is an inflammogenic substance 
which can induce the release of inflammatory mediators from macrophages and epithelial 
cells (Donaldson et of., 2001 b). Endotoxin or Lipid A, is the toxic part of 
lipopolysaccharide (LPS) which is a component of gram negative bacterial cell walls. It 
has been implicated as a factor in occupational respiratory diseases (Rylander & Haglind, 
1984). Monn & Becker (1999), found that addition of lipopolysaccharide binding protein 
(LBP) to PMIO obtained from Chapel Hill, North Carolina prevented PMIO induced 
cytokine production by monocytes. This would indicate that the Chapel Hill endotoxin 
plays an important role in the induction of cytokine production by monocytes (Stone et 
of., 2003). 
Other components of PM 10, which have received less attention than the particulates and 
metals, are the sulphates, nitrates and volatile organic compounds (VOCs) (Harrison and 
Yin, 2000). These substances mayor may not interact with other PMIO components to 
playa role in pollution induced toxicity but this aspect of PMIO composition requires 
further study. 
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1.5 BIOLOGICAL EFFECTS OF PMIO 
1.5.1 Background 
The mammalian respiratory system has evolved many effective defence mechanisms to 
protect against foreign body entry into the airways and alveolar regions of the lungs. The 
airborne particle challenge that humans face today is different from that of 50 years ago, 
when sources of air pollution were dominated by particles from industrial and domestic 
burning of coal. These sources have decreased today, but the higher number of motor 
vehicles has increased the number of particles derived from traffic exhausts (Seaton et 
al., 1995). 
Mankind has been aware of diseases resulting from inhaled particles for hundreds of 
years and in this century, history demonstrates several air pollution 'disasters' 
(Donaldson et al., 2001a and Folinsbee, 1993). In 1952, a smog enveloped London 
resulting in increased mortality as a result of cardiovascular and respiratory conditions. 
The UK Clean Air Act (1956) and subsequent amendment in 1993 reduced the level of 
air pollution and exposure standards for pollutants, but there continues to be great interest 
in air pollution particles due to changes in PMto composition resulting from a decrease in 
industrial and domestic emissions but an increase in traffic emissions. 
At least 200 epidemiological studies have been published on health effects of particulate 
air pollution. Airborne particle exposure, hospital admissions, health endpoints and 
mortality have all been well studied from different standpoints and since the 1970's, firm 
links have been established between particles and increased respiratory disease (Dockery 
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& Pope III., 1994). According to Donaldson et al., (2000b) these health effects include 
the increased use of asthma medication, attacks of pre-existing lung diseases such as 
COPD and asthma, hospital admission attributed to cardiovascular disorders and deaths 
from heart attacks, strokes and respiratory disease. Whether these health effects are 
exclusively attributable to air pollution or whether other respiratory epidemics, such as 
those of influenza or pneumonia, are sometimes partially responsible for increased 
mortality is a potential cause for concern. A mathematical study conducted in the US by 
Braga et al., (2000) showed that the association between air pollution and daily mortality 
was not affected by outbreaks of infectious respiratory disease. Schwartz (2001) 
developed an analysis, which was reported to differentiate between naturally occurring 
mortality and deaths that were induced by increased PMIO levels. The results indicated 
that during high pollution episodes, daily deaths and hospital admissions increased, but 
that there was no increase in deaths in hospitals, supporting the association between 
increased mortality and high levels of air pollution. 
Some studies have focussed on the coarse and fme component of PMIO as being an 
important influence in the biological toxicity of PM 10 (Englert., 2004) The debate as to 
which size fraction of PM IO can induce the greatest effect is a topic that is still under 
debate. The potential for fine and coarse particles to induce inflammation has been the 
subject of several studies. Hetland et aI., (2004) showed that the coarse and fine 
components in a sample of Norway PMIO were as effective as the nanoparticle fraction at 
inducing the production ofIL-8 in vitro from the epithelial type II cell line A549. Schins 
et al., (2004) found that the coarse component of rural and industrial PMIO samples from 
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Gennany induced a higher degree of inflammation than the fine component in vivo. This 
increased inflammation was associated with the endotoxin component of the PM sample 
although it was suggested that other biological or chemical contaminants might have been 
involved. Monn & Becker (1999) found that monocyte secretion of IL-6 and IL-8 
induced by the coarse fraction of North Carolina PMIO was 20 fold greater than that 
observed following treatment with the fme fraction. Cytotoxicity, as assessed by trypan 
blue exclusion, yielded similar results. Murphy et ai., (1998) concluded that, following 
an instillation study with several different types of fine particles, the surface chemistry of 
the fine particle was an important detenninant of the particle effects on rat epithelial 
cells. Pope et ai., (2002) conducted an epidemiological study, which indicated that 
independent of coarse particle increases, elevation of fine particle concentration in the 
environment caused significant increases in cardiopulmonary and lung cancer mortality 
rate. 
Many authors have suggested that the nanoparticle component plays the most important 
role in driving the health effects of PMIO (Seaton et ai., 1995, Donaldson & MacNee., 
1998, Oberdorster et ai., 1995). Nanoparticles are the most numerous type of particle in 
PMIO as well as possessing the largest portion of the particulate surface area (Harrison & 
Yin, 2000). Many studies have demonstrated increases in cytokine concentration in the 
lavage fluid of animals treated with nanoparticles (Gilmour et ai., 2004 and Li et ai., 
1999). Studies have also shown an increase in calcium levels in cells exposed to 
nanoparticles (Stone et ai., 2000a and Brown et ai., 2000). Other studies have 
demonstrated a direct toxicological effect on macrophages exposed to nanoparticles. 
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Lundborg et al., (1999 and 2001) and Renwick et al., (2001) showed impaired 
macrophage function following nanoparticle exposure. Moller et al., (2002) further 
confirmed these results, indicating that the toxicological effect of the nanopartic}es on the 
mac rophages, cytoskeleton was critical in affecting macrophage movement and 
phagocytosis. As described in chapters 4 and 5, a reduction in the efficiency of clearance 
mechanisms could result in further damage in a lung that has encountered prolonged 
particle exposure. 
Generally, cardiovascular factors such as increased blood coagulabilty caused by changes 
in fibrinogen and factor VII concentration (Seaton et al., 1995) and changes in cardiac 
electrical activity (Utell & Frampton, 2000 and Dockery, 2001) have been reported as a 
result of increased particle exposure. It is possible that no one single component of PM 10 
is toxic enough to be responsible for the adverse health effects linked to air pollution and 
it is by examining the interaction of particulates in target organs such as the lung that we 
can hope to obtain a clearer picture of the events surrounding the toxicology of air 
pollution particles. 
1.5.2 Particle Entry & Deposition in the Lung 
Particle entry and site of deposition in the lung is determined by the particle size and 
degree of aggregation. The site of particle deposition is important as it determines the 
type of cells that will be exposed to the particles. The depth that particles enter into the 
lung airways is inversely proportional to their size i.e. smaller particles have access to a 
greater depth in the lung such as the alveolar areas (Adamson and Bowden, 1978). 
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Larger particles (diameter> 20fllll) deposit in the upper respiratory tract and particles 
with a diameter of 5 - 15fllll can deposit in the conducting ahways and upper bronchial 
areas as well (Heyder et af., 1986). Particles with a diameter of between 1 and 5fllll can 
also access the terminal airways (Stahlhofen et aI., 1983,1989) and those with a diameter 
of less than 1J.llll may also deposit in the alveolar sacs (Heyder et af., 1986). The 
deposition in the alveolar region occurs via diffusion or Brownian motion i.e. the 
bombardment of the particles with other molecules causing movement (Hofmann et af., 
2003). These figures describe individual particulates although particle collections with a 
high degree of aggregation can have an altered deposition pattern. However, the high 
lipid content of the surfactant lining the airways may change the aggregation properties 
of the particles. 
Humans have a symmetrical pattern of respiratory zones which favours concentrated 
deposition of particles at bifurcations (Warheit and Hartsky, 1990). Focal deposition of 
particles may result in greater localised cellular trauma whereas an evenly distributed 
pattern of particulates may not be as damaging. Furthermore, humans may prefer to 
breathe through the mouth during exercise and vocal communication allowing greater 
particle entry into the lungs (Lippmann and Schlesinger, 1984). This is in comparison to 
rodents, which breathe through the nose, a factor that has to be taken into account when 
studying particle deposition using animal models. The particulate mass that is taken into 
the lungs is also dependant upon the ventilation rates of the individual (Miller, 2000). 
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An important study by Churg and Brauer, (2000) examined the deposition of ambient 
particulates in human airways. Examinations of particle deposition in subjects from 
Vancouver (a city with relatively low levels of PM) showed high concentrations of 
particles in the mucosa, and that increasing particle number correlated with decreasing 
airway diameter. Large numbers of particles were also observed in the respiratory 
bronchioles. It has been shown that the deposition fraction ofnanoparticles in the lung is 
around 50% and that this figure can be higher in individuals with lung disease (Anderson 
et al., 1990). Brown et al., (2002) describe the deposition of particles in healthy 
individuals and those with obstructive lung diseases such as chronic obstructive 
pulmonary disease (COPD). The authors noted that COPD afflicted individuals may also 
receive an increased nanoparticle dose due to increased ventilation rate and resulting 
particle intake. Similar observations are noted in the increased ventilation responses of 
individuals undertaking exercise (Daigle et al., 2003). The translocation of inhaled 
particles and subsequent deposition in other areas of the body are described in section 
1.6.8. 
1.5.3 Susceptibility to PMIO Induced Disease 
Health effects influenced by PMJO exposure are frequently seen in individuals with pre-
existing respiratory or cardiovascular conditions and very rarely seen in healthy 
individuals (Donaldson et al., 2001 b). Stone, (2000b) reviews several of the categories 
into which susceptibility to PMJO induced disease can be placed. Individuals who are 
susceptible to exposure are those that are exposed to airborne particulates as a result of 
lifestyle or occupational factors. Populations living in urban areas where traffic 
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emissions are high will be exposed to greater concentrations of combustion-derived 
particulate than those living in rural areas. Similarly, individuals who smoke or work in 
areas or trades that have a high airborne particulate content will also be exposed to a 
greater number of particles (Clouter et ai., 2001 and Lemiere et ai., 2000). A second 
category of susceptibility is the susceptibility to response, which describes individuals 
that have a pre-existing condition that could affect the inflammatory response to particles. 
Individuals with diseases such as asthma (penttinen et aI., 2001 and Donaldson et ai., 
2000b) and COPD (Mac Nee & Donaldson, 2000) or those that have experienced a viral 
infection (Gilmour et ai., 2001) may be primed to generate a magnified inflammatory 
response to particle exposure when compared to healthy individuals (Ning et ai., 2003). 
Studies have also shown that exposure to diesel exhaust particles can increase the 
susceptibility of the lung to subsequent viral or bacterial infection (Castranova et ai., 
2001). 
The final category of susceptibility deals with the susceptibility to increased dose where 
the clearance efficacy of macrophages dealing with deposited particles determines the 
dose to which the individual is exposed. This category also includes the physiological 
behaviour of the individual and the frequency of respirations, which can determine the 
ventilation volumes, and particle dose which is inhaled into the lungs. As described 
previously, COPD patients often have increased ventilation rate and deeper breaths, 
lending favour to increased particle exposure (Brown et ai., 2002). COPD patients and 
cigarette smokers often have damage to cilia, decreasing the effectiveness ofthe MCE in 
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clearing particle-laden macrophages and particles themselves (MacNee and Donaldson, 
2000). 
1.5.4 Particle Clearance Kinetics 
In terms of the speed of particulate removal from the lung, MCE clearance is a fast 
process, which can very rapidly remove particles from the bronchial areas. However, 
alveolar macrophage mediated clearance is very slow. In a study by Oberdorster et af., 
(1994) it was reported that rats inhaling nanoparticle Ti02 showed increased retention 
half times compared to rats exposed to fine Ti02 (117 days for fine compared to 541 days 
for nanoparticles). This illustrates both the length oftime that particles can remain in the 
lung and the biopersistence ofnanoparticles. Ferin et af., (1992) reported similar figures 
following 12 week exposure studies to Ti02 (501 days for nanoparticle Ti02 compared to 
174 days for fine Ti02). Oberdorster (1995) reported that, the alveolar retention halftime 
of macrophage mediated clearance is around 70 days in the rat. Bailey et af., (1985) 
reported alveolar retention halftimes of radio labelled silicate nanoparticles upwards of 
350 days in humans. Wanner (1977) reported that MCE clearance was fastest in the 
trachea and central bronchi where it is estimated that particles are moved up the MCE at a 
rate of around 1 cm per minute. Clearance in the peripheral bronchi is moderately 
slower. However, as described by Oberdorster et af., (1994), the clearance time of a 
given particulate is dominated by the particle characteristics. 
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1.5.5 Overload 
Dust overloading in the lungs is a hypothesis that has been used to account for pathogenic 
changes in the lungs induced by the inhalation of high concentrations of low toxicity 
dusts. Several studies have reported that large concentrations of dusts that have a low 
toxicity can cause a decrease in macrophage clearance resulting in pathological 
conditions such as fibrosis, cancer and epithelial cell hyperplasia (Morrow, 1988, 
Oberdorster 1994, 1995, Warheit et al., 1997 and Lee et al., 1985). As described 
previously, alveolar macrophages phagocytose particles and migrate out of the lung via 
the MCE without the release of large concentrations of pro-inflammatory mediators. If 
high numbers of particles are phagocytosed by the macrophages, it is thought that the 
phagocytic potential of the macrophage decreases and the macrophage appears to remain 
in the alveolar space instead of migrating out of the lung (Morrow, 1988). Morrow 
estimates that when 6% of the internal volume of the macrophage is occupied the 
clearance potential of the macrophage is affected. Dorger & Krombach (2000) report that 
when 60% of the macrophage volume is occupied by particles, the macrophage migratory 
mechanisms are completely retarded and the macrophage becomes unable to translocate 
to the MCE. This scenario would encourage more interaction of particulates with the 
epithelial cells in the alveolar space and would result in an increased pro-inflammatory 
mediator release. This would also increase the potential for transepithelial migrations of 
particles resulting in further epithelial permeability and interstitial inflammation. It is 
possible, however, that some of these problems could be countered by re-phagocytosis of 
the particulates that have been released from lysed macrophages. However, this would 
further increase the alveolar retention time of the particulate. Driscoll (1996) found that 
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when different types of instilled particles were compared, lung tumours were most 
commonly found with nanoparticles. This led to the hypothesis that lung overload is 
related to the particle surface area as opposed to the mass dose. Tran et al., (2000) 
supported this by demonstrating that impairment of clearance mechanisms was dependent 
upon the surface area and not the mass of deposited particles. This was accomplished by 
allowing rats to inhale an equivalent mass of two poorly soluble dusts with different 
surface areas (Ti02 and BaS04). It was found that the Ti02 induced a greater amount of 
inflammation in the lung compared to the BaS04 at an equivalent mass. This 
inflammation was attributed to the larger surface area ofthe Ti02. These studies support 
the hypothesis that increased surface area and free radical generation by nanoparticles is 
the primary cause ofnanoparticle induced overload conditions. 
1.5.6 Oxidative Stress 
There are several different types of oxidants to which the lung can potentially be 
exposed. These can include molecular oxygen, ozone and reactive oxygen species 
(which in turn include hydrogen peroxide, hydroxyl radicals and superoxide) (putman et 
al., 1997). The term 'free radicals' describes a reactive species that can exist 
independently i.e. possessing at least one unpaired electron. When the term reactive 
oxygen species is used, this refers to reactive species with an oxygen centre such as 
superoxide and hydrogen peroxide. Reactive nitrogen species such as nitric oxide and the 
extremely toxic peroxynitrite can also be present although it should be noted that nitric 
oxide is relatively unreactive (Halliwell, 2001). Free radical species can react with the 
biological molecules present within an organism and change their biochemical properties 
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or cause severe damage (Putman et ai., 1997). The lung has evolved various mechanisms 
for dealing with these oxidant species. For example the epithelial lining fluid contains 
high concentrations of antioxidants and free radical scavengers such as vitamin E and 
glutathione (Freeman & Crapo 1982). As free radicals are essential for some biological 
processes and are produced as normal by-products of metabolism, the presence of 
radicals in the lung does not routinely cause large amounts of damage. However, the 
presence of reactive particles and transition metals in the lung can result in excess free 
radical release and pathological consequences for lung pneumocytes. 
Free radicals can cause damage to several components in both living cells and their 
secretions and have implicated as disease causing agents for over 100 different 
pathological conditions. Freeman & Crapo (1982) provide a comprehensive review of 
the cellular targets that are susceptible to free radical damage. These include proteins 
such as enzymes, which can be denatured or inactivated by free radical exposure, DNA 
molecules and cellular membrane lipids (see table 1.5). 
Target Consequence 
DNA Cell cycle changes and mutations, strand scission, 
apoptosis 
Carbohydrates Cell surface receptor changes 
Unsaturated Lipids Cholesterol and fatty acid oxidation 
Changes in cell permeability 
Lipid peroxidation 
Antioxidants Decreased availability, oxidation, inactivation 
Proteins Denaturation and peptide chain scission 
Tissue Gross damage leading to fibrinogenesis and cancer 
. . Table 1.5 - Biological targets of free radical damage (adapted from Freeman & Crapo, 
1982) 
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As mentioned previously, there have been several studies demonstrating the potential for 
PMIO particles to generate free radicals and reactive oxygen species as a result of the 
particle surface chemistry and interaction with metals. Studies by Li et aI., (1996) and 
Gilmour et al., (1996) demonstrated that PMIO could actively generate free radicals and 
that this phenomenon was potentially related to the iron content of the samples. 
Donaldson et al., (1996) used a similar method to demonstrate that nanoparticle Ti02 
showed an enormous potential to damage a DNA plasmid in comparison to fine Ti02, 
which induced only modest strand breakage. This evidence for reactive oxygen species 
involvement in nanoparticle toxicity was further enhanced by the addition of mannitol to 
the plasmid/particle mixture, which was found to ameliorate the effects of the 
nanoparticles. Carter et al., (1997) reported that cytokine production by epithelial cells 
exposed to air pollution particles was inhibited by the addition of metal chelators or by 
free radical scavengers. Pritchard et al., (1996) also noted that the surface metals of 
particulates could influence the potential for the production of ROS and subsequent 
inflammatory response in a rat model. Dick et al., (2003) recently reported on the 
potential of four different nanoparticle types (carbon black, nickel, cobalt and Ti02) to 
generate oxidant species. It was found that the cobalt, nickel and carbon black all 
generated high numbers of free radicals as indicated by depletion of supercoiled plasmid 
DNA. This was correlated with the potential of the more reactive particles to induce 
greater neutrophil recruitment into the lung following instillation into the rat lung. 
Donaldson et al., (2003) recently reported that PMIO induced oxidative stress could 
activate pro-inflammatory signalling pathways in cells such as nuclear factor-kappa B 
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(NF-KB). Free radicals sourced from macrophages that have been activated by particle 
exposure could also potentially cause further damage (Freeman & Crapo, 1982). 
The lung is an environment where the generation of oxidative stress can occur due to the 
high concentrations of oxygen and the presence of metals such as iron from inhaled 
particulates. As the human body does not possess mechanisms for the excretion of 
excess iron, the lung has therefore evolved effective methods for the regulation of metal 
content in order to minimise oxidative mechanisms that could potentially be damaging to 
cells. Turi et al., (2004) lists several proteins including lactoferrin, ferritin and 
transferrin, which are involved in iron sequestering and regulation. Ferritin is an 
intracellular protein contained in the lung epithelium that sequesters iron that has been 
transported across the cell membrane. The potential therefore exists for particle induced 
cellular damage to allow more free iron to be released and allowed to react to fonn 
excessive reactive oxygen species. This could then lead to further damage via oxidant 
production. 
1.5.7 Complement Activation by Particles 
There have been many studies showing that asbestos can activate the alternative 
complement pathway (i.e. antibody independent), resulting in the generation of C5a 
proteins, a known chemoattractant. Saint-Remy et al., (1980), Wilson et al., (1977) and 
Warheit et al., (1985) have all demonstrated that asbestos fibres have the capacity to 
activate the alternative complement pathway. Kanemitsu et al., (1998) reported that 
diesel exhaust particles could activate complement. In a more recent publication by 
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Govema et ai., (2002), crystalline silica was also found to have the potential to cleave the 
complement protein C5 to produce a C5a-like product. This was hypothesised to be due 
to oxidative stress taking place via redox-active iron present on the silica surface. This 
obviously has important implications for silica-induced lung disease as well as 
stimulating questions regarding particulates and their potential to activate the alternative 
complement cascade. Donaldson & Tran., (2002) suggest that as PMIO is reported to 
contain endotoxin, it is likely that PMIO would initiate the complement cascade. Warheit 
et ai., (1988) concluded that alveolar macrophages are attracted to sites of deposition via 
complement activation and that the clearance of a given particulate depends on its 
potential to activate complement. 
As mentioned previously in section 1.5.6, there have been several studies showing that 
the large surface area of fine and nanoparticles demonstrates a high potential for the 
generation of reactive oxygen species and their subsequent cytotoxicity following 
inhalation or instillation into the alveolar space. For example, in a study by Li et ai., 
(1996), it was shown that PMIO generated free radical activity in vitro, and induced 
oxidative stress in vivo resulting in pulmonary inflammation. A study by Gilmour et ai., 
(1996) supported these findings, stating that hydroxyl radicals were generated by PMIO 
and that, this too occurred via an iron-dependant mechanism. Govema et ai., (2002) 
demonstrated that silica had the capacity to induce the generation of a C5a-like protein, 
perhaps due to the oxidative stress generated on the silica surface. 
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1.5.8 Particle Translocation into Interstitium and CV System 
Although the epithelium of the lung appears to be the target tissue when examining 
airborne particle exposure through inhalation, it has been shown that particles have the 
potential to breach the epithelial barrier and migrate into the interstitium and 
cardiovascular circulation (Ferin et al., 1992; Frampton, 2001 and Nemmar et al., 2002). 
This creates the possibility that other tissues may be exposed to airborne particulates. 
When particles deposit in the alveolar space, the primary mechanism of clearance is via 
phagocytosis by alveolar macrophages. However, if large numbers of particles are 
deposited and allowed to interact with the epithelial cells before phagocytosis can take 
place or if particle numbers are too high for macrophages to deal with, as in the case of 
particle overload, the epithelial cell function and integrity could be compromised as a 
result of particle exposure. This could result in increased inflammation, epithelial 
permeability and a chronic inflammatory state (Mauderly, 1996). When the epithelial 
layer has been damaged, it is possible for deposited particles, as well as inflammatory 
mediators produced in the lung, to enter the interstitium, lymph nodes and systemic 
circulation (Lehnert et al. 1986 and Donaldson et al., 2001 b) as the numerous studies 
detailed below have shown. 
Ferin et al., (1992) exposed rats to airborne fine and nanoparticle Ti02 for 12 weeks and 
noted increased inflammation with the nanoparticles. It was also noted that there was an 
increase in the transfer ofnanoparticles to the interstitium compared to the fine particles. 
This was attributed to the inflammation caused by the nanoparticles as well as the fact 
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that the type I cells in the rat lung had taken up the unphagocytosed particles. Previous 
studies had noted transepithelial migration to hilar or pleural lymph nodes (Adamson & 
Bowden, 1981, Ferin & Feldstein, 1978 and Lippmann et al., 1980). Lee and colleagues 
(1985) found Ti02 deposits in the lymphatic vessels and trace amounts in the systemic 
circulation in rats exposed by inhalation for 2 years. Nemmar et al., (2001) noted that 
intratracheal instillation of radiolabelled nanoparticles into hamsters resulted in the 
particles being observed in the systemic circulation. It was subsequently determined by 
Nemmar et al., (2002) that, in humans, inhaled radio labelled particles could quickly pass 
into the systemic circulation (within 1 minute of inhalation). Rahman et al., (1996) 
indicated that, in a study of smokers and individuals with COPD and asthma 
exacerbations, systemic antioxidant activity was decreased indicating an increased 
susceptibility to oxidative stress induced by particles. Very recently, Oberdorster et al., 
(2004) demonstrated carbon nanoparticle entry into the cerebrum and cerebellum of rats 
exposed to the particles by inhalation. This suggested that translocation of these particles 
into the olfactory bulb region of the brain could bypass the blood-brain barrier and that 
further studies are warranted to determine the health effects of central nervous system 
(CNS) exposure to inhaled particles 
In terms of health effects of particle translocation, these are determined by the particle 
properties (i.e. potential for reactive oxygen species generation), the number of particles 
and the areas to which translocation has taken place. It has already been established that 
smaller particles display a greater potential for epithelial damage and subsequent 
translocation due to their small size and reactive surface. Stone et aI., (1998) 
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demonstrated that nanoparticle carbon black induced greater oxidative stress in epithelial 
type II cells than an equivalent dose of fine CB. When taking into account the studies by 
Ferin et a!., (1992) and Rahman et al., (1996), the potential for nanoparticles to cause 
systemic damage via oxidative stress is high. Dockery & Pope (1994) observed that total 
mortality increases by 1 % per 10J.1g/m3 increase in PMIO levels. A stronger association 
for cardiovascular mortality is also observed (1.4% per 10J.1g/m3 increase in PMIO), 
illustrating the potential for extrapulmonary effects of inhaled particles. Seaton et al., 
(1995) suggested that increased coagulabilty of the blood may be a causal agent and 
Peters et al., (1997) supported this hypothesis by demonstrating an increased plasma 
viscosity in a population exposed to an incidence of increased atmospheric particulate 
matter. Salvi et al., (1999) showed an increase in the number of circulating platelets in 
the blood of humans exposed to diesel exhaust particles. Donaldson & MacNee (2001) 
hypothesised that production of procoagulants from the liver could also occur via IL-6 
and TNFa. release into the circulation by pulmonary inflammatory cells. Together with 
increases in cardiac arrhythmias and heart rate (Dockery, 2001) it is likely that increases 
in blood coagulabilty and plasma viscosity could lead to incidents involving thromboses 
and a resulting increase in mortality from particle induced cardiovascular conditions. 
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1.6 SURROGATE AIR POLLUTION PARTICLES 
The surrogate particles utilised in this study were fine and nanoparticle fonns of carbon 
black and titanium dioxide. The particle characteristics are outlined below in Table 1.6 
DUST GEOMETRIC SURFACE AREA (m"/g) 
DIAMETER (nm) 
Fine Ti02 250 6.6 
Nanoparticle Ti02 29 49.78 
Fine carbon black 260.3 7.9 
Nanoparticle carbon black 14.3 253.9 
Table 1.6 Particle Characteristics (From Brown et al., 2000) 
1.6.1 Carbon Black 
Carbon black is a paracrystalline carbon compound that is utilised in a wide variety of 
industrial processes (Degussa Technical Bulletin 15, 1986). It is utilised primarily by the 
rubber industry for the production of tyres although it is also used in printing inks, 
plastics, fibres, paper and in the construction (cement pigment) and electrical (carbon 
electrodes) industries. There are several methods that are employed for generating 
carbon black, all of which involve thennal or thennal-oxidative (partial combustion) 
decomposition (lARC Monographs, 1996). Approximately 98% of all industrial carbon 
black produced (6 million tonnes annually) is via the furnace black process. The raw 
materials used in this process include oils with a high hydrocarbon content and 
bituminous coal tar. The particles that are produced by this industrial process are 
between 10 and 100nm in size although various specifications of the particles can be 
altered including the surface area and aerodynamic diameter depending on the destined 
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application of the particles. The particles can also form long branching aggregates 
depending on the chemical composition (Degussa Technical Document - What is Carbon 
Black?). 
The composition of carbon black can vary depending on its type, but it is essentially 95 -
99% colloidal carbon. Several other elements such as hydrogen, oxygen, nitrogen and 
sulphur are also bound to the carbon atoms. Depending upon the production method and 
type of carbon black, there are also some negligible traces of metals which can be 
extracted from the surface of the carbon particles. These include common elements such 
as iron, calcium and magnesium as well as more uncommon heavy metals such as 
barium, lead, cadmium, chromium and zinc (Degussa Technical Document - What is 
Carbon Black?). The presence of extractable carbon black components was also 
examined by Degussa by boiling carbon black in toluene and it was determined that 
extraction residues from the carbon black was minimal. These results were supported in 
a study by Brown et ai., (2000) which indicated that inflammation induced by 
nanoparticle carbon black was not caused by the presence of soluble component leaching 
from the surface of the particles. 
The carbon blacks utilised in this study were fine and nanoparticle forms produced by the 
thermal black and furnace black processes respectively. The average diameter of the 
individual primary particles of fine carbon black was around 260nm and for the 
nanoparticle, 14nm as described by Renwick et ai., (2001) and Stone et ai., (1998). 
These particles were chosen as surrogate air pollution particles as they are well 
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characterised in terms of physical properties and composition and have the potential to 
induce a high degree of biological reactivity (Wilson et ai., 2002; Stone et ai., 1998). 
1.6.2 Biological Effects of Carbon Black 
The biological reactivity of carbon black has been investigated in several studies as a 
surrogate particle representing the particulate component of atmospheric air pollution. 
However, it is important when assessing these studies to highlight the distinction between 
the biological effects of the fine and nanoparticle forms of carbon black. Many in vivo 
investigations have been conducted which compare and contrast the inflammatory effects 
of the two types of carbon black (Driscoll et ai., 1996a, Li et ai., 1999, Brown et ai., 
2000, Donaldson et aI., 2001a). The IARC has classified carbon black as a group 2B 
carcinogen, surmising that it could possibly be carcinogenic in humans. The 
occupational exposure limits for workers in the UK in an industry where carbon black is 
present is 3.5mg/m3 (Degussa Technical Safety Bulletin 25, 1990). This does not take 
into account the size of particles in question, for example, an exposure metric of 
nanoparticles assessed by weight would contain a considerably higher number of 
individual particulates and a larger surface area than the equivalent mass of fine particles. 
A study by Driscoll et ai., (1996a) examined the effects of short term inhalation 
exposures of rats to carbon black particles in the nanoparticle size range and illustrated 
several adverse inflammatory responses. It was observed that increased inflammation, 
fibrosis and increased chemokine expression were all associated with the particulate 
exposure. A higher incidence of gene mutation also occurred in alveolar epithelial cells 
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in rats that had been exposed to the higher doses of the carbon black. Li et at., (1999) 
also compared the rat inflammatory response as a result of carbon black exposure, using 
both fine and nano-sized forms of the particle. This study supported the results of 
Driscoll et at., in that instillation with nanoparticle carbon black induced pulmonary 
inflammation at a relatively low dose. The inflammation brought about by the 
nanoparticle exposure was also greater in intensity compared to the fine particles, as 
demonstrated by a greater neutrophil influx, increased LDH levels and a marked decrease 
in glutathione. Li et at., (1996) had previously compared the effects of nanoparticle 
carbon black to those of fine carbon black and PMIO. This study illustrated that 
nanoparticle carbon black induced a greater neutrophil influx, decreased glutathione and 
increased epithelial permeability 6 hours post-exposure, than both the fine carbon black 
and PMIO. Increased epithelial damage and neutrophil influx as well as glutathione 
reduction was also reported by Donaldson et at., (2001a). 
Investigations were also conducted to determine the cellular basis for the increased 
inflammatory response to nanoparticle carbon black in rats. As mentioned previously in 
section 1.5.1 Lundborg et at., (1999), Renwick et at., (2001) and Moller et at., (2002)also 
reported decreased phagocytic ability and cytoskeletal toxicity in macrophages exposed 
to nanoparticle carbon black. Investigations have also focused on the reactive oxygen 
species production by nanoparticles and the possibly detrimental effects on pulmonary 
function. In 1998, Stone et at., demonstrated that oxidative stress was involved in the 
toxicological effects exerted on epithelial cells by nanoparticle carbon black. It was 
shown that fine carbon black could decrease the metabolic competence of epithelial cells 
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at a timepoint of 24 hours but that this had recovered to control levels at 48 hours. In 
contrast, the group found that nanoparticle carbon black caused a decrease in metabolic 
competency at 48 hours compared to the control. The study by Wilson et al., (2002) 
indicated that, in vitro and in the rat lung, nanoparticle carbon black can react with 
transition metals in a potentiative manner to produce reactive oxygen species which 
would be potentially damaging in a biological environment such as the lung. 
1.6.3 Titanium Dioxide 
Titanium is an extremely common element and can form over 40 different minerals when 
it combines with other elements. In industry it can be converted to metal titanium, or can 
be utilised in the production of other useful compounds (Lee et al., 1985). Titanium 
dioxide {Ti02} is a dust that is used widely in the manufacturing and cosmetics industries 
having replaced white lead and zinc white due to the fact that Ti02 is regarded as being 
relatively biologically inert. Ti02 is formed mainly from ilmenite (FeTi03) and is used to 
produce paint, paper, plastic ceramics, inks and other products (IARC Monograph, 1989 
and Chen & Fayerweather, 1988). It commonly exists in one of three crystal lattice 
forms; tertragonal rutile, tetragonal anatase or rhombic brookite. Anatase and rutile are 
produced in large amounts on an extensive industrial scale by wet processes (Degussa 
Technical Bulletin 64, 1992). 
Exposure of workers to Ti02 can occur in an industrial setting, especially when titanium 
dioxide pigment is ground to a finer dust, where atmospheric concentrations can be up to 
400mg/m3 (Elo et al., 1972). As Ti02 is generally regarded as a nuisance dust with low 
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biological activity, many countries have not set a specific exposure limit, deciding instead 
to use the general limit for exposure to dust in the workplace which is 10mg/m3 in the 
UK (Rehn et al., 2003 and Degussa Technical Bulletin 64, 1992). 
In this study, both fine and nanoparticle forms of titanium dioxide were utilised. The fine 
Ti02, obtained from Tioxide Ltd, has a diameter of 250nm. The nanoparticle form, 
obtained from Degussa, has a primary particle diameter of 29nm. The surface areas of 
the two forms of Ti02 used in this study are 6.6 and 49.78 m2/g for the fine and 
nanoparticles respectively (Renwick et al., 2001). As well as existing as single 
particulates, the Ti02 particles may also exist as branching aggregates with a marginally 
lower surface area than that of polydispersed non-agglomerated Ti02 particles. 
1.6.4 Biological Effects of Titanium Dioxide 
The biological and toxicological effects of Ti02 exposure have been well established by 
many independent studies in that most have concluded that it is a relatively inert dust 
with a low biological reactivity (!ARC Monographs, 1989, Chen & Fayerweather., 1988, 
Elo et al., 1972, Lee et al., 1985, Driscoll et al., 1990). The IARC classified Ti02 as a 
group 3 carcinogen, meaning that there is very little evidence for Ti02 exposure resulting 
in cancer in humans. The IARC also examined animal studies with various exposure 
routes (oral, intratracheal instillation, inhalation and subcutaneous injection) and found 
that only very high doses given by inhalation increased the incidence of adenomas and 
carcinomas within the lungs of the animals. Many other studies have focussed on animal 
models to establish pulmonary responses to Ti02, most commonly utilising the rat as the 
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test subject. Lee et al., (1985) conducted a chronic inhalation study exposing rats to Ti02 
for two years. This group showed that no abnormal clinical manifestations or increased 
mortality occurred in the test animals and that only very high doses (250mg/m3) induced 
the occurrence ofbronchioalveolar adenoma and squamous cell carcinomas. 
Ferin et al., (1992) conducted an investigation looking at the retention ofTi02 particles in 
the lung and recorded several observations. It was noted that the nanoparticle fonns of 
the Ti02 entered the interstitium much more readily and rapidly than the larger particles 
and that this was attributed to the particle size and a trend in increased interstitialisation 
as a result of increased dose. The numbers of lavaged neutrophils were higher in the 
nanoparticle Ti02 rats than those in the rats exposed to fine Ti02 indicating a higher level 
of inflammation. Creating a clear picture of the response of rats to high doses of Ti02, 
Warheit et al., (1997) examined the effects of high doses of Ti02 over a period of 4 
weeks. This investigation resulted in the observation that inflammation, as well as 
impairment of macrophage clearance mechanisms could occur when even a relatively 
innocuous dust is given in high doses. The deficiencies in the clearance mechanisms 
were ascribed to the in vitro examination of the decrease in phagocytic ability and 
chemotactic potential of the macrophages from the particle treated animals. 
Another two studies, which examined the effects of the surface coating of titanium 
dioxide particles in inflammatory responses in rats, also raised issues regarding Ti02 
toxicity. A key paper by Hohr et al., (2002) suggested that the surface area ofTi02 was 
responsible for the level of inflammation displayed in treated rats as opposed to the 
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surface coating of the particles. The group used hydrophobic (surface treated) and 
hydrophilic forms of fine and nanoparticle Ti02. After examining the inflammatory 
effects of both the surface treated and the untreated forms of the Ti02, the group 
suggested that it was, in fact, the surface area of the dust that determined the 
inflammatory response rather than the surface coating. These findings were supported in 
an instillation study by Rehn et al., (2003) who examined the inflammatory effects of 
surface treated Ti02. The results indicated that the rats instilled with surface treated Ti02 
samples (silanized with a hydrophobic surface) showed a similar low level of 
inflammation and DNA damage as the rats instilled with untreated (hydrophilic surface) 
Ti02. 
Studies concerned with the effects of titanium dioxide exposure in man have also been 
conducted both from an epidemiological and pathological standpoint. Elo et al., (1972) 
compared the levels of Ti02 found in lung tissue samples from normal individuals to 
those from factory workers exposed to Ti02 pigments on a daily basis. The study found 
titanium present in the tissue as well as in the interstitium and lymphatic vessels of the 
factory workers. This was accompanied by the presence of a mild amount of lung 
fibrosis. An epidemiologic study by Chen and Fayerweather (1988) investigated whether 
workers exposed to Ti02 demonstrated higher levels of lung cancer, fibrosis or chronic 
respiratory disease. This investigation suggested that exposure to Ti02 did not increase 
the risk associated with developing pulmonary fibrosis or any other pathogenic 
respiratory condition. 
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1.7 AIMS 
The aim of this thesis was to investigate the effects of particulates on clearance 
mechanisms present within the lung. The influence of particles on the primary clearance 
functions of macrophages, such as phagocytosis and chemotaxis was assessed, together 
with peripheral factors affecting particle clearance such as complement activation and 
chemotaxin secretion by epithelial cells. The interaction between nanoparticles and zinc 
was also examined with a view to determining the consequences on macrophage 
phagocytosis. 
The aim of the first data chapter (chapter 2) was to assess the potential for particles to 
induce chemoattractant release from type n cells and the potential for the chemoattractant 
to affect macrophage migration. It was hypothesised that exposure to fine and 
nanoparticles will result in the secretion of chemotactic proteins from type II cells and 
that these proteins playa key role in the recruitment of pulmonary macrophages to sites 
of particle deposition and inflammation. 
The aim of chapter 3 was to assess the potential for fine and nanoparticles to activate the 
alternative complement cascade in blood serum is investigated using the macrophage 
chemotaxis assay described in chapter 1. It was hypothesised that, due to their reactive 
surface chemistry, that nanoparticles will activate the alternative complement cascade 
and induce the generation of the chemotactic complement protein C5a. It was also 
hypothesised that exposure of blood serum to PMIO extracts or a pure oxidant such as 
tert-butyl hydroperoxide (tBHP) will also result in C5a production. 
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The aim of chapter 4 was to investigate the effects of PMJO extracts on the pulmonary 
macrophage clearance functions of phagocytosis and chemotaxis using an animal model. 
Biochemical measurements ofpro-inflamrnatory cytokines present in the bronchoalveolar 
lavage fluid were also conducted with a view to assessing any lung damage that had 
occurred. It was hypothesised that the PMJO samples would decrease macrophage 
phagocytic and chemotactic potential and cause increases in the concentrations of pro-
inflammatory cytokines and proteins present in the bronchoalveolar lavage fluid. 
The final data chapter (chapter 5) aimed to investigate the interaction between carbon 
black nanoparticles and zinc salts. The consequences on the phagocytic potential of a 
macrophage cell line exposed to zinc and nanoparticle carbon black was assessed. This 
chapter forms part of a larger study which aims to determine the effects of zinc and 
nanoparticles on various aspects of macrophage function including cytokine production 
and cytoskeletal changes. It was hypothesised that, when mixed together and added to a 
macrophage cell line, the zinc and nanoparticles will interact in a synergistic manner to 
decrease the ability of a macrophage cell line to perform phagocytosis. 
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CHAPTER 2 
MACROPHAGE MIGRATION INDUCED BY TYPE II 
EPITHELIAL CELLS EXPOSED TO FINE AND 
NANOPARTICLES 
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2.1 INTRODUCTION 
2.1.1 Type n Cells and Inflammation 
Chemotaxis is the movement of leukocytes towards a chemotactic substance i.e. where 
the direction of movement is detennined by the concentration gradient of a chemotactic 
substance. Chemotaxis is important for the migration and accumulation of inflammatory 
cells at sites of inflammation (Wilkinson, 1998 and Warheit et ai., 1988). 
Type II cells have been shown to produce chemoattractants such as monocyte 
chemoattractant protein-l (MCP-l) and RANTES. It has also been shown that 
granulocyte monocyte colony stimulating factor (GM-CSF) can be released by type II 
cells. This is a glycoprotein growth factor involved in stimulating the growth of 
macrophages (O'Brien et ai., 1998). Type II cells can also release cytokines such as IL-8 
(Simon and Paine III, 1995). As well as chemokines, type II cells have been shown to 
produce complement proteins such as C5a, which is a potent macrophage chemoattractant 
(Strunk et ai., 1988). This indicates that type II cells can act as important mediators of 
pulmonary inflammation and leukocyte influx into the alveolar space. 
There are several ways in which type II cells can participate in the modulation of 
inflammatory processes in the lung following particle inhalation. As mentioned above, 
the type II cells can release pro-inflammatory proteins such as cytokines, complement 
proteins and growth factors and may also act as antigen presenting cells to lymphocytes 
(Simon & Paine III, 1995). In terms of particle induced macrophage recruitment, studies 
have shown that a-quartz can cause an increase in MIP-2 (the rat equivalent of IL-8) 
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mRNA in type II cells (Driscoll et ai., 1996b). This is consistent with a pro-
inflammatory chemotactic response. Driscoll et ai., (1997b) has also demonstrated that 
TNFa., produced by macrophages exposed to particles, can induce type II cells to release 
chemokines such as MIP-2. Barrett et ai., (1999) showed that the production of MIP-2 
and MCP-l by a murine type II cell line following silica exposure was mediated by TNFa 
which, together with silica exposure, could induce ROS production by the type II cells. 
Becher et ai., (2001) also demonstrated that type II release of IL-6, TNFa and MIP-2 
differed depending on the type of stone particle that the cells were exposed to. 
In terms of chemotaxis of alveolar macrophages towards signals from type II cells, 
O'Brien et ai., (1998) showed that macrophages migrated towards conditioned medium 
obtained from type II cells treated with IL-l a.. This was in response to chemokines in the 
conditioned medium such as RANTES, MCP-l and GM-CSF. Eosinophil and 
lymphocyte chemotaxis in response to IL-16 and eotaxin secretions by type II cells 
stimulated with TNFa and IL-l have also been demonstrated (Cheng et ai., 2001). 
Stimulation of type II cells with bradykinin has also been shown to induce the production 
of proteins that are chemotactic for neutrophils and monocytes (Koyama et ai., 1998). 
Paine III et ai., (1993) also observed increased MCP-l production by type II cells 
stimulated with IL-l and TNFa. It has also been shown that surfactant protein A (SP-A), 
secreted by type II cells, can enhance the release of reactive oxygen species from alveolar 
macrophages (Weissbach et ai., 1994). 
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We hypothesise that exposure of a type II cell line to various fine and nanoparticles will 
result in the release of chemotactic proteins from the type II cells. We further 
hypothesise that these proteins play an important role in the recruitment of macrophages 
towards sites of inflammation. 
This chapter describes a study in which two cell lines are used as a model to look at the 
effects of fine and nanoparticle carbon black on type IT cells, and their potential to induce 
macrophage migration. The toxicity of the particles on both cell lines was examined via 
the measurement of lactate dehydrogenase (LDH) release into the cell culture medium. 
Optimisation of an in vitro chemotaxis assay enabled investigation of alveolar 
macrophage migration towards conditioned medium obtained from particle treated type II 
cells. Following testing in the chemotaxis chamber, several other techniques such as 
differential centrifugation, SDS-PAGE electrophoresis and antibody blocking were 
employed with a view to determining the primary mediators of macrophage migration 
present in the conditioned medium. 
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2.2 MATERIALS AND METHODS 
2.2.1 Chemicals and Reagents 
L-Glutamine (200mM); penicillin-streptomycin (lOOOJ.lg/ml) and foetal bovine serum 
(FBS) were obtained from Invitrogen, UK. RPMI 1640 (without L-glutamine), Zymosan 
A and Bovine Serum Albumin (BSA) were obtained from Sigma Chemicals Company, 
Dorset, UK. The Rapi Diff 2 (Romanowsky) stain set was obtained from Raymond A 
Lamb, London. All other chemicals and reagents were purchased from Sigma Chemicals 
Company, Dorset, UK unless otherwise stated. 
2.2.2 Culture ofL-2 Type n Epithelial Cell Line 
The rat alveolar type II cell line L-2 was obtained from the European Collection of 
Animal Cell Cultures (Salisbury, England). The cells were grown in 25cm2 tissue culture 
flasks in RPMI 1640 medium supplemented with 1 % L-glutamine, 1 % 
penicillin/streptomycin and 10% heat inactivated FBS. Cultures were incubated in a 
humidified incubator at 37°C / 5% CO2• Cell counts were performed using 0.3% trypan 
blue exclusion (l:1 dilution with cells) and an improved Neubauer haemocytometer. 
Cells were removed from the flask by adding 1 x trypsin / EDT A in Hanks balanced salt 
solution (HBSS) and incubating for 5 minutes, then centrifuged at 900 g for 2 minutes 
and resuspended in RPMI 1640 supplemented with 10% FBS. 
2.2.3 Culture of J774.2 Macrophage Cell Line 
The adherent murine monocytic-macrophage cell line 1774.2 was obtained from the 
European Collection of Animal Cell Cultures (Salisbury, England). The cells were 
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grown in 25cm2 tissue culture flasks in RPMI 1640 medium supplemented with 1 % L-
glutamine, 1 % penicillin/streptomycin and 10% heat-inactivated FBS. Culture flasks 
were stored in a humidified incubator at 37°C and 5% C02. Cell counts and viability 
were assessed using an improved Neubauer haemocytometer and trypan blue exclusion. 
All cells that were found to be non-adherent in the culture flasks were discarded by 
washing prior to use. 
2.2.4 Particles 
The particles used in these experiments were fine carbon black (H.Haeflher & Co Ltd., 
Chepstow, UK), fine titanium dioxide (Tioxide Ltd.) and nanoparticle carbon black and 
titanium dioxide (Degussa, UK). The particle diameter and surface area are shown in 
table 1.5. 
2.2.5 Treatment of Cells 
Cells were seeded at 40,000 cells per well in a 96 well plate and incubated for 24 hours in 
RPMI 1640 supplemented with 10% FBS. Serial dilutions (62.5 - 2000llg/ml by mass 
dose) of each type of particle were prepared in serum-free RPMI and sonicated for 5 
minutes before use. After 24 hours, the medium was removed from the cells and 
replaced with appropriate concentrations of particle before incubation for a further 24 
hours. Following particle treatments, the medium was removed from the cells and 
centrifuged for 30 minutes at 15000 g to remove the particles. The supernatants were 
removed and stored in separate tubes at -80°C for use in the LDH assay. 
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2.2.6 LDH Assay Controls 
Control samples for the LDH assay were prepared by lysing cells with 50J.ll of 0.1 % 
Triton X-IOO dissolved in phosphate buffered saline (PBS). The solutions were then 
centrifuged at 11 ,000 g for three minutes and 10J.ll of the supernatant was used as a 
positive control to indicate total releasable LDH. A negative control was obtained by 
incubating the cells with serum-free medium. 
To create a standard curve, pyruvate standards were prepared (using distilled H20 and 
Img/ml NADH dissolved in 0.75mM sodium pyruvate), ranging in concentrations 
equivalent to 0 - 2000 Units/ml of LDH. One unit of LDH activity is defined as the 
amount of LDH that reduces 4.8 x 104 J.lmol of pyruvate in 1 minute at 25°C. The 
standards were transferred (60J.l1) in triplicate, to a 96-well plate. Into all of the 
remaining wells of the plate, 50J.ll ofNADH was added. The samples were incubated at 
37°C / 5% C02 for 5 minutes. 
The test and control samples (IOJ.ll) were added to the relevant wells on the plate 
containing the NADH solution. The plate was incubated at 37°C, 5% C02 for 30 
minutes. Following incubation, 50J.ll of2, 4-dinitrophenylhydrazine (O.2mg/ml dissolved 
in 1 M HC1) was added to all of the wells and the plate was left for 20 minutes at room 
temperature. Sodium hydroxide (50J.ll of 4M concentration) was then added to each well 
and the plate was left at room temperature for 5 minutes. The plate was shaken for 5 
seconds and the absorbance of all the wells was measured at 540nm with a Dynex MRX 
microplate reader. 
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2.2.7 Chemotaxis Chamber - Overview 
The chemotaxis apparatus utilised in these studies was are-usable 96-well Neuroprobe 
chemotaxis chamber (Receptor Technologies, UK) consisting of an upper and lower half. 
The samples being tested for potential to induce macrophage migration (301l1) are 
pipetted into wells on the bottom half of the chamber, overlaid with a polycarbonate 
filter, which is then covered by the top half of the chamber. Macrophages are then loaded 
into the top wells of the chamber and allowed to migrate through. The non-migrated 
macrophages are washed off the top of the filter with PBS and the filter stained with 
Romanowsky stain (5 washes in each solution followed by 5 washes in distilled water). 
Once the staining is complete, the optical density of each well can be read using a 
multiwell plate reader. Increasing absorbance correlates with the increasing number of 
macrophages moving through the filter. 
2.2.8 Chemotaxis Protocol 
Each sample (301l1) was loaded, in triplicate, into the bottom wells of the chamber. A 
Neuroprobe polycarbonate filter (pore size 51lM) was inserted between the layers. J774.2 
macrophages (2 x 105) in 200111 of serum-free RPMI 1640 were added to the top of each 
well. The chamber was incubated at 37°C in 5% CO2 for 6 hours and the filter was 
removed, washed and stained with a Romanowsky stain as described in section 2.2.7. 
The absorbance of the filter was read at 540nm in a Dynex multiwell plate reader. 
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2.2.9 Zymosan Activated Serum (ZAS) 
ZAS is a known activator of C5a in blood serum and, as such, has been utilised in 
numerous studies as a positive control in chemotaxis assays. A stock solution of 
Zymosan A in saline (10mglml) was prepared and sonicated for 5 minutes to ensure 
adequate dispersal of the Zymosan particles. The stock Zymosan solution (100J,ll) was 
added to 900J,l1 of FBS. To prepare a control solution, 100J,l1 of sterile saline was added 
to 900J,l1 serum. Both solutions were incubated in a shaking water bath at 37°C for 2 
hours and then at 56°C for 30 minutes. The solutions were centrifuged for 5 minutes at 
2000 g then aliquoted and stored at -80°C until use. For use in the chemotaxis assay, 
both solutions were diluted to the appropriate concentration using serum-free RPM! 
1640. 
Experiments were conducted to determine the optimum incubation times and ZAS 
concentrations to use in the chemotaxis assay. A solution of ZAS (lmglml) and a 
negative control were prepared as detailed above. For the concentration response 
experiments, both solutions were diluted to 2%, 5%, 10% and 20% with RPMI 1640 
medium. Solutions were then tested using the chemotaxis protocol as described in 
section 2.2.8. For the time course experiments, 10% ZAS solution was prepared and 
tested in the chemotaxis chamber as detailed above. The cells were incubated in the 
chamber for 45 minutes, 90 minutes, 3 hours or 6 hours before the filter was removed and 
stained. 
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2.2.10 Exposure ofL-2 Cells to TNFa 
L-2 cells were seeded in a 96-well plate at a cell count of 40,000 cells per well and 
incubated overnight. Rat TNFa (Biosource, UK) was prepared at three different 
concentrations; 0.1, 1 and 1Ong/ml using sterile PBS containing 0.1 % bovine serum 
albumin. The medium from the L-2 cells was removed and replaced with 200fli ofTNFa 
at the required concentration. TNFa was also added at an equivalent concentration to 
wells that did not contain any L-2 cells in order to provide a cell-free comparison. 
Negative controls were prepared by adding serum-free RPMI to both the L-2 cells and the 
cell-free wells. The plate was incubated in a humidified incubator at 37°C and 5% CO2 
for 6 hours. Following incubation, the supernatants were removed and tested for 
potential to induce macrophage migration using the chemotaxis assay protocol as 
described previously. 
2.2.11 L-2 Cells and Particles 
A 96-well plate was seeded with L-2 cells (40,000 cells per well) and incubated overnight 
in a humidified incubator at 37°C and 5%C02. Suspensions of fine and nanoparticle 
carbon black and titanium dioxide were prepared in serum-free RPMI at a concentration 
of 125 flg/ml. The suspensions were sonicated for 10 minutes prior to use. A 1 ng/ml 
solution was also prepared in 0.1 % BSA in PBS. The dust suspensions and TNFa were 
added to the relevant wells in the 96-well plate with L-2 cells. A duplicate cell-free 96-
well plate was also prepared using identical solutions of TNFa and dust suspensions. 
Both 96-well plates were subsequently incubated in a humidified incubator at 37°C and 
5% C02. After 24 hours incubation, the two plates were removed and the supernatants 
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were extracted and stored in eppendorf tubes. The eppendorf tubes were centrifuged at 
15,000 g for 15 minutes and the supernatants transferred to fresh tubes. The samples 
were stored at -80°C prior to analysis. 
2.2.12 Preparation ofL-2 Conditioned Medium 
Trypsin in HBSS (Ix) was added to a flask ofL-2 cells at approximately 80% confluency 
and incubated for 5 minutes at 37°C / 5% CO2. Serum-free RPMI culture medium 
(lOmls) was added to the cells and the cells were centrifuged at 900 g for 2 minutes. The 
supernatant was decanted and the cells were resuspended in normal culture medium. Cell 
counts were assessed and adjusted to 1 million cells per ml. The cells were seeded in a 6 
well plate at 1 million cells per well and incubated overnight. 
To prepare particle suspension, fine and nanoparticle carbon black was weighed out and 
suspended in serum-free RPM!. The suspension was sonicated for 10 minutes and 
diluted to 125 Jig/ml of particles. The particle suspensions (200Jil) were added to the 6-
well plate and incubated for 24 hours. Cells were also incubated with serum-free RPMI 
for 24 hours. Following incubation, the conditioned medium was removed and 
centrifuged at 15,000 g for 15 minutes and the supernatants were pooled and stored at-
80°C until use. 
2.2.13 SDS-PAGE Gel Electrophoresis ofL-2 Conditioned Medium 
A 15% separating gel was prepared by mixing 23% distilled H20, 50% Acrylamide mix, 
25% Tris HCI (1.5 M, pH 8.8), 1% sodium dodecyl sulphate (SDS, 10%) and 1% 
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ammonium persulphate (APS, 10%). TEMEO was added at a concentration of 0.04% 
immediately prior to pipetting the gel into the casting apparatus. A stacking gel was 
prepared by mixing 68% H20, 17% Acrylamide mix, 12.5% Tris HCI (0.5 M, pH 6.8), 
1% SOS (10%) and 1% APS (10%). TEMEO was added at a concentration of 0.1% 
immediately prior to adding the gel to the separating gel in the casting apparatus. 
Immediately following addition of the stacking gel to the casting apparatus, 1 ~l of 
bromophenol blue was added to the stacking gel. 
To prepare the samples, 20~1 ofL-2 conditioned medium was pipetted into an eppendorf. 
For the non-reducing gel, 30~1 of sample buffer was added to the conditioned medium. 
For the reducing gel, 27~1 of sample buffer and 3~1 of OTT was added to each of the 
samples. Both sets of samples were then incubated on a heating block; 1 minute 
incubation for non-reducing samples and 2 minutes for reducing samples. After heating, 
the samples were immediately stored on ice. 
Once cast, the gels were transferred to an electrophoresis tank and immersed in 1 x 
buffer. Samples (20~l) as well as coloured molecular weight markers were added to the 
gels and the electrophoresis was run at 40mA for 45 minutes. Both gels were stained 
with the Coomassie blue stain overnight and de stained by microwaving (3 x 1 minute) the 
gels in fresh distilled water. 
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2.2.14 Differential Centrifugation ofL-2 Conditioned Medium 
Conditioned medium obtained from L-2 cells treated with nanoparticle carbon black 
according to the protocol in section 2.2.12 was separated according to molecular weight 
using Vivaspin 2 centrifuge filters (supplier) operated according to manufacturers' 
instructions. A 30kDa filter was used first, followed by a 10kDa filter and finally a 5kDa 
filter. Supernatants were stored at -80°C until tested for potential to induce macrophage 
migration using the chemotaxis protocol outlined in section 2.2.8. 
2.2.15 Statistical Analysis 
Results are expressed as the mean ± SEM. All figures are the results of three separate 
experiments with three observations in each unless otherwise stated. Statistical analysis 
was accomplished by a one-way ANOVA with Tukey's multiple comparison. 
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2.3 RESULTS 
2.3.1 LDH Release by J774.2 Cells Following Treatment with Fine & Nanoparticle 
Carbon Black and Titanium Dioxide 
Figures 2.1 and 2.2 show LDH concentrations in conditioned medium obtained from 
1774.2 cells treated for 24 hours with either fine or nanoparticle carbon black or titanium 
dioxide. The graphs indicated that, in this study, all types of particle tested showed 
cytotoxic effects towards the cells. The results also suggested that the nanoparticles 
induced a slightly cytotoxicity at the same mass dose of particles but this was not 
significant. The higher doses (l-2mg/ml) of all types of particle induced what appeared 
to be maximum LDH release. The dose-dependant increases in LDH concentration 
should be noted following doses up to and including 1 mg/ml although no further increase 
was noted with the dose of2mg/ml. 
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Figure 2.1 LDH release from 1774.2 cells following exposure to varying doses offine and 
nanoparticle Ti02 for 24 hours. All values are the mean ofthree experiments conducted in 
triplicate ± SEM. 
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Figure 2.2 LOH release from 1774.2 cells following exposure to varying doses offine and 
nanoparticle carbon black for 24 hours. All values are the mean of three experiments 
conducted in triplicate ± SEM. 
2.3.2 LDH Release by L-2 Cells Following Treatment with Fine & Nanoparticle 
Carbon Black and Titanium Dioxide 
LDH release from untreated L-2 cells was inherently lower than that of the 1774.2 cells 
(figures 2.3 and 2.4). Treatment with Img/ml fine and nanoparticle titanium dioxide 
resulted in the detection of high concentrations of LDH. Fine and nanoparticle carbon 
black treatment ofL-2 cells resulted in similar effects to those induced by Ti02 particles. 
Doses of I and 2mglml of nanoparticle carbon black resulted in a significant increase in 
LDH release compared to the negative control (p<O.05). As with the 1774.2 cells, LDH 
release from the L-2 cells increased in a dose dependant manner until a maximum was 
reached at a particle concentration of around Imglml. However, this was noted to be 
marginally lower than the LDH concentrations observed following cell lysis with Triton 
X-IOO (positive control). 
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Figure 2.3 LOH release from L-2 cells following exposure to varying doses offine and 
nanoparticle Ti02 for 24 hours. All values are the mean of three experiments conducted in 
triplicate ± SEM. Asterisks denote a significant difference from the negative control 
(* p<O.05). 
2500 
2000 
* 
- FineCB 
1500 
- Nanoparticle CB 
- Negative control 
1000 - • Positive control 
50°r-it====~~==~~--t-------------------
oL--+------~~------------------------31:25 62.5 125 250 500 1000 2000 
Particle Dose (~9/ml) 
Figure 2.4 LDH release from L-2 cells fullowing exposure to varying doses offine and 
nanoparticle carbon black for 24 hOUTS. All values are the mean ofthree experiments 
conducted in triplicate ± SEM. Asterisks denote a significant difference from the negative 
control (* p<O.05). 
2.3.3 Concentration and Time Course Studies with ZAS and J774.2 Macrophages 
Figure 2.5 shows the effects of varying concentrations ofZAS on macrophage migration 
following a 6 hour incubation period. The graph shows that the absorbance of the 
70 
chemotaxis filter increases as the concentration of ZAS increases from 2-20%. An 
increasing absorbance correlates with increasing numbers of macrophages moving into or 
through the polycarbonate filter. Significant increases in macrophage migration were 
observed at both 10% and 20% dilutions of ZAS. This was compared to the negative 
control of FBS incubated with sterile saline which indicated that no significant increases 
in macrophage migration were taking place. 
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Figure 2.5 - The effect of varying concentrations of zymosan activated serum (ZAS) 
on macrophage migration compared to a negative control of non-activated serum. (6 
hour incubation time). Asterisks denote a significant difference from the control (* 
p<O.05 and ** p<O.OI). 
ZAS induced significant increases (p<0.001) in macrophage migration at both the 3 hour 
and 6 hour time points (Figure 2.6). The highest level of macrophage migration was 
found at the 6 hour time point where macrophage migration was found to be 8 fold 
greater than that of the negative control. The negative control did not display any 
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potential for inducing macrophage migration and thus may serve as an indicator that 
random macrophage migration was minimal. 
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Figure 2.6 - A time course examination of macrophage migration towards 10% 
zymosan activated serum (ZAS) compared to a negative control of non-activated 
serum. Asterisks denote a significant difference from the control (*** p<O.OOI) 
2.3.4 Macrophage Migration Stimulated by Conditioned Medium from L-2 Cells 
Exposed to TNFa. 
L-2 cells were exposed to 1NFa. in order to induce the secretion of pro-inflammatory 
mediators such as chemotactic proteins. 1NFa., at a concentration of lng/ml, induced a 
significant increase in macrophage migration (p<O.05) compared to the negative control 
(figure 2.7). However macrophage migration was also noted at both the lower and higher 
TNFa. concentrations although this was not significant. TNFa. alone, at comparable 
concentrations to those used for cell treatments, induced minimal macrophage migration. 
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Figure 2.7 - The chemotactic effect of conditioned medium from L-2 cells exposed 
for 6 hours to varying doses ofTNFa compared with TNFa alone. Asterisks denote 
a significant change from the cell free TNFa treatment (* p<O.05). Graph shows 
the result of one experiment with three replicates. 
2.3.5 Macrophage Migration Stimulated by Conditioned Medium from L-2 CeUs 
Exposed to Fine and Nanoparticle Carbon Black and Ti02 
When compared to the negative control, nanoparticle carbon black treatment ofL-2 cells 
generated a conditioned medium that induced a significant increase (p>O.Ol) in the 
stimulation of macrophage migration (Figure 2.8). In comparison, conditioned medium 
from L-2 cells treated with fine Ti02, CB and nanoparticle Ti02 did not induce any 
significant increases in macrophage migration. It should also be noted that both fine and 
nanoparticle carbon black treatment of L-2 cells did induce significant increases in 
macrophage migration compared to medium incubated with the particles alone (p<O.Ol 
and p<O.OOl for fine and nanoparticle carbon black respectively). 
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Figure 2.8 - Macrophage migration induced by L-2 cell supernatant following 
treatment for 6 hours with 12SJ.l.g/ml fme and nanoparticle Ti02 and carbon black 
(striped bars indicate cell free treatments). Asterisks denote a significant increase 
compared to the negative control (* p<O.OS, ** p<O.Ol and *** p<O.OOl). 
Significant increases from the appropriate cell-free treatments are denoted by a cross 
(++ p<O.Ol and +++ p<O.OOl). 
2.3.6 SDS-PAGE Electrophoresis of Conditioned Medium from L-2 Cells Treated 
with a Sub-Toxic Dose ofNanoparticle Carbon Black 
Figures 2.9.1 and 2.92 show photographs of non reducing SDS-PAGE gels which were 
run with conditioned medium obtained from L-2 cells treated for 24 hours with either fme 
or nanoparticle carbon black (12SJ.l.g/ml). Cells were also incubated with serum-free 
medium for 24 hours and this conditioned medium was run together with other two 
treatments as a negative control. As can be seen from both gels, no protein bands were 
present following the treatments used. 
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Figure 2.9.1 and 2.9.2 - SDS-PAGE gels of conditioned medium from untreated L-2 
cells and L-2 cells treated with 125J.lg fine or nanoparticle carbon black for 24 hours. 
Gels were both run in non-reducing conditions. Marker bands and corresponding 
molecular weights (kDa) are indicated at the left hand side of each gel. 
M= Medium Only, F=Fine carbon black treatment, N=Nanoparticle carbon black 
treatment 
Figures 2.10.1 and 2.10.2 show conditioned medium obtained from similar particle 
treatments but run under reducing conditions. As can be seen from both gels, bands are 
present in all three treatments. It should be noted that figure 2.10.1 shows an especially 
clear representation of these bands. As can be seen from figure 2.10.1, an increased 
density and number of protein bands are observed in the lane containing the conditioned 
medium obtained from cells that have been treated with nanoparticle carbon black. Very 
clear bands are noted around the 14kDa weight and, as can be seen from the photograph, 
the density of this band is increased in the lane containing the nanoparticle treated 
conditioned medium. 
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Figure 2.10.1 and 2.10.2 - SDS-PAGE gels of conditioned medium from L-2 cells 
treated with 125~g fine or nanoparticle carbon black for 24 hours. Gels were both 
run in reducing conditions via the addition ofDTT . Marker bands and 
corresponding molecular weights (kDa) are indicated at the left hand side of each 
gel. 
M= Medium Only, F=Fine carbon black treatment, N=Nanoparticle carbon black 
treatment 
2.3.7 Differential Centrifugation and Macrophage Migration Studies of Conditioned 
Medium Obtained from L-2 Cells Treated with a Sub-Toxic Dose of Nanoparticle 
Carbon Black 
The conditioned medium generated by nanoparticle carbon black treatment (125)lg/ml) of 
L-2 cells was fractionated by centrifugation through size selective filters. It was found 
that the fraction sizes of 5-10 kDa and 10-30 kDa both induced a significant increase in 
macrophage migration (p<0.01) when compared to the negative control. The other two 
fractions (0-5 and >30 kDa) did not induce a significant increase in macrophage 
migration (Figure 2.11). 
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Figure 2.11 - Macrophage migration induced by centrifuge fractions of conditioned 
medium from L-2 cells treated with nanoparticle carbon black (12SJ..lg/ml) for 24 
hours. Asterisks denote a significant increase compared to the negative control (* 
p<O.OS, ** p<O.OI, *** p<O.OOI). 
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2.4 DISCUSSION 
2.4.1 Particle Toxicity 
Studies have shown that nanoparticles can be more toxic than an equivalent mass dose of 
fine particles (Stone et al., 1998). This is hypothesised to be due to the larger surface 
area of the particles and resulting oxidative stress. Figures 2.1 and 2.2 show LDH release 
from 1774.2 cells treated with varying doses of fine and nanoparticle carbon black and 
titanium dioxide. Although the results suggest that the nanoparticles exhibit a slightly 
higher toxicity than the fine particles, this effect was not significant. 
The concentration of LDH detected in the J774 conditioned medium increased in a dose 
dependant manner correlating with the increased dose of particulates. The maximal LDH 
release was obtained when cells were treated with 1-2 mg/ml of either fine or 
nanoparticles Ti02 or carbon black particles. At lower doses of both fine and 
nanoparticle carbon black, it was noted that the LDH concentrations detected in the 
conditioned medium were lower than that observed in the conditioned medium that had 
been obtained from untreated cells. 
The cytotoxicity that was observed when treating 1774.2 cells with fine particles and 
nanoparticle was further confirmed when similar treatments were conducted with the 
alveolar type II epithelial cell line L-2. Figures 2.3 and 2.4 indicate that, at the doses 
tested in this study, the nanoparticles appeared to demonstrate a moderately increased 
toxicity towards the cells. Indeed, at a dose of Img/ml of both types of nanoparticle 
tested, there was a significant increase in the concentration ofLDH detected compared to 
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the negative control. While the results of these experiments may provide an accurate 
representation of particle cytotoxicity by measuring LDH concentrations, it is possible 
that LDH may have been adsOlbed on the surface of the particles following release from 
the cells. Desai and Richards (1978) and Jones et al., (1972) both noted how different 
types of biological molecules could be adsorbed on to the surface of inorganic and 
mineral dusts. Brown et al., (2000) also showed extensive binding ofBSA to the surface 
of nanoparticle carbon black. This may occur when measuring LDH concentrations, 
especially when taking into account the large surface area of the nanoparticles and 
potential for protein adsorption. 
It should be noted that the 1774.2 cells released an inherently high concentration ofLDH 
even when no particles were used in the treatments. This may be attributed to the minor 
physical trauma induced during the scraping procedure by which the cells were removed 
from the culture flask prior to seeding in the microplate. Inter-species differences (i.e. rat 
versus murine) in the intracellular LDH content may also account for the differences in 
resting LDH concentration, as well as differences between two types of cells i.e. type II 
epithelial and macrophage. Certainly, differences in species-related responses to the 
same particulate have indeed been noted (Donaldson & Tran, 2002), and this may have 
had some influence on the results displayed here. Primary isolated cells may also behave 
in a different manner to those cell lines utilised !n this study and this may be a worthy 
area of comparison to study. 
79 
2.4.2 Macrophage Migration 
Dose and time response experiments were conducted with J774 macrophages with a view 
to optimising the chemotaxis assay. Zymosan activated serum has been used a positive 
stimulatory agent to induce macrophage chemotaxis in numerous studies (Donaldson et 
al., 1989, 1990 and Warheit et aI., 1985). Zymosan A is a polysaccharide extracted from 
yeast cell walls and generates large quantities of the macrophage chemoattractant C5a 
when added to serum (Snyderman et al., 1971). Figure 2.5 shows macrophage migration 
towards ZAS and non-activated serum that was diluted to a range of concentrations from 
2-20%. Increases in macrophage migration correlated with increases in the concentration 
of ZAS with significant increases in macrophage migration observed at ZAS 
concentrations of 10% and 20% (p<0.001). Therefore, it was decided, based upon a 
review of the relevant literature and the results indicated in Figure 2.5, that 10% ZAS 
would be an adequate concentration to use as a positive control in future studies using the 
chemotaxis chamber. 
Figure 2.6 shows the effects of chamber incubation time on the level of macrophage 
migration. Other macrophage chemotaxis studies have routinely allowed at least 3 hours 
incubation time to allow macrophages to complete shape change and migration 
(Milanowski et al., 1995, Warheit et al., 1985 and Donaldson et al., 1989, 1990). While 
3 hours incubation appeared to allow for a significant level of macrophage migration to 
take place, it was felt that 6 hours would provide more opportunity for the macrophages 
to migrate through the filter. This decision took into consideration the fact that future 
chemotaxis studies would be testing a very dilute conditioned medium and as such, 
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macrophages responses could possibly be slower than those observed with Zymosan 
activated serum. Previous investigations in the research group using prima,ry alveolar 
macrophages had encountered problems in measuring macrophage migration and it was 
not understood if shorter incubation times had contributed to these observations. 
2.4.3 Macrophage Migration in Response to Signals from Particle Treated Type II 
Cells 
Prior to conducting particle treatments on L-2 cells, a preliminary experiment was 
conducted to determine if stimulation by a potent pro-inflammatory cytokine such as 
TNFa could induce the type II cells to release macrophage chemoattractants. Figure 2.7 
shows the results of an experiment where L-2 cells were treated with varying 
concentrations of recombinant rat TNFa for 6 hours. The cells were also exposed to 
TNFa at equivalent concentrations for 24 hours (data not shown) but macrophage 
migration towards these conditioned medium samples did not display any significant 
changes. As can be seen from the graph, a significant increase in macrophage migration 
was observed when the L-2 cells were treated with TNFa at a concentration of Ing/ml for 
6 hours. A similar macrophage response was not observed in the cell free supernatants 
i.e. TNFa at equivalent concentrations that had been incubated for 6 hours in cell-free 
wells. The results from this experiment indicate that the L-2 cells were capable of 
releasing macrophage chemoattractants following pro-inflammatory stimulation. The 
fact that similar increases in macrophage migration were not observed with the TNFa 
alone indicated that the TNFa did not exert a chemotactic influence on the macrophages 
and that any chemoattractants present in the conditioned medium that were influencing 
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macrophage migration were released by the L-2 cells into the medium. It was decided 
that a TNFa treatment (lng/mt) would also be used in experiments examining L-2 
responses to particle treatments. This correlates well with results published by Standiford 
et ai., (1991), Paine III et ai., (1993) and O'Brien et aI., (1998) which state that TNFa is 
able to induce the secretion of chemoattractants from type II epithelial cells. Studies 
have also shown that other cytokines such as IL-9 induce the release of chemoattractants 
from bronchial epithelial cells (Little et ai., 2001). However, TNFa has been shown to be 
present in the BAL fluid of particle treated animals in many in vivo studies (Schins et ai., 
2004, Becher et aI., 2001 and Li et ai., 1999) as well as being detected in in vitro studies 
(Jimenez et ai., 2002). As such, TNFa was considered to be a better candidate to induce 
epithelial cell inflammatory processes and was used in subsequent experiments as an 
additional positive control. 
Based on the results shown in figures 2.4 and 2.5, it was decided that 125ug/ml would act 
as a sub-toxic dose for all particles tested. Figure 2.8 shows the results of an experiment 
where L-2 cells were treated with four different types of particles for 24 hours and the 
conditioned medium that was generated was tested for potential to induce macrophage 
migration. As can be seen from the graph, the nanoparticle carbon black treatment of the 
L-2 cells generated a conditioned medium that induced a significant increase in 
macrophage migration compared to the negative control, whereas none of the other 
particle treatments had a significant effect on macrophage migration. This would 
indicate that the carbon black nanoparticles, as well as showing increased cytotoxicity, 
are able to stimulate the release of macrophage chemoattractants when exposed to L-2 
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cells at sub-toxic doses. Cell-free treatments were also conducted to determine whether 
any soluble substances present on the surface of the particles had the potential to directly 
induce macrophage migration. This took into consideration studies by Milanowski et al., 
(1995) which showed macrophage chemotaxis towards bacterial and fungal products 
extracted from organic dust samples. 
Following the experiments using four different particle types, it was decided that further 
experiments should focus upon the effects of the nanoparticle carbon black on the L-2 
cells and the elucidation of the products that were released from the type II cells as a 
result of particle exposure. Figures 2.9.1 and 2.92 show SDS-PAGE gels of conditioned 
medium obtained from L-2 cells treated with 125~g of either fine or nanoparticle carbon 
black. As can be seen from the gels, no bands were visible below the 45kDa molecular 
weight. Figures 2.10.1 and 2.102 are gels with the same treatments but with the addition 
of the reducing agent DTT. As can be clearly seen from figure 2.10.1, a higher number 
of protein bands are present in the nanoparticle carbon black conditioned medium 
compared to the medium obtained from the fine carbon black and untreated cells. This 
indicates that an increased number and concentration of proteins were released from the 
type II cells into the conditioned medium as a result of the nanoparticle carbon black 
exposure. This may a~count for the increased macrophage migration observed when 
exposing macrophages to conditioned medium obtained from cells exposed to 
nanoparticle carbon black. The increased bands are present in the molecular weight 
range of approximately 14 - 35 kDa. A subsequent experiment where the conditioned 
medium was centrifuged through molecular weight filters and then tested in the 
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chemotaxis chamber indicated that the substance(s) that induced macrophage migration 
was located in the 5 - 30 kDa weight range. This is based on the observation that the 5-
10 kDa and 10-30 kDa fractions of the conditioned medium induced a significant 
increase in macrophage migration compared to the negative control. Antibody blocking 
experiments using antibodies for rat C5a, MIP-2 and RANTES were attempted but were 
unsuccessful (data not shown). 
The regulation and stimulation ofleukocyte recruitment in the lung is an important factor 
in the regulation of inflammation and several mechanisms exist to ensure that a 
homeostatic environment exists (Fantone & Ward, 1983). The response of macro phages 
to signals derived from other cells is a topic that has generated a lot of interest. Indeed, 
studies have been conducted which investigate macrophage chemotactic responses to 
signals from neutrophils (Donaldson et ai., 1989), from type II cells (O'Brien et ai., 
1998) and from other macrophages (Brieland et ai., 1995). Other studies have focussed 
on the inhibition of macrophage chemotaxis induced by molecules such as the 
lymphocyte-derived macrophage migration inhibitory factor (MIF), described by 
Hermanowski-Vosatka et ai., (1999) which inhibits macrophage movement. As 
described previously in section 2.1.1., several studies have demonstrated that type II cells 
can secrete a wide range of pro-inflammatory mediators capable of inducing macrophage 
migration to sites of inflammation. It is likely that, due to the highly toxic nature of 
carbon black nanoparticles, an increased amount of proteins designed to induce 
macrophage recruitment are secreted by the type II cell line utilised in this study. This 
may indicate an adaptive response of lung epithelial cells which would aid in the rapid 
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recruitment of inflammatory cells to sites of particle deposition and the subsequent 
removal of the particles by phagocytic cells such as macrophages and neutrophils. 
Future studies in this area could focus on the identity of the substances released by the 
type II cells in response to particle exposure. This study indicates that the factors 
inducing macrophage migration are of a molecular weight that is between 5 and 30kDa. 
However, due to the wide range of substances released by the type II cells, it is likely that 
no one single substance is responsible for inducing macrophage recruitment and, as such, 
further experiments in this area may involve deciphering the complex mixtures of 
chemotactic molecules released by the type II cells to ascertain their specific cellular 
targets. Other investigations may attempt to examine the effects of other forms of 
particles as well as various components of particulate air pollution. 
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CHAPTER 3 
THE EFFECTS OF NANOPARTICLES ON SERUM-
INDUCED MACROPHAGE MIGRATION 
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3.1 INTRODUCTION 
3.1.1 The Complement System 
It has long been accepted that the complement system is an integral part of the innate 
immune system involved in mediating inflammatory responses to foreign organisms and 
particulates. The complement system itself has evolved over a period of around 700 
million years to aid in the removal of any foreign or pathogenic substances from the body 
(Sahu & Lambris, 2000 & Sunyer & Lambris, 1999). There are several ways in which 
the complement system can accomplish this. 
Firstly the complement system recognises foreign material, and labels it for removal by 
phagocytes. The process is known as opsonisation. The complement system is also 
involved with removing self-reactive B cells from circulation as well as primary 
production of the 'membrane attack complex', a bacteriolytic complement arrangement 
(Barrington et ai., 2001). Finally, the complement system is capable of generating 
localised inflammation via release of anaphylatoxins into specific tissues. This is the 
concept which is most important in this chapter and one which deals with the 
understanding of macrophage migration (Barrington et aI., 2001, Sunyer & Lambris 1999 
and Sahu & Lambris, 2000). 
The principles behind macrophage migration were dealt with in the previous chapter, 
focusing on pulmonary macrophagic responses to inhaled particulates using an in vitro 
model. In this chapter, the ability of fine and nanoparticles to activate the complement 
cascade is studied, utilising a similar in vitro model as used in the previous chapter. 
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3.1.2 Chemotactic Complement Proteins 
Complement proteins are circulating components of normal plasma which are produced 
by the spleen, the liver and by cells such as macrophages (Johnson & Hetland, 1988). 
The proteins circulate in the blood until the cascade is activated, either by antibody 
binding to an antigen or a complement component binding to the surface of a pathogen. 
These two common pathways of complement activation are the 'classical' pathway 
(Arlaud and Colomb, 1998) and the 'alternative' pathway, both culminating in the 
cleavage of the complement protein C3 (Janeway & Travers, 1999, Zipfel, 1999 and 
Ward, 2004). 
When the alternative pathway of the complement cascade is activated (Figure 3.1), C3 is 
cleaved and two anaphylatoxins (C3a and C5a) are produced (Sahu & Lambris, 2000). 
C5a is a potent chemoattractant for macrophages and neutrophils and acts, therefore, as a 
primary mediator for macrophage recruitment and subsequent particle clearance. 
Therefore, the toxicity of a given particulate may depend on the particulate potency in 
activating the alternative complement cascade (Warheit et al., 1988). 
3.1.3 Complement in the Lung 
Studies have shown that complement proteins are present in the lung, on the surface of 
the alveolar epithelium and in the alveolar lining fluid (Watford et al., 2000). Strunk et 
al., (1988) demonstrated that lung epithelial cells could secrete complement proteins 
from both the alternative and classical pathways. Cole et al., (1983) showed that human 
bronchoalveolar macrophages could secrete complement proteins C2 and C3, but that this 
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can be affected by disease state. Johnson and Hetland (1988) reviewed several studies, 
and illustrated that macrophages possessed the ability to produce a complete set of 
complement proteins. The presence of complement proteins in the lung fluid and on the 
tissues may act as an early defence mechanism to facilitate phagocytosis and clearance of 
foreign particles. 
Alternative Classical 
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C3 --------... C3a 
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Anaphylatoxins 
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C7 
t 
C8 
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C9 
Figure 3.1 - The Complement Cascade 
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3.1.4 Complement Activation by Particles and Fibres 
There have been many studies showing that asbestos can activate the alternative 
complement pathway, resulting in the generation of C5a proteins. Saint-Remy et al., 
(1980), Wilson et al., (1977) and Warheit et al., (1985) have all demonstrated that 
different types of asbestos fibres have the capacity to activate the alternative complement 
pathway in serum both in vivo and in vitro. Kanemitsu et al., (1998) reported that diesel 
exhaust particles could also activate complement. In a more recent publication by 
Governa et al., (2002), crystalline silica was also found to have the potential to cleave the 
complement protein C5 to produce a C5a-like product. This was hypothesised to be due 
to oxidative stress taking place via redox-active iron present on the silica surface. This 
obviously has important implications for silica-induced lung disease as well as 
stimulating questions regarding particulates and their potential to activate the alternative 
complement cascade. Warheit et al., (1988) concluded that alveolar macrophages are 
attracted to sites of deposition via complement activation and that the clearance of a 
given particulate depends on its potential to activate complement. 
3.1.5 Particles and Free Radicals 
As mentioned previously, there have been several studies showing that the large surface 
area of fine and nanoparticles demonstrates a high potential for the generation of reactive 
oxygen species and their subsequent cytotoxicity following inhalation or instill;:ttion into 
the alveolar space. For example, in a study by Li et aI., (1996), it was shown that PMlO 
generated free radical activity in vitro, and induced oxidative stress in vivo resulting in 
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pulmonary inflammation. A study by Gilmour et al., (1996) supported these findings, 
stating that hydroxyl radicals were generated by PMIO and that, this too occurred via an 
iron-dependant mechanism. Greenwell et al., (2002) demonstrated that the oxidative 
stress induced by PMIO, as measured by damage to supercoiled DNA, could be decreased 
by the addition of antioxidants. Govema et al., (2002) demonstrated that silica had the 
capacity to induce the generation of a C5a-like protein which may have been due to the 
oxidative stress generated on the silica surface. 
With regard to the particles utilised in this study, Stone et aI., (1998) demonstrated that 
nanoparticle carbon black displayed higher levels of free radical activity than that of fine 
carbon black. This is hypothesised to play an important role in increased nanoparticle 
toxicity as it is well known that nanoparticles are more inflammogenic than an equivalent 
mass of fine particles when deposited in the lung (Donaldson & Tran, 2002). This may 
indeed be due to nanoparticle initiation of the complement cascade and subsequent 
chemotactic influx of macro phages and neutrophils into the alveolar space. 
3.1.6 Particle Induced Inflammation Hypothesis 
We hypothesise that the reactive oxygen species present on the surface of nanoparticles 
may have the capability to stimulate C5a generation via cleavage of precursor 
complement proteins. This could induce macrophage recruitment towards sites of 
nanoparticle deposition and result in increased inflammation. 
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This chapter describes an investigation looking at the specific effects of particulates with 
regard to activating the alternative complement pathway, using the in vitro macrophage 
chemotaxis assay described in chapter 2 as an indication of C5a generation and 
complement activation. The study compares both fine and nanoparticles in the forms of 
carbon black and titanium dioxide. It has been hypothesised that nanoparticle carbon 
black would induce the generation of chemotactic complement proteins as a result ofthe 
reactive oxygen species present on the particle surface. 
With regard to the hypothesis that reactive oxygen species generated on the nanoparticle 
surface play an integral role in the generation of chemotactic factors in serum, an 
experiment was also conducted using the oxidant tert-butyl hydroperoxide (tBHP) to 
determine if this treatment would have the potential to induce the generation of 
chemoattractants in the serum. The effects of low doses of particulate air pollution 
(PMIO) extracted from filters was also assessed. 
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3.2 MATERIALS AND METHODS 
3.2.1 Chemicals and Reagents 
Non-heat inactivated foetal bovine serum (FBS) was obtained from Invitrogen, UK. All 
other chemicals and reagents used were purchased from Sigma Chemicals Company, UK. 
3.2.2 CeU Culture and Chemotaxis Assay 
The cell culture of J774.2 cells was conducted as described in section 2.2.3. The 
macrophage migration experiments were conducted according to the protocol described 
in section 2.2.8. As described in Chapter 2, ZAS was used as a positive control. 
3.2.3 FBS Particle Treatments 
FBS was exposed to fine and nanoparticle carbon black and titanium dioxide (doses 
5mg/ml, 1.5mg/ml and Img/ml) by incubation in a shaking water bath at 37°C for 2 
hours. Following incubation, the treated serum was centrifuged at 15000 g for 30 
minutes to remove the particles. The supernatants were stored at -80°C prior to use in the 
chemotaxis assay. 
3.2.4 Serum Heat Inactivation 
FBS was treated with particles as described above. Samples were then split into two 
separate tubes and half of the samples were heat inactivated by incubation in a shaking 
water bath at 56°C for 30 minutes. Both sets of samples were then centrifuged at 15000 g 
for 30 minutes to remove the particles. The supernatants were stored at -80°C prior to 
use in the chemotaxis assay. 
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3.2.5 Diluted Serum 
In order to examine the effect of diluting serum on the stimulation of macrophage 
migration, FBS, generated by treatment with fine and nanoparticle carbon black at doses 
of 5 and 10 mg/ml as described previously, was diluted to 50% and 20% using serum-free 
RPMI 1640 medium. The diluted serum was then tested for chemotactic potential using 
the chemotaxis protocol. 
3.2.6 Antioxidants 
In order to determine the role ofROS in chemotactic factor generation in serum, FBS was 
exposed to nanoparticle carbon black (5 and 10 mg, 37°C for 2 hours) in the presence and 
absence of the antioxidants nacystelin (500)lM) or Trolox (25J.lM), before heat 
inactivation at 56°C for 30 minutes in a shaking water bath. Following incubation, the 
serum was centrifuged at 15000 g for 30 minutes to remove the particles. The 
supernatants were stored at -80°C until use in the chemotaxis assay. Particle treated 
serum was diluted to 20% with serum-free RPM! 1640 for use in the chemotaxis assay 
using the protocol described in Chapter 2. 
3.2.7 Serum and Oxidant Exposure 
FBS was exposed to tBHP at final concentrations of 0.1, 0.2 and O.3mM. The samples 
were incubated at 37°C for two hours in a shaking water bath and then stored at -80°C 
until use in the chemotaxis assay. Samples were diluted to 20% prior to use in the 
chemotaxis assay utilising the protocol described in Chapter 2 
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3.2.8 PMlO exposure 
FBS was exposed to PMJO at a final dose of Img/ml. PMIO was obtained from 3 TEOM 
filters which had been used to collect particulate matter in the area of North Kensington, 
London at the DEFRA Automated Urban Network monitoring site. Each filter had been 
used to sample PMIO for 2 weeks particulate content present on the surface. The PMJO 
was extracted from the filter into 500J.lI of sterile saline by vortexing for 10 minutes. 
Turbidometry assays were conducted by preparing serial dilutions of nanoparticle carbon 
black standards ranging from 15J.lglml to 2mglml and measuring optical density using a 
Dynex multiwell plate reader. The concentration of PMIO was determined to be 
approximately 2 mglml. The PMIO extract was added to FBS to give an estimated final 
dose of 1 mg/ml PMIO. For comparison, the FBS was also exposed to 10 mg/ml of 
nanoparticle carbon black and both sets of samples were incubated in a shaking water 
bath at 37°C for 2 hours. Following incubation, the treated serum was centrifuged at 
15000 g for 30 minutes. The serum was then tested for potential to induce macrophage 
migration. PMIO-treated serum dilu~d to 20% was also tested but due to limitations in 
the PMIO available for study, this could only be tested in one experiment (data not 
shown). 
3.2.9 Statistical Analysis 
Results are expressed as the mean ± SEM. All figures are the results of three separate 
experiments with three observations in each unless otherwise stated. Statistical analysis 
was by means ofa one-way ANOVA with Tukeys multiple comparison. 
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3.3 RESULTS 
3.3.1 Effects of Particle Treated Serum on Macrophage Migration 
The results obtained indicate that treatment of serum with fine carbon black, fine Ti02 or 
nanoparticle Ti02 at all concentrations tested did not induce the production of any 
substance able to stimulate a subsequent migratory response by macrophages (Figure 
3.2). Similarly, the 1 and 1.5 mg/ml concentrations ofnanoparticle carbon black had no 
significant effect on serum-induced macrophage migration. In contrast, the highest dose 
of nanoparticle carbon black tested (5 mg/ml) did stimulate the production of an agent(s) 
in the bovine serum that induced a significant increase in the level of macrophage 
migration measured (p<O.OOl). 
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Figure 3.2 - Migration ofJ774.2 cells stimulated by FBS exposed to either fme and 
nanoparticle carbon black or Ti02• Asterisks denote a significant change from the negative 
control (*** p<O.OOl) 
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3.3.2 The Effects of Dilution on the Potential for Particle Treated Serum to Induce 
Macrophage Migration 
To date, many studies have utilised dilutions of ZAS as a positive control in chemotaxis 
experiments (Warheit et ai., 1988 and Donaldson et at., 1990). Other studies have found 
that macrophage migration towards samples increases when samples are diluted (O'Brien 
et ai., 1998, and Warheit et ai., 1985). Therefore, dilutions of the treated serum were 
prepared to examine this observation (Figure 3.3). In contrast to the previous experiment, 
serum exposed to nanoparticle carbon black at a dose of 5 mg/ml did not induce a 
significant increase in macrophage migration at dilutions of 50% and 20% when 
compared to the negative control. Similarly, no increase was shown when the serum was 
treated with 10mg/ml nanoparticle CB and diluted to 50%. However, a significant 
increase in macrophage migration was found when serum was exposed to 10mg/ml of 
nanoparticle carbon black and diluted to 20% (p<0.001). There was no significant effect 
on migration as a result of exposure to serum incubated with any of the fine carbon black 
doses and dilutions tested. 
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Figure 3.3 - Migration of 1774.2 cells towards FBS exposed to fine or nanoparticle 
carbon black and subsequently diluted to 50% (I in 2 dilution with RPM!) and 20% (I in 
5 djlution with RPMI). Asterisks denote a significant difference from the negative 
control. (*** p<O.OOI) 
3.3.3 The Effect of Heat Inactivation on the Potential for Dilutions of Particle 
Treated Serum to Induce Macrophage Migration 
In order to detennine whether heat-labile components of the particle-treated serum were 
involved in stimulating macrophage migration, serum was treated with particles and 
subsequently heat-inactivated (Figure 3.4). Serum that had been exposed to nanoparticle 
carbon black (Smglml and 10mglml) and diluted to 20% demonstrated a significant 
increase in macrophage migratory potential compared to the negative control (p<0.01). 
When the serum was heat inactivated, the migration was decreased to a level that was no 
longer significantly different from the negative control. 
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Figure 3.4 - Migration of 1774.2 cells towards FBS treated with nanoparticle carbon 
black. Treated FBS was then heat inactivated and compared to non-heat inactivated 
FBS utilising a 20% dilution of each sample in the chemotaxis chamber. Asterisks 
denote a significant difference from the negative control. (**p<O.OI). 
3.3.4 The Effects of Serum Exposed to the Oxidant tBHP on Macrophage Migration 
Serum was exposed to three different doses of the oxidant tBHP in order to determine 
whether oxidative stress can increase the potential of serum to induce macrophage 
migration. Serum exposed to tBHP demonstrated no significant increase in the induction 
of macrophage migration at any dose tested compared to the untreated serum control 
(Figure 3.5). 
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Figure 3.5 - Migration of1774.2 cells towards FBS that has been treated with varying 
concentrations oftBHP. Asterisks denote a significant change from the negative control 
(***p<O.OO 1). 
3.3.5 Serum Exposed to Particles in the Presence of Antioxidants - Effects on 
Macrophage Migration 
As shown previously, serum exposed to nanoparticle carbon black (10 mg/ml) when 
diluted to 20%, demonstrated a significant increase in inducing macrophage migration 
(p<0 .01). Following co-exposure of serum with nanoparticle carbon black and either the 
antioxidant Trolox or nacystelin, the effect on macrophage migration was ameliorated 
and was no longer significant (Figure 3.6). In contrast to the results shown in figure 3.2, 
the 5mglml dose ofnanoparticle carbon black did not induce the production of substances 
which could significantly influence macrophage migration. 
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Figure 3.6 - Migration of 1774.2 cells towards FBS that has been treated with nanoparticle 
carbon black (5 & lOmglml) in the presence and absence of the antioxidant Trolox or 
nacystelin. Asterisks denote a significant change from the negative control (** p<O.Ol and 
*** p<O.OOl). 
3.3.6 Serum Exposed to PM10 Extracts 
Serum was exposed to extracts of PM 10 suspended in sterile saline at a fmal concentration 
of 1 mg/ml. Serum was also exposed to sterile saline to control for the particle 
suspension medium. A significant increase in the potential of the serum to induce 
migration of macrophages was not observed with either the PM 10 or sterile saline 
treatments at the doses used (Figure 3.7). As expected, the 10 mg/ml dose of 
nanoparticle carbon black induced a significant increase in the migration of macrophages 
towards the serum. PM 10 exposed serum that had been diluted to 20% was also 
examined in a single experiment but did not induce any increase in macrophage 
migration (data not shown). 
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Figure 3.7 - Migration of 1774.2 cells towards FBS that has been treated with sterile saline, 
PM IO (lmg/ml) and nanoparticIe carbon black (IOmg/ml). Asterisks denote a significant 
change from the negative control (*** p<O.OOI). 
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3.4 DISCUSSION 
To date. the majority of the research that has been conducted on the potential for various 
occupational and environmental materials to activate the complement cascade in serum 
has focussed on asbestos (Hasselbacher. 1979. Warheit et al .• 1984. 1985. 1986 & 1988. 
Donaldson et al.. 1990 and Saint-Remy & Cole. 1980). These investigations have been 
worthwhile as they have established that different forms of asbestos (chrysotile and 
crocidolite) have the potential to activate the complement cascade and potentially induce 
macrophage migration to sites of fibre deposition. Other studies have shown that silica 
could also display this potential by cleaving pre-cursor complement proteins to produce 
anaphylatoxins that are potent macrophage and neutrophil chemoattractants (Govema et 
al .• 2002). Thus. the topic of this study is particularly relevant as ambient air pollution 
nanoparticles have attracted considerable attention with respect to their potential to cause 
toxicity and inflammation leading to disease exacerbation (Donaldson et al .• 2001a). 
Engineered nanoparticles have engendered a new discipline of 'nanotoxicology' to 
address the lack of knowledge in this area. 
The results from this study indicate that nanoparticle carbon black. when exposed to 
blood serum at high doses (5-10mglml). induces the generation of a serum component 
which can cause significant increases in macrophage migration in vitro. Following 
nanoparticle carbon black treatment at a concentration of 5mglml. undiluted serum was 
found to have the potential to induce significant increases in macrophage migration. 
However. if the serum was diluted following treatment with particles. the dose of 
nanoparticle carbon black required to induce a significant increase in macrophage 
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migration was IOmglml in serum that had been subsequently diluted to 20%. The 50% 
dilution of serum at this dose of particles did not appear to induce significant increases in 
macrophage migration. This could indicate that a Gaussian-shaped balance exists 
between the concentrations of chemoattractant generated and the macrophage migration 
induced by the chemoattractant i.e. too little or too much of the chemoattractant does not 
cause any change in the potential for the serum to induce macrophage migration. 
Subsequent concentration response studies indicated that the most potent chemotactic 
response of the macrophages was found when the treated serum was diluted to 20%. 
When the serum was heat inactivated following particle treatment, the migratory effects 
of the diluted serum were reduced to a level that was no longer significantly different 
compared to the negative control. It was noted that the effect of the 20% dilution of 
particle treated serum was decreased when co-exposing the serum to particles in the 
presence of antioxidants. It should also be noted, however, that when serum was exposed 
to the oxidant tBHP or low doses of PMIO, there is no increase in the potential of the 
serum to induce macrophage migration. 
Several studies have described the interactions of various organic and inorganic 
substances with the complement system. Wilson et al., (1977) utilised an in vitro 
haemolysis assay to demonstrate that five different types of asbestos fibres activated the 
alternative complement pathway. An investigation of chrysotile asbestos by Saint- Remy 
& Cole (1980) showed a potential to activate the alternative pathway in vitro. These 
studies were supported by in an investigation by Yano et al., (1984), which showed the 
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generation of chemotactic factors in serum by both chrysotile and crocidolite asbestos. 
Warheit et al., (1985 and 1986) also demonstrated that chrysotile asbestos fibres activated 
complement in rat serum both in vitro and in vivo and noted that complement activation 
was the primary chemotactic stimulus for macrophage mediated clearance of fibres; there 
was also a suggestion that iron chemistry might be involved in these effects. Hill et ai., 
(1982) demonstrated fly ash particle induced complement activation while Olenchock et 
ai., (1978) described activation of the alternative pathway by grain dust in vitro. 
Based on the results generated by this study it is possible that, should the nanoparticles 
activate the alternative complement cascade, the anaphylatoxin C5a could be generated 
via cleavage of the pre-cursor protein C5. C5a is known to be a potent macrophage and 
neutrophil chemoattractant (Shin et ai., 1968 and Snyderman et al., 1971) and is involved 
in enhancing functional responses ofphagocytes (Ward, 2004). The enhanced migration 
of macrophages towards serum that has been exposed to nanoparticle carbon black 
indicates that such it generation ofC5a may have taken place. 
The mechanism by which asbestos fibres and particles such as silica activate the 
complement cascade is, as yet, unclear but several hypotheses have been formed to 
explain this finding. In the study by Governa et ai., (2002), it was proposed that hydroxyl 
radicals present on the surface of the silica were involved in C5 (the pre-cursor to C5a) 
cleavage and that the extent to which the C5 was cleaved was dependent on C5 
adsorption onto the surface of the silica particles. The adsorption of serum proteins on to 
the surface of coal dust and asbestos has been investigated, and it was determined that 
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selective binding of proteins took place on the surfaces of both the asbestos and silica 
(Jones et at., 1972 and Hasselbacher, 1979). Desai & Richards, (1978) demonstrated that 
the incubation of FBS with asbestos, quartz and Ti02 samples resulted in the binding of 
serum proteins to the surface of the mineral dusts. Nanoparticles have been shown to 
have a much larger surface area than an equivalent mass of fine particles. Brown et at., 
(2000) has demonstrated binding of bovine serum albumin (BSA) to nanoparticles in 
concordance with studies by Wilson et at., (personal communication) and Lightbody et 
ai., (DEFRA report EPG1I31147) which showed cytokine binding to the surface of 
nanoparticles and PMJO samples. It may be that this increased potential for protein 
binding could provide an indication as to the potential of a given particulate to activate 
the complement cascade by surface binding. 
Governa et at., (2002) also suggested that iron, a common contaminant on the surface of 
silica, assisted the reaction via Fenton or Haber-Weiss chemistry. The study by Warheit 
et ai., (1985) also supported the theory that iron played an important role in the surface 
chemistry of the reactions involved in complement activation. Wilson et at., (2002) 
noted that when nanoparticle carbon black was co-incubated in the presence of iron salts, 
ROS production increased in a potentiative manner. The summation of these studies 
would indicate that iron is a key component in potentiating surface chemistry, and that 
complement activation studies conducted with nanoparticle carbon black and iron salts 
may provide an interesting insight into the interaction between metals and particles. 
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When the serum was exposed to nanoparticle carbon black in the presence of 
antioxidants, the chemotactic potential of the serum was less than that of serum treated 
with only nanoparticle carbon black. This would further support the hypothesis that the 
activation of the complement cascade is oxidant mediated. However, when testing serum 
that has been exposed to varying concentrations of the oxidant tBHP to induce 
macrophage migration, it was found that, with an oxidant alone, there was no significant 
increase in the level of macrophage migration towards the treated serum. This could 
indicate that there were no complement proteins present that could cause macrophage 
migration. This could indicate that pure oxidants, such as tBHP, do not possess the pre-
requisites to activate complement. However, these results are not conclusive as it is 
entirely possible that further studies conducted with other oxidants such as H202, 020 - or 
ONOO- could yield different results. The observations in this study indicate that another 
factor could be involved in C5a generation. Vogt et a/., (1989) demonstrated that C5 
cleavage by radicals of H202 could form a C5b-like protein that was not chemotactic 
itself, but could be split by the proteolytic 'kallikrein-kinin' plasma system to form C5a 
(Regoli et aI., 2001). This would suggest that ROS playa key role in the generation of 
chemotaxins in serum, but that further steps are required to complete the production of 
functional chemotactic serum components. 
The complement protein C5a is known to be heat stable when heated to 56°C as opposed 
to other serum proteins that are heat labile (Georgsen et a/., 1990). When serum was heat 
inactivated following particle treatment it was found that the potential for the serum to 
induce macrophage migration was decreased. This is contrary to the hypothesis that C5a 
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is the complement component responsible for inducing macrophage migration in our 
studies. However, there could be several explanations for this. The first fact to take into 
account is that the serum tested in this set of experiments did not have a high potential for 
inducing macrophage migration when incubated with nanoparticle carbon black. It is 
possible that C5a was not the only component of serum to attract macrophages, therefore, 
when the serum was heat inactivated, a portion of the potential may have been lost 
through the destruction of a heat-labile serum protein. It may also be possible that 
following removal of the particles from the serum, residual complement activation may 
still have been occurring. The heating process prevents any further complement 
activation and as such may have halted this process. 
The results indicate that the most potent macrophage response to the particle treated 
serum was found when the serum was diluted to 20% with RPMI 1640. This is a higher 
concentration than with serum that has been incubated with Zymosan A. Zymosan is a 
potent activator of C5 and as such is hypothesised to generate a large amount of C5a in 
blood serum. Therefore, it could be suggested that nanoparticle carbon black, is not as 
potent an activator and, as such, a higher concentration of activated serum is required to 
induce a significant amount of macrophage migration. Renwick et al., (2004) found that 
a 10% dilution of ZAS acted as an adequate positive control for a macrophage 
chemotaxis study. Warheit et al., (1985) also found that a 10% dilution of asbestos and 
Zymosan activated sera induced the highest level of macrophage migration. Lower 
dilutions of ZAS were also used by Geiser et al., (1998) where it was found that a ZAS 
dilution of 1 :256 induced a high level of macrophage migration. It may be the case that 
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high concentrations of ZAS could also prove to be toxic to macrophages or that much 
lower dilutions of particle treated serum could induce levels of macrophage migration 
measured in this study. 
PMIO has been shown to induce inflammatory responses when instilled into the lung. Li 
et at., (1996) demonstrated that PMIO exhibited free radical activity and that this activity 
may playa role in the pro-inflammatory effects of PMIO. It has been shown that PMIO 
contains a mixture of nanoparticles and transition metals as well as other components that 
have a potential for inducing inflammation (Stone et at., 2003 and Gilmour et at., 1996). 
In this study, low doses of PM 10 did not appear to induce the generation of factors that 
could induce macrophage migration. This could be attributed to several factors; firstly, 
the PMIO dose utilised in this study may have been too low to induce any measurable 
effects in the serum. The PMIO mass that could be used in this investigation was limited 
by the number of filters available for use and the mass of PMIO that could be extracted 
from each filter. Further studies using higher doses of PMIO, together with various 
dilutions of PMIO treated serum may yield different results to those expressed here. 
Secondly, the composition of PM 10 has been shown to be highly variable depending upon 
a number of factors such as the location of the sampler, wind direction and other 
anthropogenic factors (Schins et at., 2004). The PMIO in this study was sourced from 
North. Kensington, London, an urban background area, and was analysed for 
inflammatory potential by Lightbody et at., (2004 - manuscript in preparation). 
Treatment of serum with a PMIO sample that has been reported to have a higher 
concentration of nanoparticles or transition metals per unit of mass may display different 
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results but due to the limitations of the PMIO samples available for this study, this avenue 
of investigation could not be pursued. Similarly, the endotoxin content of the PMJO may 
have some bearing on the potential of the sample to activate the complement cascade in 
the serum. Endotoxin has been shown to be present in airborne particulate samples 
(Soukup and Becker, 2001) and has been shown to activate complement based 
chemotactic components in serum (Snyderman et at., 1969 and Hom et at., 1984). 
Finally, the particulate component of the PMIO may have adsorbed some of the 
chemotactic proteins onto the particle surface, similar to the adsOlption phenomenon 
observed by Jones et at., (1972) and Lightbody et aI., (DEFRA report EPGl/3/147). This 
may render the proteins non-functional in terms ofinfluencing macrophage migration. 
In conclusion, the fact that complement proteins are found in lung lining fluid at 
biologically active concentrations may indicate that an early complement-based clearance 
mechanism for particles depositing in the alveolar regions of the lung. Complement 
activation can occur within minutes (Sladowski et at., 2001) and activation of 
complement cascades resulting in the generation of chemotactic proteins could induce 
recruitment ofleukocytes prior to opsonisation and phagocytosis of the particulates. This 
could result in a rapid removal of particles from the alveolar region and decrease the 
potential damage that can be caused by deposited nanoparticles. The increased potential 
of nanoparticles in activating the alternative complement cascade compared to fine 
particles may actually aid in the clearance of these particles and, as such, help prevent 
nanoparticle induced toxicity. 
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CHAPTER 4 
THE EFFECTS OF PM lO ON ALVEOLAR MACROPHAGE 
CLEARANCE MECHANISMS EX VIVO 
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4.1 INTRODUCTION 
The alveolar macrophage is the primary mediator of particle clearance in the alveolar 
space. It is hypothesised that the volumetric loading of the macrophage can have 
deleterious effects on the cells phagocytic and chemotactic ability. Morrow (1988) 
indicated that macrophages showed an impaired ability to migrate towards the 
mucociliary escalator (MCE) when approximately 6% of the internal volume of the 
macrophage was occupied by phagocytosed particles. Investigations by Tran et al., 
(2000) with two low toxicity, low solubility dusts implied that impaired clearance was in 
fact driven by the surface area metric rather than the mass metric. This supported data 
previously published by Oberdorster et a!., (1994) which illustrated prolonged 
macrophage mediated clearance of nanoparticle Ti02 from the lung compared to fine 
Ti02. Renwick et al., (2001) also demonstrated that exposure to high concentrations of 
nanoparticles of Ti02 and carbon black in vitro, could impair the phagocytic ability of a 
macrophage cell line. Hoet and Nemery (2001) also suggested that the results of 
Renwick et a!., demonstrated that low concentrations of particles could also stimulate 
phagocytosis and that further investigation was needed to establish a clearer picture. 
However, these effects of alveolar macrophage overloading may only be relevant at very 
high or overload dose exposures (Oberdorster, 1995). 
The consequences of impaired clearance mechanisms can be severe. As exposure to 
particles continues, there is a build up of dose, which can lead to direct macrophage and 
epithelial cell damage. There is also increased potential for the translocation of particles 
into the cardiovascular system as well as systemic cytokine release and increased blood 
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coagulabilty (Seaton et ai., 1995). Nemmar et aI., (2001, 2002) demonstrated how both 
instilled and inhaled nanoparticles could rapidly pass into the biood circulation. 
Oberdorster et ai., (2004) showed translocation of inhaled radioactive carbon 
nanoparticles to the cerebrum and cerebellum in a rat model. Conversely, Kreyling et ai., 
(2002) found limited evidence ofnanoparticle iridium translocation from the lungs. 
The aim of this study was to use an animal model to investigate the effects of PMIO on 
pulmonary macrophage clearance mechanisms. The ability of alveolar macrophages, 
isolated from rats treated with PMIO particles, to phagocytose indicator latex beads was 
assessed as well as the potential for PMIO treated macrophages to migrate towards a 
positive chemoattractant ex vivo. Biochemical measurements of proteins present in the 
bronchoalveolar lavage (BAL) fluid were also conducted with a view to ascertaining the 
extent to which the cellular integrity of the lung had been affected. It is hoped that the 
results presented in this chapter contribute to the understanding of the toxicological 
effects of particulate air pollution on macrophage mediated clearance mechanisms. 
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4.2 MATERIALS AND METHODS 
4.2.1 Chemicals and Reagents 
All chemicals and materials were purchased from Sigma Aldrich, UK, unless otherwise 
specified. 
4.2.2 Particle Preparation 
PMIO collected over 2-week intervals at kerbs ide TEOM samplers located in North 
Kensington, London between 1998 and 2001 were used in this study. To extract the 
particulates, the filters were immersed in 0.5 ml of sterile saline and vortexed for 10 
minutes. The suspended particulate mass was then estimated using turbidometry and 
adjusted to 1251lg and 250llg doses suspended in 0.5ml of sterile saline. Solutions were 
sonicated for 20 minutes to ensure particle suspension prior to instillation. 
4.2.3 Instillations ofPMlO 
Male Wistar rats, weighing between 200-300g were anaesthetised with halothane. One 
rat was utilised for each PMIO or control treatment i.e. 3 rats per experiment. Control rats 
were instilled with 0.5ml of sterile saline. Particle treated animals were instilled with 
either 1251lg or 250llg of PM to filter extracts in O.5ml of saline. Rats were subsequently 
sacrificed by an intra-peritoneal injection of pentobarbitone 18 hours after particle 
instillation. The lungs were lavaged 5 times with 8 ml sterile saline and the first lavage 
was stored at -80°C for cell-free biochemical analysis. The other four lavages were 
pooled and then centrifuged at 900 g to isolate the bronchoalveolar lavage (BAL) 
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leukocytes, which were then pooled with the leukocytes isolated from the first lavage. 
The remaining BAL fluid was discarded. 
The BAL cell pellet was resuspended in RPMI 1640 medium supplemented with 1% L-
glutamine and 1 % Penicillin/Streptomycin. Total cell counts and viability were assessed 
using 0.3% trypan blue exclusion and an improved Neubauer haemocytometer. To 
ascertain the numbers of neutrophils that had migrated into the lung, cytospin slides were 
also prepared and stained with Diffquik stain. (Raymond A Lamb, London), before 
counting using light microscopy. The remaining BAL cells were employed in the 
phagocytosis (section 4.2.6) and chemotaxis (section 2.2.8) assays. 
4.2.4 Cytotoxicity & Lung Damage 
Total BAL lactate dehydrogenase (LDH) levels were determined as follows (Brown et 
al.,2001). To create a standard curve, pyruvate standards were prepared (using distilled 
H20 and Img/ml NADH dissolved in 0.75mM sodium pyruvate), ranging in 
concentrations equivalent to 0 - 2000 Units/ml of LDH. One unit of LDH activity is 
defined as the amount of LDH that reduces 4.8 x 10-4 Ilmol of pyruvate in 1 minute at 
25°C. The standards were transferred (601l1) in triplicate, to a 96-well plate. Into all of 
the remaining wells of the plate, 50111 ofNADH was added. The samples were incubated 
at 37°C /5% C02 for 5 minutes. 
The test and control samples (101l1) were added to the relevant wells on the plate 
containing the NADH solution. The samples were incubated at 37°C, 5% CO2 for 30 
minutes. Following incubation, 50111 of2, 4-dinitrophenylhydrazine (O.2mg/ml dissolved 
115 
in 1M HCl) was added to all of the wells and the samples were left for 20 minutes at 
room temperature. Sodium hydroxide (50JlI of 4M concentration) was then added to 
each well and the samples were left at room temperature for 5 minutes. The plate was 
shaken for 5 seconds and the absorbance of all the wells was measured at 540nm with a 
Dynex MRX microplate reader. 
BAL protein levels were assessed using Coomassie Blue G250. Coomassie Blue protein 
reagent (Bio-Rad) was diluted 1 in 5 with distilled water and added to each well on a 96 
well plate (200Jll). BAL samples were then added (5JlI) and incubated for 15 minutes. 
The absorbance of each well was read at 450nm. 
BAL albumin was measured using Bromocresyl green reagent substrate prepared with 
0.66mM ofBromocresyl green in 100mM of succinate buffer at pH 4.2. Samples (lOOJlI) 
were added to the reagent substrate and the absorbance was read at 630nm . 
. 4.2.5 TNFa & MIP-2 ELISA 
BAL TNFa and MIP-2 protein concentrations were determined by an ELISA cytoset kit 
(Biosource, UK), according to manufacturer's instructions. Briefly, 96-well plates 
(Scientific Laboratory Supplies, UK) were coated with coating antibody and incubated 
for 18 hours at 2-8°C. Between each step of the protocol the plates were washed with 
wash buffer (PBS + 0.1% Tween 20). The plates were then blocked with 0.35g BSA 
dissolved in 70ml PBS for 2 hours. Standards and samples were then added and 
incubated for 90 minutes at room temperature. The biotinylated detection antibody was 
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added and the plate was incubated for a further 1 hour at room temperature. The 
streptavidin-horse radish peroxidase (S-HRP) conjugate (0.16%) was added (lOOJ.lI) and 
incubated for 45 minutes at room temperature. The chromagen tetramethylbenzidine 
(TMB) was added (l00J.ll) and the plate was incubated for 30 minutes in the dark. A stop 
solution of 2M sulphuric acid was added to develop the colour and the optical density of 
each well was read at a dual wavelength absorbance of 450/650nm. 
4.2.6 Phagocytosis Assay 
BAL cells were suspended in normal culture medium at a concentration of2 x IOs/ml and 
1 ml was added to each well in Labtek chamber slides. The chamber slides were 
incubated overnight in a humidified incubator at 37°C and 5% C02. The medium from 
the slides was aspirated and the slides were washed twice with normal culture medium to 
remove any non-adherent cells. The medium was replaced with Iml of culture medium 
containing 2J.lm latex beads at a bead to cell ratio of 5:1. Following incubation for 18 
hours the slides were washed twice with PBS, stained with a Diffquik stain and then 
counted using a fluorescent microscope (Carl Zeiss). The counting procedure for each 
chamber slide involved randomly counting 300 cells from each treatment, establishing 
whether PMIO was visible inside the cell or not, and counting the number of latex beads 
visible inside each cell. 
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4.2.7 Chemotaxis Assay 
The chemotaxis assay was conducted according to the protocol described in section 2.2.8. 
Macrophages that had been isolated from the PMIO treated rats were tested for their 
ability to migrate towards positive (ZAS) and negative (HIS) chemoattractants. 
4.2.8 Statistical Analysis 
Results are expressed as the mean ± SEM. All figures are the results of three separate 
experiments with three observations in each experiment unless otherwise stated. 
Statistical analysis was by a one-way ANOV A with Tukeys multiple comparisons. 
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4.3 RESULTS 
4.3.1 Inflammatory Responses to PMIO 
Figure 4.1 illustrates the number of neutrophils identified in the BAL 18 hours after 
instillation of the PMJO samples. Treatment with 250)lg of PM IO induced a significant 
increase in BAL neutrophil number compared to the saline control (p<O.05). In contrast 
the 125)lg dose of PMIO did not induce a significant change in neutrophil numbers. 
Treatment of the rats with 250)lg PMJO for 18 hours also induced a significant decrease in 
macrophage number observed in the BAL compared to the control (p<O.05) (Figure 4.2). 
Again, the 125)lg treatment induced a modest decrease in macrophage numbers that was 
not statistically significant. 
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Figure 4.1 - Total neutrophil count in BAL fluid of rats 18 hours after instillation with 
either sterile saline (control), 125)lg or 250)lg ofPMw Results are the mean ± SEM 
of three separate experiments. * indicates a significant difference from the control 
(p<O.05). 
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Figure 4.2 - Total macrophage count in BAL fluid of rats 18 hours after instillation 
with either sterile saline (control), 125 J.1g or 250J.1g of PMIO. Resuhs are the mean ± 
SEM ofthree separate experiments. * indicates a significant difference from the 
control (p<0.05). 
4.3.2 Cytotoxicity 
LDH levels in BAL were measured with a view to assessing the extent of the cellular 
damage caused by the PMIO particles. The data showed that there was no change in BAL 
LDH compared to the saline control for both PMIO doses (Figure 4.3). This was 
supported by data obtained by measuring the total protein concentration in the BAL as an 
indicator of lung permeability. As was seen with the LDH measurements, there was no 
significant change in BAL protein compared to the control (Figure 4.4). 
The albumin concentration in the BAL was also measured to determine whether the lung 
vasculature had been damaged. The results indicated that there was also no significant 
change in the concentration of albumin in the BAL after treatment with either PMJO dose 
(Figure 4.5). 
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Figure 4.3 - Concentration oflactate dehydrogenase (LDH) in BAL fluid of rats 18 
hours after instillation with either sterile saline (control), 125Jlg or 250Jlg ofPM IO• 
Results are the mean ± SEM of three separate experiments . 
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Figure 4.4 - Total protein concentration in BAL fluid of rats 18 hours after 
instillation with either sterile saline (control), 125Jlg or 250Jlg ofPMIO • Resuhs are 
the mean ± SEM oftbree separate experiments. 
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Figure 4.5 - Albumin concentration in BAL fluid of rats 18 hours after instillation 
with either sterile saline (control), 125~g or 250~g of PM to. Results are the mean ± 
SEM of three separate experiments. 
4.3.3 Cytokine release 
The concentrations of the two pro-inflammatory cytokines MIP-2 and TNFa in the BAL 
fluid were measured by ELISA. Both the 125~g and the 250~g dose of PM to induced a 
significant increase in the concentration of TNFa in the BAL compared to the saline 
control (p<O.OI and p<O.OOI respectively) (Figure 4.6). In contrast, the concentration of 
MIP-2 in the BAL remained unchanged (Figure 4.7). 
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Figure 4.6 - Concentration oflNFa in BAL fluid of rats 18 hours after instillation with either 
sterile saline (control), I 25J.lg or 250J.lg ofPMJO" Results are the mean ± SEM ofthree separate 
experiments. *** denotes a significant difference from control (p<O.OOI), ** denotes a 
significant difference from control (p<O.OI). 
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Figure 4.7 - Concentration ofMIP-2 in BAL fluid of rats 18 hours after instillation with 
either sterile saline (control), 125J.lg or 250J.lg of PM 10' Results are the mean ± SEM of 
three separate experiments. 
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4.3.4 Phagocytosis 
Figure 4.8 is a microscope image of macrophages obtained from a rat 18 hours after 
instillation of 250J.lg ofPMIO. The white arrow points towards a latex bead and the black 
arrow points towards PMIO that has been phagocytosed by the macrophage. Figure 4.9 
shows the percentage of alveolar macrophages that had phagocytosed indicator beads 
and/or PMIO after treatment of the rats with saline or PMIO. Cells that had visibly 
phagocytosed PMIO particles, indicator latex beads or both as determined by microscopy 
were termed 'phagocytic'. Cells that did not visibly phagocytose either PMIO or latex 
beads were termed 'non-phagocytic'. Treatment of the animals with 125J.lg of PMIO 
significantly decreased the number of non-phagocytic cells present in BAL (p<0.001). 
There was no significant change in the number of non-phagocytic cells from the animals 
treated with 250J.lg PMIO. The number of phagocytic cells was slightly increased 
following treatment with particles but this was not statistically significant. 
Treatment of the rats with either 125 or 250J.lg PMIO resulted in a BAL alveolar 
macrophage population that visibly contained PMIO and exhibited a significant decrease 
in the number of latex beads that they could phagocytose per cell ex vivo (p<0.05 and 
p<O.OI respectively) (Figure 4.10). The alveolar macrophages that did not visibly 
contain PMIO appeared to also phagocytose fewer latex beads than the control but this 
was not statistically significant. 
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B 
Figure 4.8 - Microscope image of macro phages obtained from rats treated for 18 hours 
with PM lO or saline (control). 'Non'phagocytic' macrophages (A), cells that have 
visibly phagocytosed indicator beads and PMJO (B) as well as cells that have only 
phagocytosed indicator beads are illustrated (C). The white arrow indicates a latex bead 
and the black arrow points towards PM JO (Magnification xlOOO). 
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Figure 4.9 - The number of macrophages exhibiting phagocytosis as indioated by PM IO or 
latex bead uptake. Macrophages were lavaged from rats 18 hours after instillation with 
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three separate experiments. *** denotes a significant change from the non-phagocytic 
control (P<O.OOI) 
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Figure 4.1 0 - Phagocytic potential of macrophages from rats instilled with sterile saline 
(control), 1251lg or 250llg of PM 10' Phagocytic potential is indicated by the number of 
latex beads phagocytosed per macrophage ex vivo. Results are the mean ± SEM of three 
separate experiments. ** denotes a significant change from the non-phagocytic control 
(P<O.Ol), * denotes a significant change from the control cells (p<O.05) 
4.3.5 Macrophage Migration Studies 
The ability of the lavaged macrophages to migrate towards the known chemoattractant 
ZAS is shown in figure 4.11. Instillation of both doses of PM 10 resulted in a significant 
decrease in macrophage migration towards ZAS (p<O.OOl). The negative control 
involved assessing migration of macrophages from control animals towards heat-
inactivated serum, and indeed this was significantly less than towards ZAS. Migration 
towards heat-inactivated serum was not altered by PMIO treatment of the rats (p<O.OO 1) 
indicating that the effect ofPMIO on ZAS-induced migration was a specific effect. 
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Figure 4.11 - Migration of macro phages obtained from rats 18 hours after instillation 
with either PMIO (125 or 250f.1g) or saline (control) towards positive (ZAS) and negative 
(heat-inactivated serum) chemoattractants. Results are the mean ± SEM of three 
separate experiments. • .. denotes a significant difference from the positive control 
(p<O.OOI) 
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4.4 DISCUSSION 
As mentioned in chapter 1, increases in environmental PMIO levels have been implicated 
as a causal agent in inducing exacerbations of disease and increased mortality from 
cardiovascular and respiratory conditions (Seaton et al., 1995). This chapter examined 
the effects of PMIO collected in North Kensington, London, on inflammation in the rat 
lung and the subsequent effects on alveolar macrophage phagocytosis and chemotactic 
capability ex vivo. 
The highest dose of PMIO utilised in this study (250J.lg/rat) caused an increase in the 
number of neutrophils present in the BAL fluid indicating that neutrophilic inflammation 
was present in the lung. This is comparable with many other studies that have also 
reported neutrophil influx as a result of ambient particle exposure (Li et al., 1996, Schins 
et al., 2004). It should also be noted that macrophage numbers were decreased in the 
lavages obtained from the PMIO treated animals. This decrease in macrophage number 
may be due to the migration of the macrophages, with their particle burden, from the lung 
via the MCE. Alternatively, the particle-laden macrophages may have undergone 
apoptosis (Soukup & Becker, 2001 and Obot et aI., 2002). 
Cytotoxicity assessments (LDH, total protein and albumin measurement) conducted in 
this study indicated that no significant cellular or lung damage was induced by the PMIO 
treatments compared with the control animals. Therefore, this indicated that the 
inflammatory responses evoked were specific to the particle treatment rather than being a 
consequence of gross lung damage. 
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TNFa and MIP-2 have previously been described to play important roles in particle 
induced lung inflammation. As mentioned previously, TNFa is a potent pro-
inflammatory cytokine that is involved in stimulating the production of chemotactic 
cytokines such as MIP-2 (Driscoll, 2000). In this study, it was noted that the 
concentration of TNFa in BAL fluid increased as a result of PMIO treatment at either 
dose. Jimenez et ai., (2002) noted that macrophages exposed to PMIO produce TNFa and 
that this TNFa is capable of stimulating lung epithelial cells to release pro-inflammatory 
cytokines for the recruitment ofleukocytes. 
As described in chapter 1, MIP-2, the rat homologue of IL-8 is a chemotactic cytokine 
involved in the recruitment of neutrophils and monocytes to localised sites of 
inflammation (Driscoll, 2000). In this study the concentration of MIP-2 was modestly 
increased following PMIO treatment at a dose of 125~g but this was not statistically 
significant compared to MIP-2 levels found in the BAL from the control rat. This may 
have been due to large variations in the concentrations detected by the ELISA method, 
but may also be attributed to the dilute nature of the BAL fluid. 
As noted previously, the impainnent of macrophage mediated phagocytosis following 
particle uptake could be an import factor in detennining the pathogenicity of particle-
induced disease. Renwick et ai., (2001) described a study in which high doses of 
ultrafine particles significantly impaired the ability of a macrophage cell line to 
subsequently phagocytose latex beads, whilst Hoet & Nemery (2001) observed that in the 
data of Renwick et aI., low concentrations of particles could be interpreted as actually 
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stimulating the phagocytic ability of the macrophages. In the present study, a decrease in 
the number of non-phagocytic cells was observed when examining macrophages treated 
with the lower dose of PMIO. This means that in the presence of PMIO, more cells could 
pha,gocytose latex beads or PMIO particles. However, when examining the phagocytic 
ability of the macrophages in terms of the number of latex beads the macrophages could 
phagocytose following particle treatment, this number actually decreased in cells that 
visibly contain PMIO. This suggests that PMIO uptake by macrophages diminishes the 
ability to further phagocytose other particles. This decrease in phagocytic ability could 
be attributable to several factors. The PMIO or specific components ofthe PMIO such as 
the ultrafine particles or transition metals may inhibit cell function, essentially decreasing 
the phagocytic ability of the macrophages. The decreased phagocytic ability of the 
macrophages when visibly loaded with PMIO also invites the question of dust overloading 
as described by Morrow (1988) and Oberdorster (1995). The presence ofPMIO inside the 
cells, could overload the macrophages to such an extent that they are not able to 
subsequently phagocytose large numbers of latex beads. Monn et at., (2002) noted 
similar observations when conducting a study with PMIO and a macrophage cell line in 
vitro. It should be noted however, that one ofthe limitations of this study is the use of a 
light microscope to determine the presence ofPMIO inside the cells. Due to the resolution 
limitations of light microscopy, nanoparticles could only be seen as aggregates and, as 
such, it is possible that non-aggregated nanoparticles could be present in cells classed as 
non-phagocytic. 
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The alveolar macrophages isolated from animals treated with PMIO showed a decreased 
potential to migrate towards the positive chemoattractant ZAS. This was in contrast to 
results published by Renwick et ai., (2004) where it was shown that rat macrophages 
exposed to carbon black nanoparticles showed increased sensitivity to the 
chemoattractant C5a. This decrease in mobility may be due to the toxicity of the PMIO 
particles and/or overload which would both restrict macrophage movement via the 
cytoskeleton (Moller et ai., 2002). Other pathogenic particles have been founc,l to inhibit 
macrophage chemotactic activity following in vivo exposure (Donaldson et ai., 1990). 
Neutrophils closely situated to macrophages in the bronchoalveolar space during 
inflammation may release factor(s) that inhibit macrophage membrane related functions 
such as phagocytosis, chemotaxis and spreading and this may provide an explanation 
(Donaldson et ai., 1988, 1989). 
In the lung, inhibition of macrophage phagocytosis and chemotaxis may result in 
particles remaining in contact with the epithelium for a protracted period and particle-
laden macrophages remaining in the alveolar region instead of migrating out of the lung 
via the MCE or lymphatic system. Both of these eventualities would allow the dose of 
particles to build up, leading to chronic inflammation, which may further exacerbate 
respiratory conditions, as well as increasing the potential for particles to move into the 
interstitium and the circulation. 
This study suggests that acute PMIO exposure has an effect on macrophage phagocytosis 
and chemotaxis that may prove deleterious to particle clearance within the alveolar region 
of the lung. Th.is may represent one mechanism that promotes inflammation following 
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increases m ambient PM levels. Further investigation is warranted to detennine the 
effects of chronic PM IO exposure on macrophage clearance mechanisms as well as 
establishing the molecular mechanisms behind decreased macrophage mobility and 
phagocytic potential as a result of ambient air particle exposure. 
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CHAPTERS 
THE EFFECTS OF ZINC AND NANOPARTICLE CARBON 
BLACK ON MACROPHAGE PHAGOCYTOSIS 
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5.1 INTRODUCTION 
Zinc is a physiologically essential element required for the development of animals and 
microorganisms. Zinc plays an extremely important role in the development of the 
immune system in animals (Rink and Gabriel, 2000 and Beisel, 1982) and, consequently, 
several studies have examined the effects of zinc deprivation on leukocytes. Tone et 01., 
(1991) found that murine phagocytes showed reduced phagocytic potential in zinc 
deficient animals. Ercan & Bor, (1991) also reported similar results with rat 
macrophages. Allen et 01., (1983) and Keen & Gershwin, (1990) reported that reduced 
zinc concentrations could inhibit macrophage and neutrophil phagocytosis as well as 
cause reductions in the phagocytic burst. 
Other studies have looked at zinc from a toxicological standpoint and observed impaired 
cell function and toxicity when exposing cells to increased concentrations of zinc. 
Chvapil et 01., (1977a) conducted a key study reporting decreases in the phagocytic 
ability of dog PMN cells following treatment with 50J.!M zinc. Increased intracellular 
concentrations of zinc were also described together with decreases in the oxidative 
metabolism ofthe cells. Chvapil et 01., (1977b) also specifically looked at the effects of 
zinc on rat peritoneal macrophages and showed that oxygen consumption decreased in 
activated macrophages exposed to OAmM zinc, but that no effect was observed in resting 
macrophages. 
Due to the fact that zinc is known to be a common component of PM to samples, a number 
of studies have examined the relationship between zinc and the onset of inflammation 
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following entry of PM 10 into the lung. Adamson et at., (2000) reported that zinc induced 
high toxicity in a sample of atmospheric air pollution but did not appear to take into 
account any interactions of zinc with other components of air pollution such as the 
particles or the other metals. A similar result was obtained in a study by Prieditis & 
Adamson, (2002) using the same atmospheric dust sample, EHC-93. Rice et at., (2001) 
compared the abilities of six transition metals, including zinc, to induce lung 
inflammation in a rat model. Zinc sulphate (10J.lmol/kg) induced significant increases in 
BAL total protein levels and neutrophil influx. However, this study did not conduct any 
experiments that examined the interactions of different metals. A human inhalation study 
using zinc oxide showed increases in several cytokines such as IL-8 and TNFa in the 
BAL fluid (Kuschner et at., 1997). Skomik and Brain, (1983) examined the uptake of 
colloidal gold particles by hamster macrophages and showed that 1 hour exposures to 
zinc sulphate (3.1 mg/m3) and zinc ammonium sulphate (10mg/m3) aerosols significantly 
inhibited macrophage endocytosis. The summation of these studies indicates that zinc 
can be a potential inflammatory agent even without interacting with the particulate 
portion of air pollution. 
This chapter is part of a study being undertaken by members of the Biomedicine 
Research Group at Napier University. The study aims to look at the effects of zinc and 
nanoparticles on various aspects of macrophage function such as TNFa, TGFp and ROS 
production as well as examining cytoskeletal and apoptotic effects. Preliminary 
investigations have already shown that, when incubated with zinc chloride salts, low 
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doses of nanoparticle carbon black induce the release of much higher concentrations of 
TNFa from macrophages than the particles or the metal alone (See figure 5.1). 
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Figure 5.1 - TNFa release from 1774.AI cells treated with varying concentrations of 
nanoparticle carbon black in the presence or absence of zinc chloride (Courtesy of Alex 
Griffiths) 
This chapter aims to investigate the effects of a range of zinc concentrations on 
macrophage phagocytosis to determine if any interaction takes place between the zinc 
and carbon black nanoparticles that would be detrimental to the ability of macrophages to 
perform phagocytosis. 
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5.2 MATERIALS AND METHODS 
5.2.1 Chemicals and Reagents 
L-Glutamine (200mM); penicillin-streptomycin (1000Jlg/ml) and FBS were obtained 
from Invitrogen, UK. RPMI 1640 (without L-glutamine) and Zymosan A were both 
obtained from Sigma Chemicals Company, Dorset, UK; Vybrant phagocytosis assay kit 
(V-6694) containing fluoroscein-Iabelled Escherichia coli (K-12 strain), HBSS and 
trypan blue was obtained from Molecular Prob~s. 
5.2.2 Culture of J774.A1 Cell Line 
Cell culture was conducted in accordance with the protocol described for 1774.2 cells in 
section 2.2.3. 
5.2.3 Flow Cytometry 
Flow cytometric analysis was conducted with single colour flow cytometry using a 
FACSCaIibur flow cytometer equipped with an argon-ion laser emitting light at 488nm 
(BD Biosciences, San Jose, California). An electronic gate was placed around the 
macrophage population in the flow cytometry scatter plot and at least 10,000 events were 
acquired for analysis. Light scatter signals were collected in linear mode and 
fluorescence signals were collected in logarithmic mode. 
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5.2.4 Treatment of J774.Al CelIs with Nanoparticle Carbon Black - Flow 
Cytometric Analysis 
A confluent culture flask of 1774.Al cells was washed and scraped and a cell count was 
performed using trypan blue exclusion. A portion of the cells (appro x 1 million) were 
removed and run through the flow cytometer prior to treatment to examine the light 
scatter properties of untreated 1774 cells and to determine the degree of aggregation for 
the cell population. 
1774.Al cells (2 million) were transferred into a centrifuge tube and centrifuged for 2 
minutes at 900 g. Following centrifugation, the supernatant was decanted and 2mls of an 
nanoparticle carbon black suspension (31.25 Jlg/ml) in RPMI 1640 was added. The tube 
was shaken gently and 0.5ml of the cell/particle suspension was added into 4 wells of a 
24 well microplate. Untreated J774.Al cells were also added to 4 wells of the 
microplate. The plate was incubated for 4 hours in a heated humidified incubator (37°C / 
5% C02). The particle suspension was removed from the wells and then 0.5ml HBSS 
was added to each well. The plates were shaken gently and the HBSS was removed. 
Using the end of a sterile Pasteur pipette, the cells were scraped off the surface of the 
microplate and resuspended in 0.5ml of HBSS. The suspensions of the treated and 
untreated cells were pooled in two separate tubes and the light scatter properties of the 
cells were analysed using the flow cytometer. 
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5.2.5 Preliminary Experiment to Determine Effectiveness of Vybrant™ 
Phagocytosis Assay Kit When Using J774.Al Macrophages Treated With Metals 
J774.Al cells were seeded at a cell count of 200,000 cells per well in RPMI with 10% 
FBS in a 24 well microplate. The plate was incubated in a heated humidified incubator 
for 18 hours at 37°C I 5% CO2. Control wells were prepared by seeding 6 wells with 
cells and treating with HBSS only. Cells were also treated with nanoparticle carbon 
black (3 1.25 Jlg/ml), FeCb (10mM) or ZnCh (lOmM) suspended in HBSS. 
The fluorescein isothiocyanate (FITC)-labelled E.coli bioparticle suspension was 
prepared according to the manufacturers instructions (dessicated particles were 
suspended in 0.5ml of lOx HBSS with 4.5ml distilled water and sonicated for 5 minutes). 
The supernatants were aspirated from the wells of the 24 well plate. The bioparticle 
suspension (250JlI) was added to all of the wells except three, to which 250Jll ofHBSS 
was added. The cells were then incubated for 2 hours at 37°C I 5% C02. Following 
incubation, the supernatants were aspirated from all of the wells and replaced with 200Jll 
trypan blue solution. The plate was incubated at room temperature for 1 minute and the 
excess trypan blue was aspirated from the wells. Cells were removed from the wells by 
scraping with a sterile Pasteur pipette then resuspended in 0.5ml HBSS. Replicate 
treatments were pooled into single flow cytometry tubes and analysed using single colour 
flow cytometry. 
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5.2.6 The Effect of Nanoparticle Carbon Black and Varying Concentrations of Zinc 
on the Phagocytic Ability of J774.Al Macrophages 
J774.Al cells were seeded in a 24 well plate according to the method in section 5.2.5. 
Cells were treated with ZnCb at concentrations of 100f.lM, If.lM and 100nM. The zinc 
treatments were conducted in the presence and absence of nanoparticle carbon black 
(31.25 f.lg/ml). The cells and treatments were incubated for 4 hours and the phagocytosis 
assay was conducted according to the protocol described above. The results of this 
experiment are displayed in figures 5.4.1 to 5.4.6 and in table 5.4.7. 
In the following experiment, cells were treated with ZnCh at concentrations of 50f.lM, 
20f.lM, 10f.lM. This experiment was repeated twice and the results are displayed in 
figures 5.5.1 to 5.5.7 and in table 5.5.8. The data from the two experiments are also 
collated in figure 5.5.9. 
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5.3 RESULTS 
5.3.1 Flow Cytometric Analysis of J774.Al Cells Treated with Nanoparticle Carbon 
Black 
Figure 5.2.1 shows the scatter plot pattern obtained from the three groups of J774.Al 
cells. The first scatter plot (l) represents cells that have been analysed using a flow 
cytometer immediately after removal from a culture flask. The second plot (2) displays 
untreated J774.Al cells following a 4 hour culture incubation period. The third plot (3) 
demonstrates cells that have been treated with 31.25Jlg ofnanoparticle carbon black for 4 
hours. The left hand axis of each plot represents side scatter light signals and the bottom 
axis represents forward scatter signals. Analysis of these scatter plots reveals that a 
distinct population is present in each case. A small amount of cellular d~bris is present in 
the bottom left hand comer of each scatter plot. The debris was excluded from the light 
scatter analysis by gating around the cell populations. From these patterns it appears that 
the J774.Al have not aggregated either during scraping or following 4 hours incubation 
in the presence and absence of nanopartic~e carbon black. This was confirmed by 
examination of the cell suspensions by conventional light microscopy. 
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Figure 5.2.1 Flow cytometry scatter plots of J774.AI cells. The plots represent (I) Cells 
analysed prior to incubation for 4 hours, (2) CeUs incubated for 4 hours with serum-free 
medium and (3) Cells treated with nanoparticle carbon black (31.25Jlg) for 4 hours. Circle 
represents gated population. 
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Figure 5.2.2 shows the fluorescence profiles for each of the three treatments. The left 
hand axis is the number of cells per channel and the bottom axis is the fluorescence 
depicted on a logarithmic scale. In comparison to the untreated cells, the pattern from the 
treated cells is very similar. The nanoparticle carbon black did not appear to cause any 
change in the background autofluoresence of the cells. This pattern is shown again in 
figure 52.3 where the treated population of cells (red) is overlayed upon the untreated 
cells. As can been seen from the graph, the changes in the fluorescence profile are 
minimal. This is echoed by the data shown in table 5.2.4 which show the mean gated 
fluorescence obtained from each population, which, as shown in previous figures, 
remains similar for each treatment. 
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Figure 5.2.2 Histogram plots of flow cytometry analysis ofJ774.AI cells. The plots 
represent (1) Cells analysed prior to incubation for 4 hours, (2) Cells incubated for 4 hours 
with serum-free medium and (3) Cells treated with nanoparticle carbon black (31.25Ilg) 
for 4 hours. 
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Figure 5.2.3 A histogram plot of treated and untreated I774.AI cells analysed by flow 
cytometry. Untreated I774.AI cells (incubated for 4 hours) are represented by the purple 
area of the graph. J774.AI cells treated with 31.2511g ofnanoparticle carbon black are 
represented by the red outline area. 
Cell Treatments Mean Gated Fluorescence 
(arbitrary units) 
(I) None (Pre-Incubation Analysis) 2.60 
(2) Serum-Free Medium 2.21 
(3) Nanoparticle Carbon Black (31.2511g) 1.74 
Table 5.2.4 Mean fluorescence data for gated population of treated and untreated I774.AI 
cells. Results are the mean of one experiment prepared in duplicate. 
5.3.2 Flow Cytometric Analysis of the Phagocytic Ability of J774.Al CeUs Exposed 
to Nanoparticle Carbon Black in the Presence and Absence of Zinc and Iron Salts 
Figure 5.3.1 shows the scatter plots for the four cell treatments that were conducted in 
this experiment. The scatter plots (1) and (2) represent the negative control (untreated 
cells) and the positive control (cells exposed to bioparticles for 2 hours) respectively. 
Scatter plots (3) and (4) represent cells treated with 10mM ZnCh or 10mM FeCl) for 4 
hours and subsequently treated with bioparticles for 2 hours. As with the previous 
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experiment, a distinct cell population was visible which was further analysed by 
excluding the debris present in the bottom left comer. 
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Figure 5.3.1 Flow cytometry scatter plots ofJ774.AI cells. The plots represent (I) 
Untreated cells (negative control), (2) Cells treated with bioparticles (positive control), (3) 
Cells treated with ZnCl2 (lOmM) and bioparticles (4) Cells treated with FeCl3 (lOmM) and 
bioparticles. Circle represents gated popUlation. 
Figure 5.3.2 shows the fluorescence profiles for the positive (cells treated with 
bioparticles for 2 hours) and negative (un.treated cells) controls in this experiment. The 
negative control (purple) has a low fluorescence as indicated by it position at the lower 
end of the scale. This is consistent with the results obtained in the previous experiment. 
The positive control (red) shows a much higher fluorescent intensity as demonstrated by 
its position at the higher end of the fluorescence scale. This is expected due to the 
exposure of the phagocytic cells to FITC-Iabelled E.coli bioparticles. 
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Figure 5.3.2 A histogram plot of treated and untreated J774.Al cells analysed by flow 
cytometry. Untreated J774.AI cells are represented by the purple area of the graph. 
J774.A I cells treated with bioparticles are represented by the red area ofthe graph. 
Figure 5.3.3 represents the fluorescence profile of J774.Al cells treated with lOmM 
ZnCh for 4 hours and has been overlayed with the fluorescence profiles of the positive 
(red) and negative (green) controls. The graph indicates that the zinc salts have an 
adverse effect on the phagocytic ability of the macrophages. This is represented by a 
decrease in fluorescence on the graph when compared to the positive control. However, 
the fluorescence intensity of these cells is higher than that of the negative control 
indicating that some phagocytosis of the bioparticles has taken place. 
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Figure 5.3.3 A histogram plot of treated and untreated J774.Al cells analysed by flow 
cytometry. J774.AI cells treated with ZnCl2 (IOmM) and bioparticles are represented by 
the purple area ofthe graph. Untreated J774.Al cells (negative control) are represented by 
the green outlined area on the graph. J774.Al cells treated with bioparticles only (positive 
control) are represented by the red outline area on the graph 
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Figure 5.3.4 shows J774.A1 cells that have been treated with lOmM FeCI] for 4 hours 
and has again been overlayed with the positive (red) and negative (green) control graphs 
for comparison. As with the previous figure, it can be observed that the iron salts cause a 
reduction in bioparticle phagocytosis, which is seen on the graph as a reduction in 
fluorescence intensity. However, as with the zinc treatments, it is apparent that some 
phagocytosis has taken place. Figure 5.3.5, an overlay ofthe two metal salt treatments, 
indicates that the iron does not appear to affect the phagocytic ability of the macrophages 
as much as zinc does. These comparisons are represented numerically in table 5.3.6 
which again indicates that zinc salts have more of an effect on the macrophages' 
phagocytic ability (approximately 90% reduction in phagocytic ability for zinc treatments 
compared to around 50% reduction following iron treatments). 
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Figure 5.3.4 A histogram plot of treated and untreated J774.Al cells analysed by flow 
cytometry. J774.A1 cells treated with FeCl3 (10mM) and bioparticles are represented by 
the purple area ofthe graph. Untreated J774.A1 cells (negative control) are represented by 
the green outlined area on the graph. J774.A1 cells treated with bioparticles only (positive 
control) are represented by the red outline area on the graph 
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Figure 5.3 .5 A histogram plot oftreated and untreated J774.AI cells analysed by flow 
cytometry. J774.AI cells treated with FeCI3 (lOmM) and bioparticles are represented by 
the purple area ofthe graph. J774.AI cells treated with ZnCl2 (lOmM) and bioparticles are 
represented by the red outline area on the graph 
Figure Cell Treatments Mean Gated Fluorescence 
(arbitrary units) 
5.3.2 SIP Medium (negative control) 3.16 
5.3.3 SIP Medium & Bioparticles (positive control) 3565.18 
5.3.4 ZnCl2 (10mM) and Bioparticles 340.92 
5.3.5 FeCI3 (10mM) and Bioparticles 1759.43 
Table 5.3.6 Mean fluorescence data for gated population of treated and untreated J774.Al 
cells. Results are the mean of one experiment prepared in duplicate. 
5.3.3 Flow Cytometric Analysis of J774.Al Macrophage Phagocytosis Following 
Nanoparticle Carbon Black Treatment in the Presence and Absence of Varying 
Concentrations of Zinc. 
Figure 5.4.1 shows the scatter plots for the nine cell treatments that were conducted with 
a view to detennining the effects of nanoparticle carbon black and ZnCh at 
concentrations of IOOflM, 1 flM and 1000M on macrophage phagocytosis. The circle 
shows the cell population that was gated and used to obtain the fluorescence data. The 
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scatter plots that represent treatments with nanoparticle carbon black i.e. 3,7,8 and 9 
show an increase in the amount of debris present in the bottom left corner. It should also 
be noted that in plot 6 (treatment of 100nM ZnCh) there was also an increase in debris. 
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Figure 5.4.1 Flow cytometry sc~tter plots of I174.AI cells. The plots represent (1) 
Untreated cells (negative control), (2) Cells treated with bioparticles (positive control), (3) 
Cells treated with 31.251lg nanoparticle carbon black (NCB) only (4) Cells treated with 
ZnCI2 (lOOfJM) and bioparticles, (5) Cells treated with ZnCI2 (1fJM) and bioparticles, (6) 
Cells treated with ZnCI2 (IOOnM) and bioparticles, (7) Cells treated with ZnCI2 (IOOfJM), 
NCB and bioparticles, (8) Cells treated with ZnCI2 (1 fJM), NCB and bioparticles, (9) Cells 
treated with ZnCI2 (lOOnM), NCB and bioparticles, Circle represents gated population. 
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Figure 5.4.2 shows the fluorescence profiles of the untreated cells and the cells that have 
phagocytosed bioparticles. Bioparticle phagocytosis by the macrophages resulted in a 
very high level of fluorescence. Figure 5.4.3 is a representation of the cells that have 
been treated with nanoparticle carbon black (purple) as well as being overlayed with the 
peak of the positive control (red outline). The treatment with nanoparticle carbon black 
causes a slight decrease in fluorescence intensity which is indicated by the movement of 
the peak to the left, i.e. less fluorescent intensity. 
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Figure 5.4.2 A histogram plot oftreated and untreated J774.AI cells analysed by flow 
cytometry. Untreated J774.AI cells are represented by the purple area of the graph. 
J774.AI cells treated with bioparticIes are represented by the red area of the graph. 
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Figure 5.4.3 A histogram plot oftreated J774.AI cel1s analysed by flow cytometry. 
J774.AI cells treated with bioparticles only are represented by the red outline area of the 
graph. J774.AI cells treated with 31.25~g nanoparticIe carbon black and bioparticles are 
represented by the purple area of the graph. 
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The three figures (5.4.4, 5.4.5 and 5.4.6) show the phagocytic responses of the 
macrophages following treatment with zinc salts in the presence and absence of 
nanoparticle carbon black. Figure 5.4.4 illustrates the highest dose of zinc salts (lOmM) 
which caused the fluorescent peak from the cells to decrease and move to the left 
indicating decreased fluorescence compared to the positive control (figure 5.4.2). When 
the cells are co-incubated in the presence of both zinc and nanoparticle carbon black, the 
peak moves even further to the left indicating a marked decrease in fluorescence. Figures 
5.4.5 and 5.4.6 show very similar patterns in that with zinc treatments alone, the 
fluorescence peak only changes slightly from the positive control. As with the high zinc 
concentrations, the addition of nanoparticle carbon black causes a small shift of the peak 
to the left indicating decreased fluorescence . 
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Figure 5.4.4 A histogram plot of J774.AI cells analysed by flow cytometry. J774.AI cells 
treated with IOOIlM ZnCl2 and bioparticles are represented by the red outline area of the 
graph. J774.Al cells co-treated with lOOtJ.M ZnCl2 /31.251lg nanoparticle carbon black 
and then bioparticles are represented by the purple area of the graph. 
150 
~~----------------------------------~------~ 
8 
~ 
10 
Figure 5.4.5 A histogram plot of J774.Al cells analysed by flow cytometry. J774.Al cells 
treated with l~M ZnCl2 and bioparticles are represented by the red outline area of the 
graph. J774.Al cells co-treated with 1 ~ ZnCl2 / 31.25~g nanoparticle carbon black and 
then bioparticles are represented by the purple area ofthe graph. 
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Figure 5.4.6 A histogram plot ofJ774.Al cells analysed by flow cytometry. J774.Al cells 
treated with IOOnM ZnCI2 and bioparticles are represented by the red outline area of the 
graph. J774.Al cells co-treated with IOOnM ZnCl2 / 3125~g nanoparticle carbon black 
and then bioparticles are represented by the purple area ofthe graph. 
Table 5.4.7 shows the mean fluorescence data for each of the cell population represented 
by the peaks in the previous five figures. The addition of nanoparticle carbon black to 
the cells causes a decrease in fluorescence units of approximately 50% compared to the 
positive control. The addition of ZnCh at a concentration of IOOIlM results in a 
fluorescence decrease of approximately 95% compared to the positive control and this is 
reduced by a further 50% when the zinc treatment is conducted in the presence of 
nanoparticle carbon black. The IIlM and 100nM zinc treatments appear to increase the 
fluorescence to levels above the positive control. Co-treatment with nanoparticle carbon 
black and zinc at these concentrations reduced the phagocytic potential of the 
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macrophages by 45% and 20% for the 1 J.lM and 100nM concentrations of zinc 
respectively. 
Cell Treatments Mean Gated Fluorescence 
(arbitrary units) 
(I) S/F Medium (negative control) 3.03 
(2) S/F Medium & Bioparticles (positive control) 1732.31 
(3) Nanoparticle Carbon Black (NCB) and Bioparticles 871.94 
(4) ZnCl2 (1 OOIlM) and Bioparticles 98.95 
(5) ZnCl2 (111M) and Bioparticles 1933.24 
(6) ZnC~ (100nM) and Bioparticles 2255.51 
(7) ZnCl2 (1 OOIlM), NCB and Bioparticles 40.40 
(8) ZnCl2 (lIlM), NCB and Bioparticles 951.54 
(9) ZnCl2 (100nM), NCB and Bioparticles 1425.20 
Table 5.4.7 Mean fluorescence data for gated population of treated and untreated J774.Al 
cells. Results are the mean of one experiment prepared in duplicate. 
5.3.4 Flow Cytometric Analysis of J774.Al Macrophage Phagocytosis Following 
Nanoparticle Carbon Black Treatment in the Presence and Absence of Low 
Concentrations of Zinc 
This experiment was repeated twice and therefore, the results section contains the scatter 
plots from each experiment grouped into individual experiments. However, fluorescence 
graphs representing the individual treatment repetitions have been grouped together to 
allow for easier comparison between experiments. 
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Figures 5.5.1 and 5.5.2 show the scatter plots obtained from cells that have been treated 
with low concentrations of zinc in the presence and absence ofnanoparticle carbon black. 
As with previous experiments the scatter plots from the positive and negative controls are 
also shown. As can be seen from the plots, the cells are a distinct population that can be 
accurately excluded from the debris in the bottom left hand comer. It is worth noting, 
however, that the second repetition of the experiment (figure 5.5.2) shows a decrease 
amount of debris present compared with figure 5.5.1. 
Figure 5.5.3 shows the two fluorescence graphs from the positive and negative control for 
both repetitions of the experiment. As can be seen from the graphs, the profiles for each 
control are similar to previous experiments in that the negative control peak indicates low 
fluorescence and the positive control peak displays high fluorescence indicating that 
phagocytosis of the bioparticles has taken place. The second experiment shows a slight 
decrease in the negative control fluorescence but is still located in a similar area to 
previous negative control peaks. 
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Figure 5.5.1 Flow cytometry scatter plots of J774.AI cells. The plots represent (I) 
Untreated cells (negative control), (2) Cells treated with bioparticles (positive control), (3) 
Cells treated with 31.25~g nanoparticle carbon black (NCB) only (4) Cells treated with 
ZnCl2 (50J.1M) and bioparticles, (5) Cells treated with ZnCl2 (20J.1M) and bioparticles, (6) 
Cells treated with ZnCl2 (lO~M) and bioparticles, (7) Cells treated with ZnCl2 (50J.1M), 
NCB and bioparticles, (8) Cells treated with ZnCl2 (20J.1M), NCB and bioparticles, (9) Cells 
treated with ZnCl2 (1 O~M), NCB and bioparticles. Circle represents gated population. 
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Figure 5_5.2 Repeated Flow cytometry scatter plots of J774_A 1 cells_ The plots represent 
(1) Untreated cells (negative control), (2) Cells treated with bioparticles (positive control), 
(3) Cells treated with 3L25J.lg nanoparticle carbon black (NCB) only (4) Cells treated with 
ZnCl2 (50J.1M) and bioparticles, (5) Cells treated with ZnCl2 (20J.lM) and bioparticles, (6) 
Cells treated with ZnCl2 (10J.lM) and bioparticles, (7) Cells treated with ZnCl2 (50J.1M), 
NCB and bioparticles, (8) Cells treated with ZnCI2 (20J.1M), NCB and bioparticles, (9) Cells 
treated with ZnCl2 (10J.lM), NCB and bioparticles_ Circle represents gated population_ 
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Figure 5.5.3 Two histogram plots of repeat treatments of 1774.AI cells analysed by flow 
cytometry. In both graphs, untreated 1774.AI cells are represented by the purple area of 
the graph. 1774.Al cells treated with bioparticles are represented by the red area ofthe 
graph. 
Figure 5.5.4 shows the two repetitions of the nanoparticle carbon black treatment of the 
cells compared to the positive control cells. The graph indicates, in both cases, that a 
slight decrease in fluorescence has occurred which is suggestive of a slight impairment to 
the phagocytic ability of the macrophages. Figure 5.5.5 shows the graphs obtained when 
the cells have been treated with 50llM ZnCh in the presence and absence ofnanoparticle 
carbon black. The two graphs both reflect a distinct decrease in fluorescence following 
zinc treatment (red outline) and an even greater decrease when the cells are incubated in 
the presence of the carbon black. This indicates that macrophage phagocytosis has been 
inhibited. It should also be noted that the shape of the graphs are different when the 
experiments are compared to each other. The first repetition shows a much greater drop 
in fluorescence than the second one and is further decreased in the presence of 
nanoparticle carbon black. The graph of the zinc-only treatment in experiment one also 
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appears to show two individual peaks although examination of the scatter plot does not 
indicate the presence of two individual groups of cells. 
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Figure 5.5.4 Two histogram plots of repeat treatments J774.Al cells analysed by flow 
cytometry. In both graphs, J774.Al cells treated with bioparticles only are represented by 
the red outline area of the graph. J774.Al cells treated with 31 .25~g nanoparticle carbon 
black and bioparticles are represented by the purple area ofthe graph. 
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Figure 5.5.5 Two histogram plots ofrepeated treatments ofJ774.Al ceUs analysed by 
flow cytometry. In both graphs, J774.Al cells treated with 50~M ZnCl2 and biopartic1es 
are represented by the red outline area. J774.Al cells co-treated with 50~M ZnCl2 / 
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31.25 ~g nanoparticle carbon black and then biopartic1es are represented by the purple area. 
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Figure 5.5.6 shows the two graphs obtained from treating the J774.AI cells with 20JlM 
ZnCh in the presence and absence of nanoparticle carbon black. The graphs indicate that 
as a result of the zinc treatment alone (red curve) there is a very slight decrease in 
fluorescence compared to the positive control, and when co-treatment of zinc and carbon 
black is carried out there is a further increase in the number of cells showing a lower 
intensity of fluorescence. This is indicated on the graph as a small peak near the middle 
of the graph. Figure 5.5.7 shows the effect of IOJlM ZnCh treatment on the cells. With 
the zinc only treatment there does not appear to be any change in the level of 
fluorescence compared to the positive control cells but the fluoresence is decreased in the 
presence of both zinc and nanoparticle carbon black. This is indicated on the graph as 
slight shifts in the purple graph at the lower end of the fluorescence scale. 
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Figure 5.5.6 Two histogram plots of repeated treatments of I774.Al cells analysed by 
flow cytometry. In both graphs, I774.Al cells treated with 20~ ZnCl2 and bioparticles 
are represented by the red outline area. I774.Al cells co-treated with 20JlM ZnCl2 / 
31.25Jlg nanoparticle carbon black and then bioparticles are represented by the purple area. 
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Figure 5.5.7 Two histogram plots of repeated treatments of J774.A1 cells analysed by 
flow cytometry. In both graphs, J774.A1 cells treated with lOJiM ZnCI2 and bioparticles 
are represented by the red outline area. J774.A1 cells co-treated with 10J1M ZnCl2 / 
31.25 Jig nanoparticle carbon black and then bioparticles are represented by the purple area. 
Table 5.5.8 shows the mean numerical fluorescence data for each cell population in both 
experiments. This data is also presented in figure 5.5.9 as a histogram. The figures 
representing the positive control cells show a difference in that the positive control of 
experiment 2 was approximately 30% lower than that of experiment 1. Carbon black 
treatments resulted in decreases of between 30-35% in phagocytic ability. The data 
indicate that there was only a small decrease in fluorescence following the zinc-only 
treatment at concentrations of 20 and IOIlM. The 50llM shows a dramatic decrease 
(approximately 65%) in experiment 1 but only 20% in experiment 2. Following carbon 
black co-treatments with all zinc doses, the phagocytic ability of the macrophages was 
decreased. The zinc (20 and IOIlM) and carbon black treatments decreased to similar 
levels (approximately 60-75%) but the 50llM zinc / carbon black treatment showed 
decreases between 65% and 95%. 
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e 
Cell Treatments Mean Gated Fluorescence 
(arbitrary units) 
Experiment 1 Experiment 2 
(1) S/F Medium (negative control) 2.74 1.11 
(2) S/F Medium & Biopartic1es (positive control) 1954.37 1200.39 
(3) Nanoparticle Carbon Black (NCB) and Bioparticles 1421.79 770.40 
(4) ZnC~ (50~M) and Bioparticles 610.07 977.74 
(5) ZnC~ (20~M) and Bioparticles 1728.18 1084.56 
(6) ZnC~ (1 O~M) and Bioparticles 1906.47 1086.90 
(7) ZnCl2 (50~), NCB and Bioparticles 160.44 413.31 
(8) ZnC~ (20~, NCB and Bioparticles 1514.31 739.44 
(9) ZnCl2 (l O~M), NCB and Bioparticles 1295.86 739.56 
Table 5.5.8 Mean fluorescenc~ data for the phagocytic potential of a gated population of 
treated and untreated J774.Al cells. Cells were treated with varying concentrations ofZnCl2 
in the presence and absence ofnanoparticle carbon black (31.25~g). Results are the mean of 
two separate experiments. 
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Figure 5.5 .9 Graph showing the phagocytic potential ofJ774.Al cells treated with varying 
concentrations of ZnCI2 in the presence and absence of nanoparticle carbon black (31.25~g) 
Each cell treatment is represented as a % ofthe fluorescence from the positive control cells. 
Results shown are from two repeated experiments. The purple bars represent the data from the 
ftrst experiment and the red bars represent the data from the second experiment 
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5.4 DISCUSSION 
This chapter aimed to investigate if any interactions took place between zinc chloride 
salts and nanoparticle carbon black that could prove to be deleterious to macrophage 
phagocytic ability. The results obtained from this study indicate that any interactions 
between the particles and the metal do not appear to have any adverse effects on 
macrophage phagocytosis over and above the effects observed when incubating 
macrophages with zinc or particles individually. 
The initial experiments in this study examined the possibility of measuring macrophage 
phagocytosis using a flow cytometer, using high doses of zinc and iron salts to induce 
measurable inhibition of phagocytic ability. The addition of zinc salts to the 
macrophages reduced macrophage phagocytosis by approximately 90% whereas the 
addition of iron salts reduced macrophage phagocytosis by approximately 50%. 
Macrophages possess several intracellular iron regulatory proteins such as IRP1, IRP2 as 
well as possessing receptors for the iron-binding plasma glycoprotein, transferrin (Mulero 
& Brock, 1999). In fact, Drapier et al., (1993) notes that 1774 cells express high levels of 
transferrin receptors indicating that the J774 cells are capable of binding large amounts of 
iron. This suggests that J774 cells are physiologically capable of managing iron uptake 
and, as such, may continue to show adequate phagocytic function even after being 
exposed to a high dose of iron. 
Subsequent experiments in this chapter focussed on the effect of zinc chloride salts on 
macrophage phagocytosis. The results indicated that, at concentrations higher than 
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20IlM, the zinc chloride salts caused a large decrease in the phagocytic ability of the 
macrophages. This is not unexpected, as zinc has been shown to be a highly toxic metal 
in several studies. Chvapil et aI., (l977a & 1977b) reported that macrophages showed 
decreased phagocytic potential and oxygen uptake when exposed to zinc salts. Zinc 
oxide inhalation studies have shown increases in BAL TNFu and IL-8 concentrations 
together with impairment of the phagocytic function of alveolar macrophages (Kuschner 
et aI., 1997 and Gordon et al., 1992). Skomik & Brain (1983) also demonstrated 
significantly reduced macrophage phagocytic function in hamsters following the 
inhalation of zinc sulphate aerosols. In contrast, Lastra et al., (2001) demonstrated that 
supplementation of mice with low concentrations of zinc (O.lmM) actually improved 
macrophage phagocytic function. 
The interaction of zinc chloride salts with nanoparticle carbon black particles was also 
examined at a range of doses. The inhibition of macrophage function by nanopartic1e 
carbon black alone was difficult to assess due to the high variability of the results, which 
varied from 20% inhibition up to 50% inhibition. Co-incubation of the nanoparticles 
with varying concentrations of zinc salts resulted in further inhibition of the macrophage 
phagocytic ability. This inhibition was proportional to the percentage inhibition observed 
when exposing the macrophages to zinc salts and to nanoparticles individually. These 
results suggest that any interaction that was taking place between the zinc and the 
particles was not inducing any further reductions in macrophage phagocytosis but was 
acting in an additive manner i.e. the addition of zinc chloride to the nanoparticle carbon 
black treatment caused a decrease that was greater than the carbon black alone. 
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Studies such as those by Adamson et ai., (2000) have stated that zinc is the toxic metal in 
environmental air pollution. This study did not take into account interactions between the 
particles and the metals in the air pollution samples. Preliminary investigations by our 
group have already indicated incre~sed TNFa production by 1774 cells in response to 
incubation with zinc chloride and equivalent doses of nanoparticle carbon black used in 
this study indicating that an interaction was taking place. However, based on the results 
of this study, this interaction is unlikely to be manifested as a potentiative decrease in 
macrophage phagocytic function at the exposure concentrations and timepoints utilised in 
this study. The decreases in phagocytic ability observed in this study appeared to be 
additive effects from the zinc and the carbon black particles. Subsequent investigations 
should focus on using a range ofnanoparticle doses as opposed to the single dose utilised 
in this study together with a wider range of exposure timepoints. Examination of the 
macrophage cytoskeleton should also be conducted to assess possible changes in the 
micro filaments which could subsequently affect macrophage phagocytic potential. 
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CHAPTER 6 
GENERAL DISCUSSION 
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A review of the current literature reveals that there have been numerous studies that have 
investigated the effects of components of particulate air pollution on the lungs and the 
mechanisms by which these effects are created. The nanoparticle component has been 
implicated as ;,t key factor in PMIO induced toxicity (Seaton et aI., 1995), but the variable 
nature of PMIO means that the interaction of several other components can also have 
major roles (Stone et al., 2003). The responses of the organisms that are exposed to the 
particles and physiological mechanisms that have evolved to cope with the constant 
exposure to particulate air pollution are key areas that must be fully understood in order 
to determine how particle induced disease is initiated. The studies conducted in this 
thesis were directed towards learning more about the clearance mechanisms present in the 
lung and how these mechanisms respond when challenged by PMIO and some of its 
components. 
The biological effects of PMIO have been examined in a large number of studies. The 
links between increased levels of environmental particulate pollution and increased 
respiratory disease have been investigated using modern epidemiological techniques 
since the 1970's (Dockery & Pope III, 1994). Mathematical and epidemiological studies 
have demonstrated increased mortality from respiratory and cardiovascular events 
following instances of increased pollution levels (Donaldson et al., 2000, Braga et al., 
2000 and Schwartz, 2001). Several authors have attributed these increases in mortality to 
the nanoparticle component of PM 10 (Seaton et al., 1995, Donaldson & MacNee., 1998, 
Oberdorster et al., 1995). In addition, the toxicological impact of nanoparticles has now 
come under increased scrutiny due to the emergence of a relatively new technological 
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discipline; nanotechnology (Donaldson et aI., 2004). Substances such as carbon 
nanotubes are now being investigated for use in a wide range of applications such as 
potential drug delivery agents, and the toxicological impact ofthese substances has yet to 
be fully assessed. By understanding the mechanisms by which the body responds to 
nanoparticles, we can hope to further understand the potential impact that exposure to 
nanosubstances would generate. 
From the results presented in this thesis, it is apparent that the responses of different types 
of pneumocytes could influence the biopersistenceof nanoparticles in the alveolar region 
of the lung. In chapter 2, we showed that the alveolar type II cell generates increased 
chemoattractants in response to nanoparticle exposure compared to equivalent 
concentrations of fine particle exposure. These findings were in partial concurrence with 
the original hypothesis for this study i.e. that particles would induce chemoattractant 
secretion. However, it should be noted that the fine particles used in this study did not 
appear to share the same properties for chemoattractant generation compared to the fme 
particles. An important limiting factor in this set of experiments was the dose of 
particles, and although 125Jlg/ml was ~stablished as a sub-toxic dose for all particles 
used, it is unknown if higher dose of lower toxicity particles would induce increased 
generation of chemotactic molecules. However, this area of investigation may be 
incongruous to chemoattractant generation by resulting in a higher toxicity for the type II 
cells and ultimately resulting in cell death. 
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Another aspect of this study to consider is the use of an alveolar macrophage cell line to 
measure chemoattractant release by the type II cells. Although the alveolar macrophage 
is the primary mediator of particle clearance in the alveolar region of the lung, the 
neutrophil may also play an important role and, as such, future studies could focus on the 
release of neutrophil chemoattractants from type II cells. The isolation and culture of 
primary type II cells for utilisation in ex vivo particle treatments may also yield data that 
could provide a more accurate picture of events precluding particle uptake by phagocytes. 
In chapter 3, it was demonstrated that nanoparticles possess the potential to induce the 
generation of macrophage chemotactic factors in blood serum. This study acted as a 
model to ascertain the effects of nanoparticles on complement proteins which are known 
to be present in the alveolar lining fluid. It was noted that the migration of macrophages 
towards particle-treated serum could be extremely variable and, as such, the repeated 
measurements that were made during the course of this study were subject to a degree of 
variation. This resulted in larger SEM values from this assay compared to other assays. 
Factors which may have affected these values include variances in the batches of serum 
used or species-specific effects i.e. murine macrophages migrating towards bovine serum. 
However, significant increases in macrophage migration were measured in spite of these 
factors and as such, provided a base upon which to draw conclusions. 
A factor in this study which should also be noted is the high dose of particles that was 
required to activate chemotactic factors within the serum. Although it is unlikely that 
such a physiological dose of nanoparticles would be deposited in the alveolar regions of 
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the lung in one instance, it is possible that failed clearance and subsequent retention of 
particles in the alveolar spaces could result in an accumulated dose of particles. It may 
be possible that investigations utilising primary rat alveolar macrophages together with 
blood serum may yield more repeatable results at lower particle doses. Another area of 
investigation which would be useful to pursue would be an assessment of the potential for 
PMIO samples to activate the complement cascade. Due to limitations in the quantity of 
PMIO samples available for this study, an equivalent dose to that of the carbon black 
nanoparticles could not be achieved and, as such, this would be a worthy area of 
comparison to study. 
Although further studies are warranted to determine if this phenomenon would also occur 
in the complement proteins present in epithelial lining fluid, this is a step forward in 
understanding methods of leukocyte recruitment in the lung. The molecular mechanisms 
of nanoparticle-induced complement activation should be explored in detail to provide a 
clearer picture of particle mediated leukocyte recruitment. 
Both of the chapters mentioned above describe methods by which the cells of the lung 
can aid in the rapid removal of inhaled particles from the alveolar region of the lung. 
Conversely, other data presented in this thesis describes mechanisms by which 
nanoparticle exposure can decrease this clearance potential. In chapter 4, the potential 
for PMIO to cause adverse effects in macrophage clearance mechanisms is examined. The 
data indicates that when PMIO particles are visibly present inside a cell, the phagocytic 
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potential of the cell is impaired. We have also shown that the chemotactic potential of 
cells from particle exposed animals is decreased. 
As previously mentioned, the neutrophilic inflammation observed in chapter 4 is 
consistent with other studies where particle instillation has taken place. The reduction in 
macrophage number may be due to migration out of the alveolar regions of the lung via 
the MCE or could be attributed to macrophage apoptosis. However, one of limitations of 
this study is that one single timepoint was used for all treatments (18 hours). This 
timepoint was used as it was thought that this would allow inflammatory cells to migrate 
to the alveolar space following particle treatment. A drawback of this, however, is that 
18 hours after instillation, it is feasible that some cells may have already moved out of the 
alveolar space and would not appear in the lavage fluid. As such, future studies could 
concentrate on a range of timepoints to provide a more complete picture of cellular 
activities following particle instillation. However, this would result in increased usage of 
animals and so the benefits of the results must be considered in relation to the number of 
animals sacrificed. 
The conclusions that are taken from the study in chapter 4 are contrary to that of the 
previous chapters 2 and 3, but are supported by data obtained from the experiments in 
chapter 5. In chapter 5, the potential for nanoparticles and zinc chloride to adversely 
affect the phagocytic potential of a macrophage cell line is examined. The results 
indicate that the nanoparticles and the zinc chloride salts act in an additive manper to 
reduce the phagocytic potential of the cells. This study used a range of concentrations of 
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zinc chloride salt together with a continuous low dose (31.25 J-lg) of nanoparticle carbon 
black to examine the interaction between zinc and nanoparticles. Although this study 
used two surrogate materials to represent component of PMIO, we believe that this 
provides an appropriate model to examine the effects of two common PMJO components 
and their effects on phagocytic cells. 
The flow cytometric analysis of the phagocytic ability of the macrophages is believed to 
provide an accurate measurement of the potential for macrophages to phagocytose 
fluorescent bioparticles following particle and zinc exposure. However, the 
measurements were subject to fluctuations in the repeatability of the data which may 
have been due to the presence ofnartoparticle carbon black within the cellular solution. It 
should also be noted that whilst the addition of trypan blue to the cell suspension is 
designed to quench unphagocytosed bioparticle fluorescence, it is unknown as to how 
this would affect only partially phagocytosed bioparticles. The macrophage-bioparticle 
incubation time of 2 hours was based upon the manufacturers recommendations but a 
time-series measurement of phagocytic potential may be appropriate. Similarly, 
alteration ofnanoparticle and zinc treatment times may also present alternative results. 
Both chapter 4 and chapter 5 therefore give examples of how particle exposure can 
reduce the efficacy of clearance mechanisms as opposed to inducing increased clearance. 
Should inhibition of these functions occur in the lung ofPMJO exposed animals, this may 
result in particle-laden macrophages remaining inside the alveolar space for an extended 
period of time instead of migrating out of the alveolar space via the MCE or to the lymph 
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nodes. This could result in the particles causing increased inflammation in the alveolar 
space over a long period of time resulting in the exacerbation of pre-existing respiratory 
conditions. Future investigations in this area should focus on the effects of chronic 
exposure to PMIO on alveolar macrophage functions and the effects ofPMIO exposure on 
the cytoskeletal and molecular processes involved in macrophage-mediated clearance. 
At first glance, the data from chapter 2 and chapter 3 appear to contradict the 
observations from chapters 4 and 5 in that these chapters suggest that particle clearance is 
impeded by nanoparticles whereas chapters 2 and 3 would support the hypothesis that 
particle clearance is promoted by nanoparticles by manner of increased leukocyte 
recruitment. Based upon the results in this thesis, it is hypothesised that the interaction of 
nanoparticles with different types of cells causes clearance mechanisms to be initiated 
within the alveolar space. The success of the activated clearance mechanisms is 
dependant upon the relative toxicity of the particles towards the alveolar macrophage, the 
key cell in the clearance process. Figure 6.1 is a schematic diagram outlining the 
hypothetical pathway that particle deposition and clearance could follow based upon the 
results described in this thesis. The diagram shows particle entry into the lung and 
interaction with cell and proteins present in the alveolar space. At this point, leukocytes 
are recruited to sites of particle deposition via chemoattractant generation from type II 
cells and complement proteins. At this point, the divergent nature ofthe pathway could 
determine the fate of the particles, and indeed, the macrophages that have phagocytosed 
them. Following phagocytosis ofnanoparticles, we have observed that macrophages 
display decreased potential for further phagocytosis and decreased chemotactic potential. 
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It is hypothesised, therefore, that macrophages displaying these characteristics would not 
be able to migrate towards the MCE as would be expected in 'normal' circumstances, but 
would be retained within the alveolar space i.e. particle retention. However, on the other 
side of the pathway, the process of leukocyte recruitment, particle phagocytosis and 
clearance is displayed. This is due to the observation that nanoparticles induce increased 
generation of chemoattractants. 
These outcomes may help to explain the increased toxicity observed when examining the 
fate ofnanoparticles in the lung. Following entry, the nanoparticles appear to stimulate 
epithelial cells and complement to generate chemotactic factors that recruit macrophages 
to sites of particle deposition. The macrophages that are recruited may not be able to 
effectively phagocytose the particles and, as such, the particles and macrophages persist 
in the lung tissue and the particle-induced inflammation is exacerbated leading to disease. 
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Figure 6.1 - The hypothesised consequences ofnanoparticle entry into the alveolar region of the 
lung. 
In summary, it has been shown that the components of particulate air pollution can have a 
wide range of effects on the clearance mechanisms that have evolved in the mammalian 
lung. The effective recruitment of phagocytic cells may indeed occur following 
inhalation of particles, but the impairment of normal macrophage functions such as 
chemotaxis and phagocytosis may have important ramifications in the continued 
challenge of air pollution that the lungs face on a daily basis. further research into the 
exact nature of these effects is warranted, if only to provide a greater understanding when 
attempting to regulate human exposure to different types of airborne pollutants. 
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Furthermore, the models employed in this project will provide useful tools for the study 
of new and emerging nanoparticles including buckyballs, nanotubes and quantum dots. 
174 
REFERENCES 
Adams, D. O. and Hamilton, T. A. (1984). The cell biology of macrophage activation. 
Annu. Rev. Immunol2: 283-318. 
Adamson, I. Y. R. and Bowden, D. H. (1974). The type 2 cell as progenitor of alveolar 
epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab 
Invest. 30(1): 35-42. 
Adamson, I. Y. R. and Bowden, D. H. (1978). Adaptive responses ofthe pulmonary 
macrophagic system to carbon. II. Morphologic studies. Lab Invest. 38(4): 430-438. 
Adamson, I. Y. R. and Bowden, D. H. (1981). Dose response of the pulmonary 
macrophagic system to various particulates and its relationship to transepithelial passage 
of free particles. Exp. Lung Res. 2(3): 165-175. 
Adamson, I. Y. R., Prieditis, H., Hedgecock, C. and Vincent, R. (2000). Zinc is the toxic 
factor in the lung response to an atmospheric particulate sample. Toxicol. Appl. 
Pharmacol. 166(2): 111-119. 
Aderem, A. and Underhill, D. M. (1999). Mechanism of phagocytosis in macrophages. 
Ann. Rev. Immunol. 17: 593-623. 
Allen, J.I., Perri, R. T., McClain, C. J. and Kay, N. E. (1983). Alterations in human 
natural killer cell activity and monocyte cytotoxicity induced by zinc deficitlncy. J. Lab 
Clin. Med. 102(4): 577-589. 
Anderson, P. J., Wilson, J. D. and Hiller, F. C. (1990). Respiratory tract deposition of 
ultrafine particles in subjects with obstructive or restrictive lung disease. Chest. 97(5): 
1115-1120. 
175 
Arlaud, G. J. and Colomb, M. G. (1998). Complement: classical pathway. Nature 
Encyclopedia of Life Sciences. London: Nature Publishing Group. 
Ashcroft, G. S. (1999). Bidirectional regulation of macrophage function by TGF-beta. 
Microbes. Infect. 1(15): 1275-1282. 
Bailey, M. R., Hodgson, A. and Smith, H. (1985). Respiratory tract retention of relatively 
insoluble particles in rodents. J. Aerosol Sci. 16(4): 279-293. 
Barrett, E. G., Johnston, C., Oberdorster, G. and Finkelstein, J. N. (1999). Silica-induced 
chemokine expression in alveolar type II cells is mediated by TNF -alpha-induced oxidant 
stress. Am. J. Physiol. 276(6 Pt 1): L979-L988. 
Barrington, R., Zhang, M., Fischer, M. and Carroll, M. C. (2001). The role of 
complement in inflammation and adaptive immunity. Immunol. Rev. 180: 5-15. 
Bayram, H., Devalia, J. L., Sapsford, R. J., Ohtoshi, T., Miyabara, Y., Sagai, M. and 
Davies, R. J. (1998). The effect of diesel exhaust particles on cell function and release of 
inflammatory mediators from human bronchial epithelial cells in vitro. Am. J. Respir. 
Cell Mol. BioI. 18(3): 441-448. 
Becher, R., Hetland, R. B., Refsnes, M., Dahl, J. E., Dahlman, H. J. and Schwarze, P. E. 
(2001). Rat lung inflammatory responses after in vivo and in vitro exposure to various 
stone particles. Inhal. Toxicol. 13(9): 789-805. 
Becker, S., Soukup, J. M., Gilmour, M. I. and Devlin, R. B. (1996). Stimulation of human 
and rat alveolar macrophages by urban air particulates: effects on oxidant radical 
generation and cytokine production. Toxicol. Appl. Pharmacol. 141(2): 637-648. 
Beisel, W. R. (1982). Single nutrients and immunity. Am. J. Clin. Nutr. 35(2 suppl): 417-
468. 
176 
BeruBe, K. A., Jones, T. P., Williamson, B. J., Winters, C., Morgan, A. J. and Richards, 
R. J. (1999). Physiochemical characterisation of diesel exhaust particles: factors for 
assessing biological activity. Atmos. Environ. 33, 1599-1614. 
Bishop, A. E. (2004) Pulmonary epithelial stem cells. Cell Prolif. 37(1): 89-96. 
Bitterman, P. B., Saltzman, L. E., Adelberg, S., Ferrans, V. J. and Crystal, R. G. (1984). 
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear 
phagocyte population in the chronically inflammed lung. J. Clin. Invest. 74: 460-469. 
Blusse Van Oud Ablas, A. and Van Furth, R. (1979). Origin, Kinetics and characteristics 
of pulmonary macrophages in the normal steady state. J. Exp. Med.149: 1504-1518. 
Bogdan, C., Rollinghoff, M. and Diefenbach, A. (2000). Reactive oxygen and reactive 
nitrogen intermediates in innate and specific immunity. Curro Opin. Immunol. 12(1): 64-
76. 
Bogdan, C. (2001). Macrophages. Nature Encyclopedia of Life Sciences. London: Nature 
Publishing Group. 
Boland, S., Bonvallot, V., Fournier, T., Baeza-Squiban, A., Aubier, M. and Marano, F. 
(2000). Mechanisms ofGM-CSF increase by diesel exhaust particles in human airway 
epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 278(1): L25-L32. 
Braga, A. L., Zanobetti, A. and Schwartz, J. (2000). Do respiratory epidemics confound 
the association between air pollution and daily deaths? Eur. Respir. J. 16(4): 723-728. 
Brain, J. D., Gehr, P. and Kavet, R. I. (1984). Airway macrophages. The importance of 
the fixation method. Am. Rev. Respir. Dis. 129(5): 823-826. 
177 
Brieland, J. K., Flory, C. M., Jones, M. L., Miller, G. R., Remick, D. G., Warren, J. S. 
and F antone, J. C. (1995). Regulation of monocyte chemoattractant protein-I gene 
expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, 
tumor necrosis factor-alpha, and interleukin-I beta. Am. J. Respir. Cell Mol. Bioi. 12(1): 
104-109. 
Brown, L. A. (1994). Glutathione protects signal transduction in type IT cells under 
oxidant stress. Am. J. Physiol. 266(2 Pt I): L 172-L177. 
Brown, G. M., Brown, D. M., Donaldson, K., Drost, E. and MacNee, W. (1995). 
Neutrophil sequestration in rat lungs. Thorax 50(6): 661-667. 
Brown, D. M., Stone, V., Findlay, P., MacNee, W. and Donaldson, K. (2000). Increased 
inflammation and intracellular calcium caused by ultrafine carbon black is independent of 
transition metals or other soluble components. Occup. Environ. Med. 57(10): 685-691. 
Brown, J. S., Zeman, K. L. and Bennett, W. D. (2002). Ultrafine particle deposition and 
clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 166(9): 
1240-1247. 
Carter, J. D., Ghio, A. J., Samet, J. M. and Devlin, R. B. (1997). Cytokine production by 
human airway epithelial cells after exposure to an air pollution particle is metal 
dependent. Toxicol. Appl. Pharmacol. 146: 180-188. 
Castranova, V., Ma, J. Y., Yang, H. M., Antonini, J. M., Butterworth, L., Barger, M. W., 
Roberts, J. and Ma, J. K. (2001). Effect of exposure to diesel exhaust particles on the 
susceptibility of the lung to infection. Environ. Health Perspect. 109(SuppI4): 609-612. 
Chantry, D., Turner, M., Abney, E. and Feldmann, M. (1989). Modulation of cytokine 
production by transfonning growth factor-beta. J. Immunol. 142(12): 4295-4300. 
178 
Chen, J. L. and Fayerweather, W. E. (1988). Epidemiologic study of workers exposed to 
titanium dioxide. J. Occup. Med. 30(12): 937-942. 
Cheng, G., Ueda, T., Eda, F., Arima, M., Yoshida, N. and Fukuda, T. (2001). A549 cells 
can express interleukin-16 and stimulate eosinophil chemotaxis. Am. J. Respir. Cell Mol. 
Bio!. 25(2): 212-218. 
Churg, A. and Brauer, M. (2000). Ambient atmospheric particles in the airways of human 
lungs. Ultrastrnct. Patho!. 24(6): 353-361. 
Chvapil, M., Stankova, L., Zukoski, C. and Zukoski III, C. (1977) Inhibition of some 
functions of polymorphonuclear leukocytes by in vitro zinc. J. Lab. Clin. Med. 89(1): 
135-146. 
Chvapil, M., Stankova, L., Bernhard, D. S., Weldy, P. L., Carlson, E. C. and Campbell, J. 
B. (1977). Effect of zinc on peritoneal macrophages in vitro. Infect. Immun. 16(1): 367-
373. 
Clark, H., Palaniyar, N., Strong, P., Edmondson, J., Hawgood, S. and Reid, K. B. (2002). 
Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J. Immunol. 169(6): 
2892-2899. 
Clouter, A., Brown, D., Hohr, D., Borm, P. and Donaldson, K. (2001). Inflammatory 
effects of respirable quartz collected in workplaces versus standard DQ12 quartz: particle 
surface correlates. Toxicol. Sci. 63(1): 90-98. 
Cole, F. S., Matthews, W. J. Jr., Rossing, T. H., Gash, D. J., Lichtenberg, N. A. and 
Pennington, J. E. (1983). Complement biosynthesis by human bronchoalveolar 
macrophages. Clin. Immunol. Immunopathol. 27(2): 153-159. 
179 
Crapo, J. D., Barry, B. E., Gehr, P., Bachofen, M. and Weibel, E. (1982). Cell number 
and cell characterisation of the normal human lung. Am. Rev. Respir. Dis. 125: 332-337. 
Cross, C. E. (1974). The granular type II pneumocyte and lung antioxidant defence. Ann. 
Intern. Med. 80: 409-411. 
Dai, J., Xie, C., Vincent, R. and Churg, A. (2003). Air pollution particles produce airway 
wall remodeling in rat tracheal explants. Am. J. Respir. Cell Mol. Bio!. 29(3 Pt 1): 352-
358. 
Daigle, C. C., Chalupa, D. C., Gibb, F. R., Morrow, P. E., Oberdorster, G., Utell, M. J. 
and Frampton, M. W. (2003). Ultrafine particle deposition in humans during rest and 
exercise. Inhal. Toxieo!. 15(6): 539-552. 
Degussa Technical Bulletin Pigments No. 15. (1986). Carbon blacks/or coatings and 
printing inks.,- a survey. Germany: Degussa AG. 
Degussa Technical Bulletin Pigments No. 25. (1990). Technical safety data - carbon 
blacks and coloured pigments. Germany: Degussa AG. 
Degussa Technical Bulletin Pigments No. 64. (1992). The biological effects o/SiO], 
Ah03 and TiO]. Gennany: Degussa AG. 
Degussa Technical Document - What is carbon black? Germany: Degussa AG. 
Desai, R. and Richards, R. J. (1978). The adsorption of biological macromolecules by 
mineral dusts. Environ. Res. 16(1-3): 449-464. 
Dick, C. A., Dennekamp, M., Howarth, S., Cherrie, J. W., Seaton, A., Donaldson, K. and 
Stone, V. (2001). Stimulation ofIL-8 release from epithelial cells by gas cookerPMlO: a 
pilot study. Oecup. Environ. Med. 58(3): 208-210. 
180 
Dick, C. A., Brown, D. M., Donaldson, K. and Stone, V. (2003). The role offree radicals 
in the toxic and inflammatory effects of four different ultrafine particle types. Inhal. 
Toxicol. 15(1): 39-52. 
Dobbs, L. G. (1990). Isolation and culture of alveolar type II cells. Am. J Physiol. 258(4 
Pt 1): L134-LI47. 
Dockery, D. W. (200 I). Epidemiologic evidence of cardiovascular effects of particulate 
air pollution. Environ. Health Perspect. 109 (Suppl4): 483-486. 
Dockery, D. W. and Pope, C. A., III (1994). Acute respiratory effects ofparticulate air 
pollution. Annu. Rev. Public Health. 15: 107-132. 
Donaldson, K., Slight, J. and Bolton, R. E. (1988). The effect of products from 
bronchoalveolar-derived neutrophils on oxidant production and phagocytic activity of 
alveolar macrophages. Clin. Exp. Immunol. 74(3): 477-482. 
Donaldson, K., Slight, J. and Brown, D. M. (1989). Effects of products from 
inflammatory pulmonary neutrophils on alveolar macrophage chemotaxis, spreading, and 
thymidine incorporation. Inflammation 13(4): 443-453. 
Donaldson, K., Brown, G. M., Brown, D. M., Slight, J., Robertson, M. D. and Davis, J. 
M. (1990). Impaired chemotactic responses ofbronchoalveolar leukocytes in 
experimental pneumoconiosis. J Pathol. 160(1): 63-69. 
Donaldson, K., Beswick, P. H. and Gilmour, P. S. (1996). Free radical activity associated 
with the surface of particles: a unifying factor in determining biological activity? Trxicol. 
Lett. 88(1-3): 293-298. 
181 
Donaldson, K., Brown, D. M., Mitchell, C., Dineva, M., Beswick, P. H., Gilmour, P. and 
MacNee, w. (1997). Free radical activity of PM 1 0: iron-mediated generation of hydroxyl 
radicals. Environ. Health Perspect. 105(SuppI5): 1285-1289. 
Donaldson, K., Stone, V., Clouter, A., Renwick, L. and MacNee, W. (200 1 a). Ultrafine 
particles. Occup. Environ. Med. 58(3): 211-215. 
Donaldson, K. and MacNee, W. (2001 b). Potential mechanisms of adverse pulmonary 
and cardiovascular effects of particulate air pollution (PMIO). Int. J. Hyg. Environ. 
Health. 203(5-6): 411-415. 
Donaldson, K., and MacNee, W. (1998). The mechanism of injury caused by PMIO. 
Issues In Environ. Sci. Technol. 10: 21-32. 
Donaldson, K. and Tran C L (2002). Inflammation caused by particles and fibers. Inhal. 
Toxicol. 14: 5-27. 
Donaldson, K., Stone, V., Gilmour, P., Brown, D. M. and MacNee, W. (2000a). U1trafine 
particles: mechanisms oflung injury. Phil. Trans. R. Soc. Lond. A. 358: 2741-2749. 
Donaldson, K., Gilmour, M. I. and MacNee, W. (2000). Asthma and PMIO. Respir. Res. 
1(1): 12-15. 
Donaldson, K., Stone, V., Borm, P. J., Jimenez, L. A., Gilmour, P. S., Schins, R. P., 
Knaapen, A. M., Rahman, I., Faux, S. P., Brown, D. M. and MacNee, W. (2003). 
Oxidative stress and calcium signaling in the adverse effects of environmental particles 
(PMIO). Free Radic. Bioi. Med. 34(11): 1369-1382. 
Donaldson, K., Stone, V., Tran, C L., Kreyling, W. and Borm, P. J. (2004). 
Nanotoxicology. Occup. Environ. Med. 61(9): 727-728. 
182 
Dong, W., Lewtas, J. and Luster, M. I. (1996). Role of endotoxin in tumor necrosis factor 
alpha expression from alveolar macrophages treated with urban air particles. Exp. Lung 
Res. 22(5): 577-592. 
Dorger, M. and Krombach, F. (2000). Interaction of alveolar macrophages with inhaled 
mineral particulates. J. Aerosol Med. 13(4): 369-380. 
Dormans, J. A. M. A. and Van Bree, L. (1995). Function and response of type 2 cells to 
inhaled toxicants. Inha!. Toxieol. 7: 319-342. 
Drapier, J. C., Hirling, H., Wietzerbin, J" Kaldy, P. and Kuhn, L. C. (1993). Biosynthesis 
of nitric oxide activates iron regulatory factor in macrophages. Embo. J. 12(9): 3643-
3649. 
Driscoll, K. E., Lindenschmidt, R. C., Maurer, J. K., Higgins, J. M. and Ridder, G. 
(1990). Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar 
macrophage-derived cytokines, and histopathology. Am. J. Respir. Cell Mol. BioI. 2(4): 
381-390. 
Driscoll, K. E., Carter, J. M., Howard, B. W., Hassenbein, D. G., Pepelko, W., Baggs, R. 
B. and Oberdorster, G. (1996a). Pulmonary inflammatory, chemokine, and mutagenic 
responses in rats after subchronic inhalation of carbon black. Toxieol. App!. Pharmaeol. 
136(2): 372-380. 
Driscoll, K. E., Howard, B. W., Carter, J. M., Asquith, T., Johnston, C., Detilleux, P., 
Kunkel, S. L. and Isfort, R. J. (1996). Alpha-quartz-induced chemokine expression by rat 
lung epithelial cells: effects of in vivo and in vitro particle exposure. Am. J. Pathol. 
149(5): 1627-1637. 
Driscoll, K. E. (1996). Role of inflammation in the development of rat lung tumours in 
response to chronic particle exposure. Inhal. Toxieo!. 8(Suppll): 139-153. 
183 
Driscoll, K. E., Deyo, L. C., Carter, J. M., Howard, B. W., Hassenbein, D. G. and 
Bertram, T. A. (1997a). Effects of particle exposure and particle-elicited inflammatory 
cells on mutation in rat alveolar epithelial cells. Carcinogenesis. 18(2): 423-430. 
Driscoll, K. E., Carter, J. M., Hassenbein, D. G. and Howard, B. (1997). Cytokines and 
particle-induced inflammatory cell recruitment. Environ. Health Perspect. 105(Suppl 5): 
1159-1164. 
Driscoll, K. E. (2000). TNF alpha and MIP-2: role in particle-induced inflammation and 
regulation by oxidative stress. Toxicol. Lett. 112-113: 177-184. 
Drost, E. M. and MacNee, W. (2002). Potential role oflL-8, platelet-activating factor and 
TNF-alpha in the sequestration ofneutrophils in the lung: effects on neutrophil 
deformability, adhesion receptor expression, and chemotaxis. Eur. J. Immunol. 32(2): 
393-403. 
Duffin, R., Gilmour, P. S., Schins, R. P., Clouter, A., Guy, K., Brown, D. M., MacNee, 
W., Borm, P. J., Donaldson, K. and Stone, V. (2001). Aluminium lactate treatment of 
DQ 12 quartz inhibits its ability to cause inflammation, chemokine expression, and 
nuclear factor-kappaB activation. Toxicol. Appl. Pharmacol. 176(1): 10-17. 
Elo, R., Maatta, K., Uksila, E. and Arstila, A. V. (1972). Pulmonary deposits of titanium 
dioxide in man. Arch. Pathol. 94: 417-424. 
Englert, N. (2004). Fine particles and human health - a review of epidemiological studies. 
To~icoI.Lett. 149(1-3): 235-242. 
Ercan, M. T. and Bor, N. M. (1991). Phagocytosis by macrophages in zinc-deficient rats. 
Int. J Rad. Appl. Instrum. B. 18(7): 765-768. 
184 
Fantone, J. C. and Ward, P. A. (1983). Chemotactic mechanisms in the lung: Vol 19 
Lung biology in health and disease Immunopharmacology of the lung. Marcel Dekker, 
New York: 243-272. 
Faurschou, M. and Borregaard, N. (2003). Neutrophil granules and secretory vesicles in 
inflammation. Microbes. Infect. 5(14): 1317-1327. 
Fehrenbach, H. (2001). Alveolar epithelial type II cell: defender ofthe alveolus revisited. 
Respir. Res. 2(1), 33-46. 
Fels, A. O. and Cohn, Z. A. (1986). The alveolar macrophage. J. Appl. Physiol. 60(2): 
353-369. 
Ferin, J., Oberdorster, G. and Penney, D. P. (1992). Pulmonary retention of ultra fine and 
fine particles in rats. Am. J. Respir. Cell Mol. Bioi. 6(5): 535-542. 
Ferin, J. and Feldstein, M. L. (1978). Pulmonary clearance and hilar lymph node content 
in rats after particle exposure. Environ. Res. 16(1-3): 342-352. 
Finkelstein, J. N., Johnston, C., Barrett, T. and Oberdorster, G. (1997). Particulate-cell 
interactions and pulmonary cytokine expression. Environ. Health Perspect. 105(Suppl 5): 
1179-1182. 
Folinsbee, L. J. (1993). Human health effects of air pollution. Environ. Health Perspect. 
100: 45-56. 
Frampton, M. W. (2001). Systemic and c~rdiovascular effects of airway injury and 
inflammation: ultrafine particle exposure in humans. Environ. Health Perspect. 109 
(SuppI4): 529-532. 
185 
Freeman, B. A., and Crapo, J. D. (1982). Biology of disease: free radicals and tissue 
injury. Lab. Invest. 47(5): 412-426. 
Geiser, M., Schupbach, R., Waber, U. and Gehr, P. (1998). Bioassay for hamster 
macrophage chemotaxis: application to study particle-lung interactions. Cell Mol. Life 
Sci. 54(2): 179-185. 
Georgsen, J., Rasmussen, S. and Pederson, J. O. (1990). Granulocyte chemotaxis. 
Influence of radiographic contrast media on the chemoattractive properties of serum. 
Acta. Radiol. 31(5): 531-536. 
Gilmour, P. S., Brown, D. M., Lindsay, T. G., Beswick, P. H., MacNee, W. and 
Donaldson, K. (1996). Adverse health effects ofPMJO particles: involvement of iron in 
generation of hydroxyl radical. Occup. Environ. Med. 53(12): 817-822. 
Gilmour, P. S., Rahman, I., Hayashi, S., Hogg, J. C., Donaldson, K. and MacNee, W. 
(2001). Adenoviral EIA primes alveolar epithelial cells to PMJO-induced transcription of 
interleukin-8. Am. J. Physiol. Lung Cell Mol. Physiol. 281(3): L598-L606. 
Gilmour, P. S., Ziesenis, A., Morrison, E. R., Vickers, M. A., Drost, E. M., Ford, I., Karg, 
E., Mossa, C., Schroeppel, A., Ferron, G. A., Heyder, J., Greaves, M., MacNee, W. and 
Donaldson, K. (2004). Pulmonary and systemic effects of short-term inhalation exposure 
to ultrafine carbon black particles. Toxicol. Appl. Pharmacol. 195(1): 35-44. 
Goerdt, S., Politz, 0., Schledzewski, K., Birk, R., Gratchev, A., Guillot, P., Hakiy, N., 
Klemke, C. D., Dippel, E., Kodelja, V. and Orfanos, C. E. (1999). Alternative versus 
classical activation of macro phages. Pathobiology. 67(5-6): 222-226. 
Gordon, T., Chen, L. C., Fine, J. M., Schlesinger, R. B., Su, W. Y., Kimmel, T. A and 
Amdur, M. Q. (1992). Pulmonary effects of inhaled zinc oxide in human subjects, guinea 
pigs, rats, and rabbits. Am. Ind. Hyg. Assoc. J. 53(8): 503-509. 
186 
Gordon, S. (2003). Alternative activation of macro phages. Nat. Rev. Immunol. 3(1): 23-
35. 
Gormand, F., Cheria-Sammari, S., Aloui, R., Guibert, B., Malicier, D., Perrin-Fayolle, 
M., Lagarde, M. and Pacheco, Y. (1995). Granulocyte-macrophage colony stimulating 
factors (GM-CSF) and interleukin 8 (IL-8) production by human bronchial epithelial cells 
(HBEC) in asthmatics and controls. Lack of in vitro effect of sa Ibuta mol compared to 
sodium nedocromil.Pulm. Pharmacol. 8(2-3): 107-113. 
Governa, M., Fenoglio, I., Amati, M., Valentino, M., Bolognini, L., Coloccini, S., Volpe, 
A. R., Carmignani, M. and Fubini, B. (2002). Cleavage of the Fifth Component of 
Human Complement and Release of a Split Product with C5a-like Activity by Crystalline 
Silica through Free Radical Generation and Kallikrein Activation. Toxicol. Appl. 
Pharmacol. 179(3): 129-136. 
Greenwell, L. L., Moreno, T., Jones, T. P. and Richards, R. J. (2002). Particle-induced 
oxidative damage is ameliorated by pulmonary antioxidants. Free Radic. Bioi. Med. 
32(9): 898-905. 
Halliwell, B. (2001). Role offree radicals in the neurodegenerative diseases: therapeutic 
implications for antioxidant treatment. Drugs Aging. 18(9): 685-716. 
Harrison, R. M. and Yin, J. (2000). Particulate matter in the atmosphere: which particle 
properties are important for its effects on health? Sci. Total Environ. 249(1-3): 85-101. 
Hasselbacher, P. (1979). Binding of immunoglobulin and activation of complement by 
asbestos fibers. J. Allergy Clin. Imm uno I. 64(4): 294-298. 
187 
Heasman, S. J., Giles, K. M., Rossi, A. G., Allen, J. E., Haslett, C. and Dransfield, I. 
(2004). Interferon gamma suppresses glucocorticoid augmentation of macrophage 
clearance of apoptotic cells. Eur. J. Immunol. 34(6): 1752-1761. 
Hermanowski-Vosatka, A., Mundt, S. S., Ayala, J. M., Goyal, S., Hanlon, W. A., 
Czerwinski, R. M., Wright, S. D. and Whitman, C. P. (1999). Enzymatically inactive 
macrophage migration inhibitory factor inhibits monocyte chemotaxis and random 
migration. Biochemistry. 38(39): 12841-12849. 
Hetland, R. B., Cassee, F. R., Refsnes, M., Schwarze, P. E., Lag, M., Boere, A. J. and 
Dybing, E. (2004). Release of inflammatory cytokines, cell toxicity and apoptosis in 
epithelial lung cells after exposure to ambient air particles of different size fractions. 
Toxicol. In Vitro. 18(2): 203-212. 
Heyder, J., Gebhart, R. G., Schiller, C. F. and Stahkhofen, W. (1986). Deposition of 
particles in the human respiratory tract in the size range 0.005-15IlM. J. Aerosol Sci. 
17(5): 811-825. 
Hill, J. 0., Rothenberg, S. J., Kanapilly, G. M., Hanson, R. L. and Scott, B. R. (1982). 
Activation of immune complement by fly ash particles from coal combustion. Environ 
Res. 28(1): 113-122. 
Hoet, P. H. and Nemery, B. (2001). Stimulation of phagocytosis by ultrafine particles. 
Toxicol. Appl. Pharmacol. 176(3): 203. 
Hofinann, W. and Asgharian, B. (2003). The effect oflung structure on mucociliary 
clearance and particle retention in human and rat lungs. Toxicol. Sci. 73(2): 448-456. 
Hoffinan, R. M., Claypool, W. D., Katyal, S. L., Singh, G., Rogers, R. M. and Dauber, J. 
H. (1987). Augmentation of rat alveolar macrophage migration by surfactant protein. Am. 
Rev. Respir. Dis. 135(6): 1358-1362. 
188 
Hohr, D., Steinfartz, Y., Schins, R. P., Knaapen, A. M., Martra, G., Fubini, B. and Borm, 
P. J. (2002). The surface area rather than the surface coating determines the acute 
inflammatory response after instillation offine and ultrafine Ti02 in the rat. Int. J. Hyg. 
Environ. Health. 205(3): 239-244. 
Hom, J. K., Goldstein, I. M. and Flick, M. R. (1984). Complement and endotoxin-
induced lung injury in sheep. J. Surg. Res. 36(5): 420-427. 
Hunninghake, G. W., Gader, J. E., and Lawley, T. J. (1981). Mechanisms of neutrophil 
accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J. CUn. Invest. 
68: 259-269. 
IARC Monograph (1989). IARC Monograph on the Evaluation of the Carcinogenic Risk 
of Chemicals to Humans. Vol 47: Some organic solvents, resin monomers and related 
compounds, pigment~ and occupational exposures in paint manufacture and painting. 
IARC Press, Lyon, France. 
IARC Monograph (1996). IARC Monograph on the Evaluation of the Carcinogenic Risk 
of Chemicals to Humans. Vo I 65: Printing process and printing inks, Carbon Black, and 
some nitro compounds. IARC Press, Lyon, France. 
Janeway, C. A., Travers, P., Walport, M. and Capra, J. D. (1999). Immunobiology: The 
immune system in health and disease (lh Edition). Elsevier Science Ltd / Garland 
Publishing. USA. 
Jimenez, L. A., Thompson, J., Brown, D. A., Rahman, I., Anton ice iii, F., Duffin, R., 
Drost, E. M., Hay, R. T., Donaldson, K. and MacNee, W. (2000). Activation ofNF-
kappa8 by PMIO occurs via an iron-mediated mechanism in the absence ofIkappaB 
degradation. Toxicol. Appl. Pharmacol. 166(2): 101-110. 
189 
Johnson, E. and Hetland, G. (1988). Mononuclear phagocytes have the potential to 
synthesize the complete functional complement system. Scand. J. Immunol. 27(5): 489-
493. 
Jones, B. M., Edwards, J. H., and Wagner, J. C. (1972). Absorption of serum proteins by 
inorganic dusts. Br. J. Ind. Med. 29(3): 287-292. 
Kanemitsu, H., Na~asawa, S., Sagai, M. and Mori, Y. (1998). Complement activation by 
diesel exhaust particles (DEP). Bioi. Pharm. Bull. 21(2): 129-132. 
Keen, C. L. and Gershwin, M. E. (1990). Zinc deficiency and immune function. Annu. 
Rev. Nutr. 10: 415-431. 
Keshav, S., Chung, L. P. and Gordon, S. (1990). Macrophage products in inflammation. 
Diagn. Microbiol. Infect. Dis. 13(5): 439-447. 
Kim, K. J. and Malik, A. B. (2003). Protein transport across the lung epithelial barrier. 
Am. J. Physiol. Lung Cell Mol. Physiol. 284(2): L247-L259. 
Kreyling, W. G., Semmler, M., Erbe, F., Mayer, P., Takenaka, S., SchulZ, H., 
Oberdorster, G. and Ziesenis, A. (2002). Translocation of ultra fine insoluble iridium 
particles from lung epithelium to extrapulmonary organs is size dependent but very low. 
J. Toxicol. Environ. Health A. 65(20): 1513-] 530. 
Koyama, S., Sato, E., Nomura, H., Kubo, K., Miura, M., Yamashita, T., Nagai, S. and 
Izumi, T. (1998). Bradykinin stimulates type II alveolar cells to release neutrophil and 
monocyte chemotactic activity and inflammatory cytokines. Am. J. Pathol. 153(6): 1885-
1893 
190 
Kruth, H. S., Chang, J., Ifrim, I. and Zhang, W. Y. (1999). Characterization of 
patocytosis: endocytosis into macrophage surface- connected compartments. Eur. J. Cell 
Bioi. 78(2): 91-99. 
Kuschner, W. G., D'Alessandro, A., Wong, H. and Blanc, P. D. (1997). Early pulmonary 
cytokine responses to zinc oxide fume inhalation. Environ. Res. 75(1): 7-11. 
LaForce, F. M., Kelly, W. J. and Huber, G. L. (1973). Inactivation of staphylococci by 
alveolar macrophages with preliminary observations on the importance of alveolar lining 
material. Am. Rev. Respir. Dis. 108(4): 784-790. 
Lang, J. D., McArdle, P. J., O'Reilly, P. J. and Matalon, S. (2002). Oxidant-antioxidant 
balance in acute lung injury. Chest. 122(6 Suppl): 314S-320S. 
Laskin, D. L., and Laskin, J. D. (1996). Macrophages, inflammatory mediators, and lung 
injury. Methods. 10(1): 61-70. 
Lastra, M. D., Pastelin, R., Camacho, A., Monroy, B. and Aguilar, A. E. (2001). Zinc 
intervention on macrophages and lymphocytes response. J. Trace Elem. Med. Bioi. 15(1): 
5-lO. 
Lightbody, J., Hutchison, G., Donaldson, K and Stone, V. (2003). The influence of 
particle composition and size on in vitro and in vivo biological models. DEFRA report 
EPGl/3/147. 
Lee, K. P., Trochimowicz, H. J., and Reinhardt, C. F. (1985). Pulmonary response of rats 
exposed to titanium dioxide (fi02) by inhalation for two years. Toxicol. Appl. 
Pharmacol. 79(2): 179-192. 
191 
Lehnert, B. E., Valdez, Y. E. and Stewart, C. C. (1986). Translocation of particles to the 
tracheobronchial lymph nodes after lung deposition: kinetics and particle-cell 
relationships. Exp. Lung Res. 10: 245-266. 
Lemiere, C., Cartier, A., Malo, J. L. and Lehrer, S. B. (2000). Persistent specific 
bronchial reactivity to occupational agents in workers with normal nonspecific bronchial 
reactivity. Am. J. Respir. Crit. Care Med. 162(3 Pt 1): 976-980. 
Letterio, J. J. and Roberts, A. B. (1998). Regulation of immune responses by TGF-beta. 
Annu. Rev. Immunol. 16: 137-161. 
Li, X. Y., Gilmour, P. S., Donaldson, K. and MacNee, W. (1996). Free radical activity 
and pro-inflammatory effects of particulate air pollution (PMIO) in vivo and in vitro. 
Thorax 51(12): 1216-1222 
Li, X. Y., Brown, D., Smith, S., MacNee, W. and Donaldson, K. (1999). Short-term 
inflammatory responses following intratracheal instillation offine and ultrafine carbon 
black in rats. Inhal. Toxieol. 11(8): 709-731. 
Lippmann, M., Yeates, D. B. and Albert, R. E. (1980). Deposition, retention, and 
clearance of inhaled particles. Br. J. Ind. Med. 37(4): 337-362. 
Lippmann, M. and Schlesinger, R. B. (1984). Interspecies comparisons of particle 
deposition and mucociliary clearance in tracheobronchial airways. J. Toxieol. Environ. 
Health. 13(2-3): 441-469. 
Little, F. F., Cruikshank, W. W. and Center, D. M. (2001). IL-9 stimulates release of 
chemotactic factors from human bronchial epithelial cells. Am. J. Respir. Cell Mol. BioI. 
25(3): 347-352. 
192 
Lohmann-Matthes, M. L., Steinmuller, C. and Franke-Ullmann, G. (1994). Pulmonary 
macrophages.Eur. Respir. J. 7(9): 1678-1689. 
Lukacs, N. W. and Ward, P. A. (1999). Inflammatory mediators, cytokines, and adhesion 
molecules in pulmonary inflammation and injury. Adv. Immunol. 62: 257-304. 
Lundborg, M., Johansson, A., Lastbom, L. and Camner, P. (1999). Ingested aggregates of 
ultrafine carbon particles and interferon-gamma impair rat alveolar macrophage function. 
Environ. Res. 81(4): 309-315. 
Lundborg, M., Johard, U., Lastbom, L., Gerde, P., and Camner, P. (2001). Human 
alveolar macrophage phagocytic function is impaired by aggregates of ultra fine carbon 
particles. Environ. Res. 86(3): 244-253. 
MacNee, W. and Donaldson, K. (2000). Exacerbations ofCOPD: environmental 
mechanisms. Chest 117(5 Suppl 2): 390S-397S. 
Malpel, S. and Cardroso, W. V. (2001). Lung development. Nature Encyclopedia of Life 
Sciences. London: Nature Publishing Group. 
Matalon, S., Holm, B. A., Baker, R. R., Whitfield, M. K. and Freeman, B. A. (1990). 
Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim. 
Biophys. Acta. 1035(2): 121-127. 
Mauderly, J.L. (1996). Lung overload: the dilemma and opportunities for resolution. 
Inhal. Toxicol. 8(Suppl 1): 1-28. 
MetchnikotI, E. (1905). Immunity to infectious diseases. CambridgelLondonlNY: 
Cambridge University Press. 
193 
Mercer, R. R., Russell, M. L., Roggli, V. L. and Crapo, J. D. (1994). Cell number and 
distribution in human and rat airways. Am. J. Respir. Cell Mol. BioI. 10(6): 613-624. 
McCormack, F. X. (2001). Functional mapping of surfactant protein A. Pediatr. Pathol. 
Mol. Med. 20(4): 293-318. 
Milanowski, J., Sorenson, W. G., Lewis, D. M. and Dutkiewicz, J. (1995). Chemotaxis of 
alveolar macrophages and neutrophils in response to microbial products derived from 
organic dust. J. Investig. Allergol. Clin. Immunol. 5(4): 221-227. 
Miller, F. J. (2000). Dosimetry of particles in laboratory animals and humans in 
relationship to issues surro\lnding lung overload and human health risk assessment: a 
critical review. Inhal. Toxieol. 12(1-2): 19-57. 
Mills, P. R., Davies, R. J. and Devalia, J. L. (1999). Airway epithelial cells, cytokines, 
and pollutants. Am. J. Respir. Crit. Care Med. 160(5 Pt 2): S38-S43. 
Moller, W., Hofer, T., Ziesenis, A., Karg, E. and Heyder, J. (2002). Ultrafine particles 
cause cytoskeletal dysfunctions in macrophages. Toxieol. Appl. Pharmaeol. 182(3): 197-
207. 
Monn, C. and Becker, S. (1999). Cytotoxicity and induction of proinfiammatory 
cytokines from human monocytes exposed to fine (PM2.s) and coarse particles (PMIO-2.S) 
in outdoor and indoor air. Toxieol. Appl. Pharmaeol. 155(3): 245-252. 
Monn, C., Fendt, R. and Koller, T. (2002). Ambient PMJO extracts inhibit phagocytosis of 
defined inert model particulates by alveolar macrophages. Inhal. Toxieol. 14(4): 369-385. 
Morrow, P. E. (1988). Possible mechanisms to explain dust overloading of the lungs. 
Fundam. Appl. Toxieol. 10(3): 369-384. 
194 
Mulero, V. and Brock, 1. H. (1999). Regulation of iron metabolism in murine 1774 
macrophages: role of nitric oxide-dependent and -independent pathways following 
activation with gamma interferon and lipopolysaccharide. Blood. 94(7): 2383-2389. 
Murphy, S. A., BeruBe, K. A., Pooley, F. D. and Richards, R. 1. (1998). The response of 
lung epithelium to well characterised fine particles. Life Sci. 62(19): 1789-1799. 
Namangala, B., De Baetselier, P., Noel, W., Brys, L. and Beschin, A. (2001). Alternative 
versus classical macrophage activation during experimental African trypanosomosis. J. 
Leukoc. Bioi. 69(3): 387-396. 
Nemery, B. (1990). Metal toxicity and the respiratory tract. Eur. Respir. J. 3(2): 202-219. 
Nemmar, A., Vanbilloen, H., Hoylaerts, M. F., Hoet, P. H., Verbruggen, A. and Nemery, 
B. (2001). Passage of i ntratrac he ally instilled ultrafine particles from the lung into the 
systemic circulation in hamster. Am. J. Respir. Crit. Care Med. 164(9): 1665-1668. 
Nemmar, A., Hoet, P. H., Vanquickenbome, B., Dinsdale, D., Thomeer, M., Hoylaerts, 
M. F., Vanbilloen, H., Mortelmans, L. and Nemery, B. (2002). Passage of inhaled 
particles into the blood circulation in humans. Circulation 105(4): 411414. 
Neumann, B., Zantl, N., Veihelmann, A., Emmanuilidis, K., Pfeifer, K., Heidecke, C. D. 
and Holzmann, B. (1999). Mechanisms of acute inflammatory lung injury induced by 
abdominal sepsis. Int. Immunol. 11(2): 217-227. 
Newman, V., Gonzalez, R. F., Matthay, M. A. and Dobbs, L. G. (2000). A novel alveolar 
type I cell-specific biochemical marker of human acute lung injury. Am. J. Respir. Crit. 
Care Med. 161(3 Pt 1): 990-995. 
195 
Ning, Y., Imrich, A., Goldsmith, C. A., Qin, G. and Kobzik, L. (2000). Alveolar 
macrophage cytokine production in response to air particles in vitro: role of endotoxin. J. 
Toxieol. Environ. Health. A. 59(3): 165-180. 
Ning, Y., Tao, F., Qin, G., Imrich, A., Goldsmith, C. A., Yang, Z. and Kobzik, L. (2003). 
Particle-epithelial interaction: effect of priming and bystander neutrophils on interleukin-
8 release. Am. J. Respir. Cell Mol. Bioi. 30(5): 744-750. 
O'Brien, A. D., Standiford, T. J., Christensen, P. J., Wilcoxen, S. E. and Paine, R., III 
(1998). Chemotaxis of alveolar macrophages in response to signals derived from alveolar 
epithelial cells. J. Lab. Clin. Med. 131(5): 417-424. 
Oberdorster, G., Ferin, J. and Lehnert, B. E. (1994). Correlation between particle size, in 
vivo particle persistence, and lung injury. Environ. Health Perspeet. 102 (SuppI5): 173-
179. 
Oberdorster, G. (1995). Lung particle overload: implications for occupational exposures 
to particles. Regul. Toxieol. Pharmaeol. 21(1): 123-135. 
Oberdorster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W. and Cox, C. 
(2004). Translocation of inhaled ultrafine particles to the brain. Inhal. Toxieol. 16(6-7): 
437-445. 
Obot, C. J., Morandi, M. T., Beebe, T. P., Hamilton, R. F. and Holian, A. (2002). Surface 
components of airborne particulate matter induce macrophage apoptosis through 
scavenger receptors. Toxieol. Appl. Pharmaeol. 184(2): 98-106. 
Olenchock, S. A., Mull, J. C., Major, P. C., Peach III, M. J., Gladish, M. E. and Taylor, 
G. (1978). In vitro activation of the alternative pathway of complement by settle9 grain 
dust. J. Allergy. Clin. Immunol. 62(5): 295-300. 
196 
Otto, W. R. (2002). Lung epithelial stem cells. J Pathol. 197(4): 527-535. 
Paine, R., III, Rolfe, M. W., Standiford, T. J., Burdick, M. D., Rollins, B. J. and Strieter, 
R. M. (1993). MCP-l expression by rat type II alveolar epithelial cells in primary culture. 
J Immunol. 150(10): 4561-4570. 
Pendino, K. J., Shuler, R. L., Laskin, J. D. and Laskin, D. L. (1994). Enhanced 
production of interleukin-l, tumor necrosis factor-alpha, and fibronectin by rat lung 
phagocytes following inhalation ofa pulmonary irritant. Am. J Respir. Cell. Mol. Bioi. 
11(3): 279-286. 
Penttinen, P., Timonen, K. L., Tiittanen, P., Mirme, A., Ruuskanen, J. and Pekkanen, J. 
(2001). Ultrafine particles in urban air and respiratory health among adult asthmatics. 
Eur. Respir. J 17(3): 428-435. 
Perkins, R. C., Scheule, R. K., Hamilton, R., Gomes, G., Freidman, G. and Holian, A. 
(1993). Human alveolar macrophage cytokine release in response to in vitro and in vivo 
asbestos exposure. Exp. Lung Res. 19(1): 55-65. 
Peters, A., Wichmann, H. E., Tuch, T., Heinrich, J. and Heyder, J. (1997). Respiratory 
effects are associated with the number of ultra fine particles. Am. J Respir. Crit. Care 
Med. 155(4): 1376-1383. 
Pope, C. A., III, Burnett, R. T., Thun, M. J., Calle, E. E., Krewski, D., Ito, K. and 
Thurston, G. D. (2002). Lung cancer, cardiopulmonary mortality, and long-term exposure 
to fine particulate air pollution. JAMA 287(9): 1132-1141. 
Prieditis, H. and Adamson, I. Y. (2002). Comparative pulmonary toxicity of various 
soluble metals found in urban particulate dusts. Exp. Lung Res. 28(7): 563-576. 
197 
Pritchard, R. J., Ghio, A. J., Lehmann, J. R., Winsett, D. W., Tepper, J. S., Park, P., 
Gilmour, I. N., Df(!her, K. L. and Costa, D. L. (1996). Oxidant generation and lung injury 
after particulate air pollutant exposure jncrease with the concentration of associated 
metals. Inhal. Toxicol. 8: 457-477. 
Putman, E., van Golde, L. M. and Haagsman, H. P. (1997). Toxic oxidant species and 
their impact on the pulmonary surfactant system. Lung 175(2): 75-103. 
Rahman, I. and MacNee, W. (1999). Oxidant/antioxidant imbalance in smokers and 
chronic obstructive pulmonary disease. Thorax. 51(4): 348-350. 
Regoli, D., Rizzi, A., Perron, S. I. and Gobeil Jr., F. (2001). Classification of kinin 
receptors. Bioi. Chem. 201(1): 31-35. 
Rehn, B., Seiler, F., Rehn, S., Bruch, J. and Maier, M. (2003). Investigations on the 
inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and 
surface treated. Toxicol. Appl. Pharmacol. 189(2): 84-95. 
Renwick, L. C., Donaldson, K. and Clouter, A. (2001). Impairment of alveolar 
macrophage phagocytosis by ultrafine particles. Toxicol. Appl. Pharmacol. 172(2): 119-
127. 
Renwick, L. C., Brown, D., Clouter, A. and Donaldson, K. (2004). Increased 
inflammation and altered macrophage chemotactic responses caused by two ultrafine 
particle types. Occup. Environ. Med. 61(5): 442-447. 
Rice, T. M., Clarke, R. W., Godleski, J. J., AI Mutairi, E., Jiang, N. F., Hauser, R. and 
Paulauskis, J. D. (2001). Differential ability of transition metals to induce pulmonary 
inflammation. Toxicol. Appl. Pharmacol. 177(1): 46-53. 
198 
Rink, L. and Gabriel, P. (2000). Zinc and the immune system. Proc. Nutr. Soc. 59(4): 
541-552. 
Rosseau, S., Selhorst, J., Wiechmann, K., Leissner, K., Maus, U., Mayer, K., 
Grimminger, F., Seeger, W. and Lohmeyer, J. (2000). Monocyte migration through the 
alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines. J. 
Immunol. 164(1): 427-435. 
Roveri, A., Bruni, R., Baritussio, A., Coassin, M., Benevento, M., Maiorino, M. and 
Ursini, F. (1989). Antioxidant defences of rabbit alveolar lining fluid. Respiration. 
55(Suppl 1): 68-73. 
Rylander, R. and Haglind, P. (1984). Airborne endotoxins and humidifier disease. Clin. 
Allergy. 14(1): 109-112. 
Sahu, A. and Lambris, J. D. (2000). Complement inhibitors: a resurgent concept in anti-
inflammatory therapeutics. Immunopharmacology. 49(1-2): 133-148. 
Saint-Remy, J. M. and Cole, P. (1980). Interactions of chrysotile asbestos fibres with the 
complement system. Immunology. 41(2): 431-437. 
Salvi, S., Blomberg, A., Rudell, 8., Kelly, F., Sandstrom, T., Holgate, S. T. and Frew, A. 
(1999). Acute inflammatory responses in the airways and peripheral blood after short-
term exposure to diesel exhaust in healthy human volunteers. Am. J. Respir. Crit. Care 
Med. 159(3): 702-709. 
Schins, R. P., Lightbody, J. H., Borm, P. J., Shi, T., Donaldson, K. and Stone, V. (2004). 
Inflammatory effects of coarse and fine particulate matter in relation to chemical and 
biological constituents. Toxicol. Appl. Pharmacol. 195(1): 1-11. 
199 
Schneider, E. and Dy, M. (1985). Activation of macro phages. Compo Immunol. 
Microbiol. Infect. Dis. 8(2): 135-146, 
Schwartz, J. (2001). Is there harvesting in the association of airborne particles with daily 
deaths and hospital admissions? Epidemiology 12(1): 55-61. 
Seaton, A., MacNee, W., Donaldson, K. and Godden, D. (1995). Particulate air pollution 
and acute health effects. Lancet. 345(8943): 176-178. 
Shellito, J., Esparza, C. and Armstrong, C. (1987). Maintenance ofthe normal rat 
alveolar macrophage cell population. The roles of monocyte influx and alveolar 
macrophage proliferation in situ. Am. Rev. Respir. Dis. 135(1): 78-82. 
Shin, H. S., Snyderman, R., Friedman, E., Mellors, A. and Mayer, M. M. (1968). 
Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig 
complement. Science. 162(851): 361-363. 
Sibille, Y. and Reynolds, H. Y. (1990). Macrophages and polymorphonuclear neutrophils 
in lung defense and injury. Am. Rev. Respir. Dis. 141(2): 471-501. 
Simon, R. H. and Paine Ill, R., (1995). Participation of pulmonary alveo lar epithelial 
cells in lung inflammation. J. Lab. Clin. Med. 126(2): 108-118. 
Skornik, W. A. and Brain, J. D. (1983). Relative toxicity of inhaled metal sulfate salts for 
pulmonary macrophages. Am. Rev. Respir. Dis. 128(2): 297-303. 
Sladowski, D., Kinsner, A., Langezaal, I., Kay, S. and Coecke, S. (2001). Activation of 
the complement system as an indicator of pyrogenic reaction to lipopolysaccharide 
(LPS). Toxicol. In Vitro. 15(4-5): 339-342. 
200 
Smith, K. R. and Aust, A. E. (1997). Mobilization of iron from urban particulates leads to 
generation of reactive oxygen species in vitro and induction of ferritin synthesis in human 
lung epithelial cells. Chem. Res. Toxicol. 10(7): 828-834. 
Snydennan, R., Shin, H. S., Phillips, J. K., Gewurz, H. and Mergenhagen, S. E. (1969). A 
neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with 
endotoxin. J Immunol. 103(3): 413-422. 
Snydennan, R., Shin, H. S. and Hausman, M. H. (1971). A chemotactic factor for 
mononuclear leukocytes. Proc. Soc. Exp. Bioi. Med. 138(2): 387-390. 
Soukup, J. M. and Becker, S. (2001). Human alveolar macrophage responses to air 
pollution particulates are associated with insoluble components of coarse material, 
including particulate endotoxin. Toxicol. Appl. Pharmacol. 171(1): 20-26. 
Stahlhofen, W., Gebhart, J. and Heyder, J. (1983). New regional deposition data of the 
human respiratory tract. J. Aerosol Sci. 14: 186-188. 
Stahlhofen, W., Rudolf, G. and James, A. C. (1989). Intercomparison of experimental 
regional aerosol deposition data. J. Aerosol Med. 2: 285-308. 
Standiford, T. J., Kunkel, S. L., Phan, S. H., Rollins, B. J. and Strieter, R. M. (1991). 
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-l 
expression from human pulmonary type II-like epithelial cells. J. BioI. Chern. 266(15): 
9912-9918. 
Stone, V., Shaw, J., Brown, D. M., MacNee, W., Faux, S. P. and Donaldson, K. (1998). 
The role of oxidative stress in the prolonged inhibitory effect of ultra fine carbon black on 
epithelial cell function. Toxicol. In Vitro 12: 649-659. 
201 
Stone, V., Tuinman, M., Vamvakopoulos, J. E., Shaw, J., Brown, D., Petterson, S., Faux, 
S. P., Bonn, P., MacNee, W., Michaelangeli, F. and Donaldson, K. (2000a). Increased 
calcium influx in a monocytic cell line on exposure to ultrafine carbon black. Eur. Respir. 
J. lS(2): 297-303. 
Stone, V. (2000b). Environmental air pollution. Am. J Respir. Crit. Care Med. 162(2 Pt 
2): S44-S47. 
Stone, V., Wilson, M. R., Lightbody, J. H. and Donaldson, K. (2003). Investigating the 
potential for interaction between the components ofPM IO• Environmental Health & 
Preventative Medicine. 7(6): 246-253. 
Stringer, B. and Kobzik, L. (1998). Environmental particulate-mediated cytokine 
production in lung epithelial cells (A549): role of pre-existing inflammation and oxidant 
stress. J Toxicol. Environ. Health A. SS(1): 31-44. 
Strunk, R. C., Eidlen, D. M. and Mason, R. J. (1988). Pulmonary alveolar type II 
epithelial cells synthesize and secrete proteins of the classical and alternative complement 
pathways. J. Clin. Invest. 81(5): 1419-1426. 
Sunyer, J. O. and Lambris, J. D. (1999). Complement. Nature Encyclopedia of Life 
Sciences. London: Nature Publishing Group. 
Tao, F., Gonzalez-Flecha, B. and Kobzik, L. (2003). Reactive oxygen species in 
pulmonary inflammation by ambient particulates. Free Radic. Bioi. Med. 3S(4): 327-340. 
Tarling, J. D. and Coggle, J. E. (1982). Evidence for the pulmonary origin of alveolar 
macrophages. Cell Tissue Kinet. lS(6): 577-584. 
Tarling, J. D., Lin, H. S. and Hsu, S. (1987). Self-renewal of pulmonary alveolar 
macrophages: evidence from radiation chimera studies. J Leukoc. Bioi. 42(5): 443-446. 
202 
Teran, L. M., Campos, M. G., Begishvilli, B. T., Schroder, J. M., Djukanovic, R., Shute, 
J. K., Church, M. K., Holgate, S. T. and Davies, D. E. (1997). Identification of neutrophil 
chemotactic factors in bronchQalveolar lavage fluid of asthmatic patients. Clin. Exp. 
Allergy. 27(4): 396-405. 
Thompson, A. B., Robbins, R. A., Romberger, D. J., Sisson, J. H., Spurzem, J. R., 
Teschler, H. and Rennard, S. I. (1995). Immunological functions of the pulmonary 
epithelium. Eur. Respir. J. 8(1): 127-149. 
Tone, K., Suzuki, T. and Todoroki, T. (1991). Influence of zinc deficiency on 
phagocytosis in mice. Kitasato Arch. Exp. Med. 64(4): 263-269. 
Tortora, G. J. and Grabowski, S. R. (1996). Principles of anatomy and physiology (lfh 
Edition). John Wiley & Sons. USA. 
Tran, C. L., Buchanan, D., Cullen, R. T., Searl, A., Jones, A. D. and Donaldson, K. 
(2000). Inhalation of poorly soluble particles II: Influence of particle surface area on 
inflammation and clearance. Inhal. Toxico!. 12(12): 1113-1126. 
Tsutahara, S., Shijubo, N., Hirasawa, M., Honda, Y., Satoh, M., Kuroki, Y. and Akino, T. 
(1993). Lung adenocarcinoma with type II pneumocyte characteristics. Eur. Respir. J. 
6(1): 135-137. 
Turi, J. L., Yang, F., Garrick, M. D., Piantadosi, C. A. and Ghio, A. J. (2004). The iron 
cycle and oxidative stress in the lung. Free Radic. Bioi. Med. 36(7): 850-857. 
Turner, M., Chantry, D. and Feldmann, M. (1990). Transforming growth factor beta 
induces the production ofinterleukin 6 by human peripheral blood mononuclear cells. 
Cytokine. 2(3): 211-216. 
203 
Uhal, B. D. (1997). Cell cycle kinetics in the alveolar epithelium. Am. J Physiol. 272(6 
Pt 1): LI031-LI045. 
Utell, M. J., and Frampton, M. W. (2000). Acute health effects of ambient air pollution: 
the ultrafine particle hypothesis. J Aerosol Med. 13(4): 355-359. 
Verkman, A. S., Matthay, M. A. and Song, Y. (2000). Aquaporin water channels and 
lung physiology. Am. J Lung Cell Mol. Physiol. 278(5): L867-L879. 
Vogt, W., Damerau, B., von, Z., I, Nolte, R. and Brunahl, D. (1989). Non-enzymic 
activation ofthe fifth component of human complement, by oxygen radicals. Some 
properties of the activation product, C5b-like C5. Mol. Immunol. 26(12): 1133-1142. 
Wahl, S. M. (1992). Transforming growth factor beta (TGF-beta) in inflammation: a 
cause and a cure. J Clin.Immunol. 12(2): 61-74. 
Wanner, A. (1977). Clinical aspects ofmuco-ciliary transport. Am Rev. Respir. Dis. 116: 
73-125 
Ward, P. A. (2004). The dark side ofC5a in sepsis. Nature Reviews Immunology 4: 1-11. 
Warheit, D. B. and Hartsky, M. A. (1990). Species comparisons of proximal alveolar 
deposition patterns of inhaled particulates. Exp. Lung Res. 16(2): 83-99. 
Warheit, D. B., Chang, L. Y., Hill, L. H., Hook, G. E., Crapo, J. D. and Brody, A. R. 
(1984). Pulmonary macrophage accumulation and asbestos-induced lesions at sites of 
fiber deposition. Am.Rev. Respir. Dis. 129(2): 301-310. 
Warheit, D. B., George, G., Hill, L. H., Snyderman, R. and Brody, A. R. (1985). Inhaled 
asbestos activates a complement-dependent chemoattractant for macrophages. Lab. 
Invest. 52(2): 505-514. 
204 
Warheit, D. B., Hill, L. H., George, G. and Brody, A. R. (1986). Time course of 
chemotactic factor generation and the corresponding macrophage response to asbestos 
inhalation. Am. Rev. Respir. Dis. 134(1): 128-133. 
Warheit, D. B., Overby, L. H., George, G. and Brody, A. R. (1988). Pulmonary 
macrophages are attracted to inhaled particles through complement activation. Exp. Lung 
Res. 14(1): 51-66. 
Warh~it, D. B. and Hartsky, M. A. (1990). Species comparisons of proximal alveolar 
deposition patterns ofinhaled particulates. Exp. Lung Res. 16(2): 83-99. 
Warheit, D. B., Hansen, J. F., Yuen, I. S., Kelly, D. P., Snajdr, S. I. and Hartsky, M. A. 
(1997). Inhalation of high concentrations of low toxicity dusts in rats results in impaired 
pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. 
Pharmacol. 145(1): 10-22. 
Watford, W. T., Ghio, A. J. and Wright, J. R. (2000). Complement-mediated host defense 
in the lung. Am. J. Physiol. Lung Cell Mol. Physiol. 279(5): L 790-L 798. 
Weissbach, S., Neuendank, A., Pettersson, M., Schaberg, T. and Pison, U. (1994). 
Surfactant protein A modulates release of reactive oxygen species from alveolar 
macrophages. Am. J. Physiol. 267(6 Pt 1): L660-L666. 
Widdicombe, J. G. and Pack, R. J. (1982). The clara cell. Eur. J. Respir. Dis. 63(3): 202-
220. 
Wilkinson, P. C. (1998). Assays ofleukocyte locomotion and chemotaxis. J. Immunol. 
Methods. 216(1-2): 139-153. 
205 
Wilson, M. R., Gaumer, H. R. and Salvaggio, J. E. (1977). Activation of the alternative 
complement pathway and generation of chemotactic factors by asbestos. J. Allergy Clin. 
Immunol. 60(4): 218-222. 
Wilson, M. R., Lightbody, J. H., Donaldson, K., Sales, J. and Stone, V. (2002). 
Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol. 
Appl. Pharmacol. 184(3): 172-179. 
Yano, E., Takeuch, A., Yukiyamo, Y. and Brown, R. C. (1984). Chemotactic factor 
generation by asbestos. Fibre type differences and the effects ofleaching. Br. J. Exp. 
Pathol. 65(2): 223-229. 
Zipfel, P. F. (1999). Complement: alternative pathway. Nature Encyclopedia of Life 
Sciences. London: Nature Publishing Group 
206 
IMAGING SERVICES NORTH 
Boston Spa, Wetherby 
West Yorkshire, LS23 7BQ 
www.bl.uk 
PUBLISHED PAPER 
EXCLUDED FROM 
DIGITISED THESIS 
PLEASE REFER TO THE 
ORIGINAL TEXT TO SEE 
. . 
. .. . THIS MATERIAL 
